
<html lang="en"     class="pb-page"  data-request-id="39d16bed-3139-489c-bd42-ed448663e9b5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b00750;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-15"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2S,3R)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid" /></meta><meta name="dc.Creator" content="Niels  Krogsgaard-Larsen" /></meta><meta name="dc.Creator" content="Morten  Storgaard" /></meta><meta name="dc.Creator" content="Charlotte  Møller" /></meta><meta name="dc.Creator" content="Charles S.  Demmer" /></meta><meta name="dc.Creator" content="Jeanette  Hansen" /></meta><meta name="dc.Creator" content="Liwei  Han" /></meta><meta name="dc.Creator" content="Rune N.  Monrad" /></meta><meta name="dc.Creator" content="Birgitte  Nielsen" /></meta><meta name="dc.Creator" content="Daniel  Tapken" /></meta><meta name="dc.Creator" content="Darryl S.  Pickering" /></meta><meta name="dc.Creator" content="Jette S.  Kastrup" /></meta><meta name="dc.Creator" content="Karla  Frydenvang" /></meta><meta name="dc.Creator" content="Lennart  Bunch" /></meta><meta name="dc.Description" content="Herein we describe the first structure–activity relationship study of the broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by exploring the pharmacological ..." /></meta><meta name="Description" content="Herein we describe the first structure–activity relationship study of the broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by exploring the pharmacological ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 22, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00750" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00750" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00750" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00750" /></link>
        
    
    

<title>Structure–Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2S,3R)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00750" /></meta><meta property="og:title" content="Structure–Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2S,3R)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0009.jpeg" /></meta><meta property="og:description" content="Herein we describe the first structure–activity relationship study of the broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by exploring the pharmacological effect of substituents in the 4, 4′, or 5′ positions and the bioisosteric substitution of the distal carboxylic acid for a phosphonic acid moiety. Of particular interest is a hydroxyl group in the 4′ position 2a which induced a preference in binding affinity for homomeric GluK3 over GluK1 (Ki = 0.87 and 4.8 μM, respectively). Two X-ray structures of ligand binding domains were obtained: 2e in GluA2-LBD and 2f in GluK1-LBD, both at 1.9 Å resolution. Compound 2e induces a D1–D2 domain opening in GluA2-LBD of 17.3–18.8° and 2f a domain opening in GluK1-LBD of 17.0–17.5° relative to the structures with glutamate. The pyrrolidine-2-carboxylate moiety of 2e and 2f shows a similar binding mode as kainate. The 3-carboxyphenyl ring of 2e and 2f forms contacts comparable to those of the distal carboxylate in kainate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00750"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00750">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00750&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00750&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00750&amp;href=/doi/10.1021/acs.jmedchem.5b00750" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6131-6150</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00737" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00773" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2<i>S</i>,3<i>R</i>)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niels++Krogsgaard-Larsen">Niels Krogsgaard-Larsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Morten++Storgaard">Morten Storgaard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charlotte++M%C3%B8ller">Charlotte Møller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+S.++Demmer">Charles S. Demmer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeanette++Hansen">Jeanette Hansen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liwei++Han">Liwei Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rune+N.++Monrad">Rune N. Monrad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Birgitte++Nielsen">Birgitte Nielsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Tapken">Daniel Tapken</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darryl+S.++Pickering">Darryl S. Pickering</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jette+S.++Kastrup">Jette S. Kastrup</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karla++Frydenvang">Karla Frydenvang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lennart++Bunch">Lennart Bunch</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Chemical Neuroscience Group, <sup>‡</sup>Biostructural Research Group, <sup>§</sup>Medicinal Chemistry Group, <sup>∥</sup>Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div><div class="corresp-info"><strong>*</strong>For L.B.: Phone, +45 35336244; E-mail, <a href="/cdn-cgi/l/email-protection#bad6dfd8cffac9cfd4de94d1cf94ded1"><span class="__cf_email__" data-cfemail="3a565f584f7a494f545e14514f145e51">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For K.F. (regarding the X-ray crystallographic work): phone, +45 35336207; E-mail, <a href="/cdn-cgi/l/email-protection#a8c3c9dac4c986cedad1cccdc6dec9c6cfe8dbddc6cc86c3dd86ccc3"><span class="__cf_email__" data-cfemail="c0aba1b2aca1eea6b2b9a4a5aeb6a1aea780b3b5aea4eeabb5eea4ab">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00750&amp;href=/doi/10.1021%2Facs.jmedchem.5b00750" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6131–6150</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 22, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 May 2015</li><li><span class="item_label"><b>Published</b> online</span>22 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00750" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00750</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6131%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNiels%2BKrogsgaard-Larsen%252C%2BMorten%2BStorgaard%252C%2BCharlotte%2BM%25C3%25B8ller%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b00750%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BIonotropic%2BGlutamate%2BReceptor%2BAntagonist%2B%25282S%252C3R%2529-3-%25283-Carboxyphenyl%2529pyrrolidine-2-carboxylic%2BAcid%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6150%26publicationDate%3DAugust%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00750"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1440</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00750" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2S,3R)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Niels&quot;,&quot;last_name&quot;:&quot;Krogsgaard-Larsen&quot;},{&quot;first_name&quot;:&quot;Morten&quot;,&quot;last_name&quot;:&quot;Storgaard&quot;},{&quot;first_name&quot;:&quot;Charlotte&quot;,&quot;last_name&quot;:&quot;Møller&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;S. Demmer&quot;},{&quot;first_name&quot;:&quot;Jeanette&quot;,&quot;last_name&quot;:&quot;Hansen&quot;},{&quot;first_name&quot;:&quot;Liwei&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Rune&quot;,&quot;last_name&quot;:&quot;N. Monrad&quot;},{&quot;first_name&quot;:&quot;Birgitte&quot;,&quot;last_name&quot;:&quot;Nielsen&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Tapken&quot;},{&quot;first_name&quot;:&quot;Darryl&quot;,&quot;last_name&quot;:&quot;S. Pickering&quot;},{&quot;first_name&quot;:&quot;Jette&quot;,&quot;last_name&quot;:&quot;S. Kastrup&quot;},{&quot;first_name&quot;:&quot;Karla&quot;,&quot;last_name&quot;:&quot;Frydenvang&quot;},{&quot;first_name&quot;:&quot;Lennart&quot;,&quot;last_name&quot;:&quot;Bunch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6131-6150&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00750&quot;},&quot;abstract&quot;:&quot;Herein we describe the first structure–activity relationship study of the broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by exploring the pharmacological effect of substituents in the 4, 4′, or 5′ positions and the bioisosteric substitution of the distal carboxylic acid for a phosphonic acid moiety. Of particular interest is a hydroxyl group in the 4′ position 2a which induced a preference in binding affinity for homomeric GluK3 over GluK1 (Ki = 0.87 and 4.8 μM, respectively). Two X-ray structures of ligand binding domains were obtained: 2e in GluA2-LBD and 2f in GluK1-LBD, both at 1.9 Å resolution. Compound 2e induces a D1–D2 domain opening in GluA2-LBD of 17.3–18.8° and 2f a domain opening in GluK1-LBD of 17.0–17.5° relative to the structures with glutamate. The pyrrolidine-2-carboxylate moiety of 2e and 2f shows a similar binding mode as kainate. The 3-carboxyphenyl ring of 2e and 2f forms contacts comparable to those of the distal carboxylate in kainate.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00750&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00750" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00750&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00750" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00750&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00750" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00750&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00750&amp;href=/doi/10.1021/acs.jmedchem.5b00750" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00750" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00750" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00750%26sid%3Dliteratum%253Aachs%26pmid%3D26200741%26genre%3Darticle%26aulast%3DKrogsgaard-Larsen%26date%3D2015%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BIonotropic%2BGlutamate%2BReceptor%2BAntagonist%2B%25282S%252C3R%2529-3-%25283-Carboxyphenyl%2529pyrrolidine-2-carboxylic%2BAcid%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D15%26spage%3D6131%26epage%3D6150%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/jmcmar.2015.58.issue-15/20150813/jmcmar.2015.58.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we describe the first structure–activity relationship study of the broad-range iGluR antagonist (2<i>S</i>,3<i>R</i>)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (<b>1</b>) by exploring the pharmacological effect of substituents in the 4, 4′, or 5′ positions and the bioisosteric substitution of the distal carboxylic acid for a phosphonic acid moiety. Of particular interest is a hydroxyl group in the 4′ position <b>2a</b> which induced a preference in binding affinity for homomeric GluK3 over GluK1 (<i>K</i><sub>i</sub> = 0.87 and 4.8 μM, respectively). Two X-ray structures of ligand binding domains were obtained: <b>2e</b> in GluA2-LBD and <b>2f</b> in GluK1-LBD, both at 1.9 Å resolution. Compound <b>2e</b> induces a D1–D2 domain opening in GluA2-LBD of 17.3–18.8° and <b>2f</b> a domain opening in GluK1-LBD of 17.0–17.5° relative to the structures with glutamate. The pyrrolidine-2-carboxylate moiety of <b>2e</b> and <b>2f</b> shows a similar binding mode as kainate. The 3-carboxyphenyl ring of <b>2e</b> and <b>2f</b> forms contacts comparable to those of the distal carboxylate in kainate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the mammalian central nervous system (CNS), (<i>S</i>)-glutamate (Glu) functions as the major excitatory neurotransmitter (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The glutamatergic neurotransmitter system is involved in a vast number of basic neurophysiological processes such as memory and cognition as well as neuronal plasticity and development.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7">(2-7)</a> Thus, psychiatric diseases or neurological disorders such as depression,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> anxiety,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> addiction,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> migraine,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and schizophrenia<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> may be directly related to disordered glutamatergic neurotransmission. Moreover, elevated synaptic Glu levels or excessive Glu signaling are neurotoxic and will ultimately cause neuronal death.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Thus, it is believed that neurodegenerative diseases such as Alzheimer’s,<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> Huntington’s,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> amyotrophic lateral sclerosis (ALS),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> cerebral stroke,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and epilepsy<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> may be due to malfunction of the glutamatergic neurotransmitter system, which may be overturned by action of small molecule Glu ligands.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Once released from the presynaptic neuron into the synapse, Glu activates a number of pre- and postsynaptic Glu receptors. On the basis of their pharmacological profile and ligand selectivity, the Glu receptors have been grouped in two main classes: the fast-acting ionotropic Glu receptors (iGluRs) comprising three groups, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (subunits GluA1–4), kainate (KA) receptors (subunits GluK1–5),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptors (subunits GluN1, GluN2A-D, and GluN3A,B),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and the G-protein coupled metabotropic Glu receptors (mGluRs, subunits mGluR1–8),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which produce a slower signal transduction through second messenger systems.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chemical Structures of Glu, iGluR Group-Defining Agonists AMPA, KA, and NMDA, Rationally Designed iGluR Antagonist <b>1</b>, and Reported iGluR Antagonists (All Values in μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0005.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">native iGluRs (synaptosomes)</th><th class="rowsep1 colsep0" colspan="4" align="center">cloned homomeric iGluRs</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">AMPA IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">KA IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">NMDA <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluA2 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK1 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK2 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK3 <i>K</i><sub>i</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">51</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">6.0</td><td class="colsep0 rowsep0" align="center">67</td><td class="colsep0 rowsep0" align="center">4.3</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATPO</td><td class="colsep0 rowsep0" align="center">16<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>100<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>100<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">60 ± 5</td><td class="colsep0 rowsep0" align="center">2.6 ± 0.4</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UBP282<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">9.25 (func)</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">--</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LY466195<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">269</td><td class="colsep0 rowsep0" align="center">0.05</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UBP310</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.022 ± 0.005</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.93 ± 0.12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">From ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">From ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">From ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">From ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>. Radioligands used for synaptosomal binding: AMPA, [<sup>3</sup>H](<i>RS</i>)-AMPA; KA, [<sup>3</sup>H]KA; NMDA, [<sup>3</sup>H]CGP 39653. Recombinant receptor binding: presented are mean values ± SEM of at least three experiments, conducted in triplicate at 12–16 drug concentrations. Radioligands used: GluA2, [<sup>3</sup>H](<i>RS</i>)-AMPA; GluK1–3, [<sup>3</sup>H](2<i>S</i>,4<i>R</i>)-4-methyl Glu (SYM2081). Hill coefficients were not different from unity. --, not available.</p></div></div></div><div class="NLM_p">Summarizing the field of the iGluR antagonists (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), AMPA/KA antagonists are well-known, as e.g., (<i>S</i>)-2-amino-3-[5-<i>tert</i>-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and (<i>S</i>)-4-((3-(2-amino-2-carboxyethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoic acid (UBP282).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In contrast, only subtype selective antagonists have been reported for GluK1, e.g., (3<i>S</i>,4a<i>R</i>,6<i>S</i>,8a<i>R</i>)-6-(((<i>S</i>)-2-carboxy-4,4-difluoropyrrolidin-1-yl)methyl)decahydroisoquinoline-3-carboxylic acid (LY466195)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and (<i>S</i>)-3-((3-(2-amino-2-carboxyethyl)-5-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiophene-2-carboxylic acid (UBP310).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, there is a striking unmet need for the discovery of selective antagonists for the GluA1–4 and GluK2–5 subunits, as such compounds serve as pharmacological tools for studying the role and function of the iGluRs under both physiological and pathological conditions. On the basis of conformational analysis of known iGluR antagonists and the vast structural information on the GluA2-LBD and GluK1-LBD, (2<i>S</i>,3<i>R</i>)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (<b>1</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was designed as a broad-acting iGluR antagonist.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Completing its synthesis, pharmacological characterization of <b>1</b> disclosed low-to-medium micromolar binding affinity to AMPA, KA, and NMDA receptors and functioned as an antagonist in a nondesensitizing functional GluK1 assay.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, the design of antagonist <b>1</b> was successful and it defined a new lead structure for the discovery of subunit selective iGluR antagonists. Herein, we describe the first structure–activity relationship (SAR) study of broad-acting iGluR antagonist <b>1</b> together with X-ray crystallographic structures of <b>2e</b> in GluA2-LBD and <b>2f</b> in GluK1-LBD.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of rationally designed analogues <b>2a</b>–<b>h</b> of lead structure <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is well-known that AMPA/KA receptors are highly dynamic in nature and that the degree of closure of the ligand binding domain (LBD) is connected to agonist vs antagonist function.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> The apo (unbound) form of the LBD adopts an open cleft conformation. Antagonists have been shown to stabilize this open cleft form, whereas agonists induce cleft closure to various extents. On the design of analogues of antagonist <b>1</b>, we were faced with two challenges: (a) synthetic feasibility and (b) ligand–receptor interactions probing for iGluR subunit selectivity. In terms of (a), the 2,4-<i>cis</i> position as well as the 4′- and 5′-positions appeared accessible based on synthetic methodology already described for this class of compounds. In terms of (b), the in silico predicted binding mode of antagonist <b>1</b> in the X-ray structure of GluA2-LBD with ATPO (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N0T">1N0T</a>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> suggests that a substituent in the 4′-position is directed into an area of the receptor presenting extensive hydrogen bonding capabilities, e.g., Ser673, Ser675, and Thr676 (GluA2 numbering with signal peptide), including harboring of a changing number of water molecules across the D1 and D2 domains. This area of the receptor is similar among the four GluA1–4 subunits but differs from and in between the five GluK1–5 subunits (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). We therefore designed ligands <b>2a</b> and <b>2e</b> for improved hydrogen bonding capabilities. We were also interested in investigating the effect of substituting the 3′-carboxylic acid with a phosphonic acid functionality, <b>2h</b>. Such substitution has previously led to selectivity for native AMPA receptors over KA and NMDA receptors, e.g., for antagonist ATPO.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> On the other hand, a substituent in the 5′-position of the phenyl ring is guided into a spacious conically shaped cleft between the D1 and D2 domains. Here, we envisaged that a lipophilic group could disrupt the water matrix and/or displace water molecules from the ligand binding pocket, thereby enhancing entropy contribution to ligand binding. This strategy gave rise to the synthesis of ligands <b>2b</b>–<b>d</b>. Finally, the analysis disclosed that a substituent in the 2,4-<i>cis</i> position is directed into a rigid area of the receptor, defined by the residues Glu423, Tyr471, and Pro499 (GluA2 numbering). Residues Glu423 and Tyr471 are conserved throughout GluA1–4 and GluK1–5, whereas Pro499 is different in GluK4,5. To investigate how the different receptor subtypes would respond, a small and larger lipophilic group were introduced, providing ligands <b>2f</b>,<b>g</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Docking of <b>1</b> into the Structure of GluA2-LBD in Complex with the Antagonist ATPO (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N0T">1N0T</a>) and Listing of GluA1–4 and GluK1–5 Amino Acid Residues (<i>Homo sapiens</i>), Which Define the D1–D2 Domain Ligand Binding Pocket (Highlighted in Green) As Well As Additional Residues within 4.5 Å Radius<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0006.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0007.gif" alt="" id="GRAPHIC-d829e791-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Residues of differentiation to GluA2 are highlighted in grey.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of compound <b>2a</b> commenced with double protection of commercially available optically pure (<i>S</i>)-5-(hydroxymethyl)-2-pyrrolidinone (<b>3</b>) to give <b>4</b> in high yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Subsequently, introduction of the double bond was carried out under standard selenylation conditions to give enone <b>5</b>. For target compound <b>2a</b>, the synthesis of suitably protected phenyl bromide <b>6a</b> was synthesized starting from commercially available phenolic alcohol <b>12</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Reduction of the lactam functionality by borane gave pyrrolidinone <b>8a</b> in low-to-acceptable yield (32–46%), with the byproduct being reductive opening of the isopropylidene group (determined by LC-MS). At this stage, a shortcut was attempted: full deprotection of pyrrolidinone <b>8a</b> in <i>p</i>-TsOH/MeOH at room temperature (rt) gave the expected phenolic diol <b>13</b> in high yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). However, oxidation to the corresponding diacid <b>14</b> was unsuccessful although several conditions were tried: RuCl<sub>3</sub>–NaIO<sub>4</sub>, TEMPO–NaOCl–NaClO<sub>2</sub>, Pd–C/O<sub>2</sub>/NaBH<sub>4</sub>, PDC in DMF, and KMnO<sub>4</sub> in acetone (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Instead, a ruthenium-catalyzed oxidation of pyrrolidinone <b>8a</b> gave the desired acid-lactone <b>10a</b>, together with acid <b>11</b> as the side product in a 1:2 ratio (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The two products were easily separated by flash chromatography, after which acid-lactone <b>10a</b> was fully deprotected in TFA/H<sub>2</sub>O to give target compound <b>2a</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>2a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBSCl, imidazole, DCM, rt, 24 h, aq workup, then BOC<sub>2</sub>O, DMAP, CH<sub>3</sub>CN, rt, 16 h (two steps, 91%); (b) LHMDS, PhSeCl, THF, −78 °C, then 30% H<sub>2</sub>O<sub>2</sub>, EtOAc, 0 °C to rt (two steps, 64%); (c) <b>6a</b>, <i>tert</i>-BuLi, CuCN, Et<sub>2</sub>O, −78 to −42 °C (70%); (d) BH<sub>3</sub>·THF, THF, reflux, 3.5 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 3.5 h (46%); (e) TBAF, THF, rt, 2 h (87%); (f) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 1.5 h (<b>10a</b>, 22%; <b>11</b>, 40%); (g) <b>10a</b> only, TFA:H<sub>2</sub>O (1:1), rt, 16 h (59%).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0015.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Bromide <b>6a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2-dimethoxypropane, ZnCl<sub>2</sub>, acetone, 40 °C, 1.5 h (88%).</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0016.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Attempted Oxidation of Phenolic Diol <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p</i>-TsOH, MeOH, rt, 5 h (71%).</p></p></figure><div class="NLM_p">The synthesis of target structures <b>2b</b>–<b>e</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) followed the strategy described for compound <b>2a</b> with only few changes. First, suitably protected phenyl bromides <b>6b</b>–<b>d</b> were prepared starting from commercially available acid <b>15</b> in two steps (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Because of the bulkiness of the phenyl bromides <b>6b</b>–<b>d</b>, conjugate addition to enone <b>5</b> was carried out by use of a mixed-cyano Gilman cuprate, as previously described by us to be advantageous for this specific enone.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Reduction of the lactam functionality gave pyrrolidinones <b>8a</b>–<b>d</b> in acceptable yields (51–60%), and fluoride facilitated removal of the TBS groups provided the free diols <b>9b</b>–<b>d</b> in high yield. Subsequent ruthenium-catalyzed oxidation to give diacids <b>10b</b>–<b>d</b> was carried out at 0 °C to prevent overoxidation of the electron-rich phenyl ring, resulting in the side product <i>N</i>-BOC-<span class="smallcaps smallerCapital">l</span>-<i>trans</i>-2,3-dicarboxy-pyrrolidine <b>17</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Finally, removal of the BOC-group under dry, acidic conditions gave target compounds <b>2b</b>–<b>d</b>, as the HCl salts in purities of 97–99% (HPLC). The 5′-phenolic analogue <b>2e</b> was obtained by hydrogenation of benzyloxy <b>2c</b> over Pd/C to give the desired product <b>2e</b> in 44% after purification by preparative HPLC.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>2b</b>–<b>e</b> and Chemical Structure of Side Product <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6b</b>–<b>d</b>, <i>tert</i>-BuLi, CuCN, lithium thiophene, Et<sub>2</sub>O, −78 to −42 °C (42–62%); (b) BH<sub>3</sub>·THF, THF, reflux, 20 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 1 h (51–60%); (c) TBAF, THF, rt, (92–94%); (d) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 2 h (66–83%); (e) 2 M HCl in Et<sub>2</sub>O, AcOH, rt, 18 h (87–99%); (f) <b>2c</b> only, H<sub>2</sub>(g), Pd/C (10%), AcOH, rt, 6 days (44%).</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted Phenylbromides <b>6b</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>·THF, THF, 0 °C to rt, aq workup, then TBSCl, imidazole, DMF, 0 °C to rt (71%); (b) for <b>6b</b>, <i>n</i>-PrBr, K<sub>2</sub>CO<sub>3</sub>, rt in DMF (90%); for <b>6c</b>,<b>d</b>, RBr, K<sub>2</sub>CO<sub>3</sub>, reflux in acetone (92–95%).</p></p></figure><div class="NLM_p">The synthesis of the two <i>cis</i>-2,4-substituted analogues <b>2f</b>,<b>g</b> commenced with a stereoselective alkylation of lactam <b>18</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> with allyl bromide and benzyl bromide to give <b>19a</b> and <b>19b</b>, respectively (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). In both cases, the expected 3,4-<i>trans</i> relationship, being energetically favored over the 3,4-<i>cis</i> relationship, was determined by COSY and HMQC NMR experiments. The subsequent sequence of reactions followed the strategy described for proline analogues <b>2a</b>–<b>e</b>: reduction of the lactam functionality to give <b>20a</b>,<b>b</b>, hereafter removal of the TBS-groups to give diols <b>21a</b>,<b>b</b>, followed by oxidation to diacids <b>22a</b>,<b>b</b>, and finally removal of the BOC group to give the target compounds <b>2f</b> and <b>2g</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>cis</i>-2,4-Substituted Target Compounds <b>2f</b> and <b>2g</b> from Intermediate <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, RBr, THF −42/–52 °C (49% and 72%); (b) for <b>19a</b>, first H<sub>2</sub>, Pd/C, rt, then for both <b>19a</b>,<b>b</b>, BH<sub>3</sub>·THF, THF, reflux, 20 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 1 h (59% and 30%); (c) TBAF, THF, rt, (89% and 79%); (d) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 2 h (93% and 45%); (e) HCl in AcOH, rt, 18 h (82% and 69%).</p></p></figure><div class="NLM_p">As for <b>2a</b>–<b>g</b>, the synthesis of <b>2h</b> also commenced with a 1,4-addition of a cuprate to enone <b>5</b> to give adduct <b>23</b> as a single diastereomer, determined by <sup>1</sup>H NMR (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Chemoselective reduction of the lactam with a solution of BH<sub>3</sub>·THF under reflux conditions afforded pyrrolidine <b>24</b>. At this stage, the phosphonate was introduced by metal–halogen exchange of the 3′-bromine with <i>n</i>-BuLi followed by addition of ClPO<sub>3</sub>Et<sub>2</sub> to give <b>25</b>.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Removal of the TBS protection group by treatment with TBAF led to alcohol <b>26</b>, which was oxidized according to the modified Sharpless procedure using a catalytic amount of Ru(III) and periodate as the co-oxidant to give acid <b>27</b>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Purification of <b>27</b> on silica gel was accompanied by hydrolysis of the phosphonate ester, even with prior washing with NEt<sub>3</sub>. For this reason, crude <b>27</b> underwent global deprotection in 2 M HCl to give desired product <b>2h</b>, which was then purified by HPLC.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Strategy for the Synthesis of <b>2h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-dibromobenzene, <i>n</i>-BuLi, CuCN, TMSCl, THF, −50 °C (63%); (b) BH<sub>3</sub>·THF then NaOH, H<sub>2</sub>O<sub>2</sub> (73%); (c) <i>n</i>-BuLi, ClPO<sub>3</sub>Et<sub>2</sub>, THF, −78 °C (66%); (d) TBAF, THF rt, (65%); (e) RuCl<sub>3</sub>, NaIO<sub>4</sub>, H<sub>2</sub>O, CH<sub>3</sub>CN, EtOAc, rt (82%); (f) 2 N HCl, H<sub>2</sub>O, 80 °C (40%).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pharmacological Characterization</h3><div class="NLM_p">All analogues <b>2a</b>–<b>h</b> were characterized pharmacologically in radioligand binding assays at native iGluRs (rat synaptosomes) and cloned rat homomeric subtypes, GluK1–3 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). 4′-Hydroxy analogue <b>2a</b> displayed a generally higher binding affinity for the iGluRs in native tissue and reduced iGluR class selectivity compared to lead structure <b>1</b>. In detail, a 25- and 15-fold higher affinity for AMPA and KA receptors was observed, while a 6-fold higher affinity at NMDA receptors could be demonstrated. However, most interestingly, <b>2a</b> displayed a 10-fold increase in binding affinity for homomeric GluK3 (<i>K</i><sub>i</sub> = 0.87 μM), while affinity for homomeric GluK1 and GluK2 was essentially unchanged. This 5-fold preference for GluK3 over GluK1 (<i>K</i><sub>i</sub> = 4.8 μM) is indeed a unique binding affinity profile for a KA receptor antagonist and encourages future structure–activity relationship (SAR) investigations of the 4′-position. Furthermore, as the binding affinity profile of the 5′-hydroxy analogue <b>2e</b> is essentially unchanged compared to lead structure <b>1</b>, this strengthens the interest in the 4′-position as a point of modification to obtain receptor selectivity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Chemical Structures and Binding Affinities of Analogues <b>2a</b>–<b>g</b> at Native iGluRs (Rat Synaptosomes) and Homomeric Recombinant iGluRs (All Values in μM)<a class="ref internalNav" href="#t3fn5" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0008.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">native iGluRs (synaptosomes)<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="4" align="center">cloned homomeric iGluRs<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">AMPA IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">KA IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">NMDA <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluA2 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK1 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK2 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">GluK3 <i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i>1/<i>K</i>3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">51</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">6.0</td><td class="colsep0 rowsep0" align="center">67</td><td class="colsep0 rowsep0" align="center">4.3</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">8.1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="center">HO–</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">2.0 [5.71 ± 0.03]</td><td class="colsep0 rowsep0" align="center">1.4 [5.87 ± 0.07]</td><td class="colsep0 rowsep0" align="center">1.0 [6.02 ± 0.11]</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">4.8 ± 1.5</td><td class="colsep0 rowsep0" align="center">10–100<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.87 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">PrO–</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">25 [20;30]</td><td class="colsep0 rowsep0" align="center">7.2 [6.4;8.0]</td><td class="colsep0 rowsep0" align="center">5.0 [3.9;6.4]</td><td class="colsep0 rowsep0" align="center">35 ± 0.29</td><td class="colsep0 rowsep0" align="center">1.7 ± 0.05</td><td class="colsep0 rowsep0" align="center">56 ± 1.4</td><td class="colsep0 rowsep0" align="center">2.7 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">BnO–</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">6.3 [5.20 ± 0.04]</td><td class="colsep0 rowsep0" align="center">6.7 [5.18 ± 0.06]</td><td class="colsep0 rowsep0" align="center">4.1 [5.41 ± 0.10]</td><td class="colsep0 rowsep0" align="center">6.45 ± 0.29</td><td class="colsep0 rowsep0" align="center">3.7 ± 0.80</td><td class="colsep0 rowsep0" align="center">32 ± 2.5</td><td class="colsep0 rowsep0" align="center">2.1 ± 0.40</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">mPh-BnO–</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">4.9 [5.34 ± 0.09]</td><td class="colsep0 rowsep0" align="center">12 [4.92 ± 0.03]</td><td class="colsep0 rowsep0" align="center">4.0 [5.41 ± 0.08]</td><td class="colsep0 rowsep0" align="center">6.10 ± 0.32</td><td class="colsep0 rowsep0" align="center">8.7 ± 1.2</td><td class="colsep0 rowsep0" align="center">68 ± 7.6</td><td class="colsep0 rowsep0" align="center">8.6 ± 0.60</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">HO–</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">54 [4.28 ± 0.05]</td><td class="colsep0 rowsep0" align="center">34 [4.52 ± 0.11]</td><td class="colsep0 rowsep0" align="center">5.4 [5.27 ± 0.04]</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">8.3 ± 0.20</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">8.5 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">Pr–</td><td class="colsep0 rowsep0" align="center">48[4.32 ± 0.03]</td><td class="colsep0 rowsep0" align="center">22[4.72 ± 0.11]</td><td class="colsep0 rowsep0" align="center">25[4.61 ± 0.03]</td><td class="colsep0 rowsep0" align="center">--</td><td class="colsep0 rowsep0" align="center">0.62 ± 0.10</td><td class="colsep0 rowsep0" align="center">81 ± 8.3</td><td class="colsep0 rowsep0" align="center">2.2 ± 0.37</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">Bn–</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">8.8 ± 1.5</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">34 ± 1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">130 ± 26</td><td class="colsep0 rowsep0" align="center">>1000</td><td class="colsep0 rowsep0" align="center">78 ± 0.80</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn5"><div class="footnote" id="t3fn5"><sup>a</sup><p class="last">-, H. --, value not determined.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Data are mean values of three to six individual experiments performed in triplicate. For AMPA and KA: pIC<sub>50</sub> values with SEM in brackets. For NMDA: p<i>K</i><sub>i</sub> values with SEM in brackets.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">IC<sub>50</sub> values of two experiments. pIC<sub>50</sub> is given in parentheses [mean ± SEM].</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">Values obtained from ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>.</p></div><div class="footnote" id="t3fn4"><sup>e</sup><p class="last">Mean ± SEM has not been included for <b>2a</b> due to limited amount of compound available. </p></div></div></div><div class="NLM_p">Lipophilic 5′-ethers <b>2b</b>–<b>d</b> displayed increased affinity for native AMPA receptors (up to 10-fold) with increasing steric bulk of the 5′-substituent, while binding affinities at KA and NMDA receptors were largely unaffected. At cloned homomeric GluK1–3 the three analogues <b>2b</b>–<b>d</b> displayed only modest changes in affinity as compared to <b>1</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>); a general 4-fold increase was observed for <b>2b</b>, whereas <b>2c</b> only displayed a 4-fold higher affinity for GluK2 and −3. Analogue <b>2d</b> displayed slightly lower affinity for GluK1, midmicromolar affinity for GluK2, and comparable affinity for GluK3 with lead structure <b>1</b>. Together, these data suggest that a lipophilic side chain in the 5′-position is directed into the spacious compartment in the receptors located between the D1 and D2 domains, in agreement with preliminary structural data (see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>). By further exploring and targeting differences in amino acid residues in this area of the receptors, it may be possible to achieve class or subtype selectivity.</div><div class="NLM_p">The influence of placing a substituent in the 2,4-<i>cis</i>-position was explored by the design and synthesis of analogues <b>2f</b> and <b>2g</b>. An <i>n</i>-propyl group, analogue <b>2f</b>, induced an 8-fold increase in affinity for GluK1 (<i>K</i><sub>i</sub> = 0.62 μM) and a 4-fold increase in affinity for GluK3. At the same time, native AMPA and KA receptors were unaffected, whereas a 4-fold decrease in affinity for native NMDA receptors was observed. Introduction of a benzyl group in the very same position, analogue <b>2g</b>, led to a noticeable reduction in binding affinity at all iGluRs, except for subtype GluK1 at which it displayed affinity in the low micromolar range (<i>K</i><sub>i</sub> = 8.8 μM).</div><div class="NLM_p last">Phosphonic acid <b>2h</b> displayed negligible affinity (12–30% displacement at 100 μM) at native AMPA, KA, and NMDA receptors. At cloned homomeric GluA2 receptors binding affinity was also low (3 ± 3% displacement at 100 μM). <b>2h</b> also displayed low affinity at cloned homomeric GluK1 and GluK3 receptors (<i>K</i><sub>i</sub> = 130 and 78 μM, respectively) and no affinity for GluK2 subtype (<i>K</i><sub>i</sub> >1 mM). In comparison with <b>1</b> and ATPO, the low-affinity pharmacological profile of <b>2h</b> is unexpected and the underlying origin remains to be understood.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> X-ray Crystal Structure of <b>2e</b> in GluA2-LBD and <b>2f</b> in GluK1-LBD</h3><div class="NLM_p">To unequivocally determine the binding mode of the core scaffold and obtain structural insight into how substituents in the 5′-position (R<sup>2</sup> groups) and 4-position (R<sup>3</sup> groups) are accommodated by iGluR proteins, we attempted to crystallize analogues <b>2c</b>, <b>2d</b>, <b>2e</b>, and <b>2f</b> in GluA2-LBD and GluK1-LBD. Crystals suitable for data collection were obtained of <b>2c</b>, <b>2d</b>, and <b>2e</b> in GluA2-LBD and of <b>2f</b> in GluK1-LBD.</div><div class="NLM_p">The structure of GluA2-LBD with <b>2e</b> was determined at 1.9 Å resolution (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) and comprises two molecules in the asymmetric unit of the crystal, forming a dimer (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). The compound <b>2e</b> induces a D1–D2 domain opening in GluA2-LBD of 18.8° (molA) and 17.3° (molB) relative to the structure of GluA2-LBD with glutamate (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTJ">1FTJ</a>, molB). This domain opening is similar to that observed with the antagonist DNQX (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTL">1FTL</a>) (17.4° (molA) and 15.9° (molB)). On the basis of the close structural relationship to the parent antagonist <b>1</b>, combined with a domain opening typical of antagonists, it suggests that compound <b>2e</b> also acts as an antagonist.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Crystal Data, Data Collection, and Refinement Statistics of GluA2-LBD in Complex with <b>2e</b> and GluK1-LBD in Complex with <b>2f</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">GluA2-LBD with <b>2e</b></th><th class="colsep0 rowsep0" align="center">GluK1-LBD with <b>2f</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Crystal Data</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beamline</td><td class="colsep0 rowsep0" align="left">I911-3</td><td class="colsep0 rowsep0" align="left">I911-3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub></td><td class="colsep0 rowsep0" align="left"><i>P</i>4<sub>1</sub>2<sub>1</sub>2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell dimensions</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i> (Å)</td><td class="colsep0 rowsep0" align="left">48.88</td><td class="colsep0 rowsep0" align="left">71.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>b</i> (Å)</td><td class="colsep0 rowsep0" align="left">65.25</td><td class="colsep0 rowsep0" align="left">71.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">91.55</td><td class="colsep0 rowsep0" align="left">230.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β (deg)</td><td class="colsep0 rowsep0" align="left">92.36</td><td class="colsep0 rowsep0" align="left">90.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">molecules in a.u.<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Data Collection</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">36.39–1.89 (2.00–1.89)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">44.90–1.93 (2.03–1.93)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique reflections</td><td class="colsep0 rowsep0" align="left">45862</td><td class="colsep0 rowsep0" align="left">46519</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">average multiplicity</td><td class="colsep0 rowsep0" align="left">4.2 (4.1)</td><td class="colsep0 rowsep0" align="left">7.5 (6.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">100 (100)</td><td class="colsep0 rowsep0" align="left">100 (100)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wilson <i>B</i>-factor (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">20.9</td><td class="colsep0 rowsep0" align="left">18.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub> (%)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">8.3 (37.2)</td><td class="colsep0 rowsep0" align="left">7.1 (33.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>I</i>/σ<i>I</i></td><td class="colsep0 rowsep0" align="left">6.3 (2.0)</td><td class="colsep0 rowsep0" align="left">6.1 (2.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Refinement</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amino acid residues</td><td class="colsep0 rowsep0" align="left">518</td><td class="colsep0 rowsep0" align="left">507</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand molecules</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="left">698</td><td class="colsep0 rowsep0" align="left">488</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycerol/ethylene glycol/PEG</td><td class="colsep0 rowsep0" align="left">2/2/0</td><td class="colsep0 rowsep0" align="left">0/1/1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sulfate/acetate/chloride</td><td class="colsep0 rowsep0" align="left">6/1/0</td><td class="colsep0 rowsep0" align="left">0/4/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub> (%)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a>/R<sub>free</sub> (%)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">17.1/22.9</td><td class="colsep0 rowsep0" align="left">17.9/22.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">average <i>B</i> values (Å<sup>2</sup>) for:</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">residues/ligands</td><td class="colsep0 rowsep0" align="left">27.0/18.9</td><td class="colsep0 rowsep0" align="left">29.4/17.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="left">32.8</td><td class="colsep0 rowsep0" align="left">29.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycerol/ethylene glycol/PEG</td><td class="colsep0 rowsep0" align="left">47.8/49.8/–</td><td class="colsep0 rowsep0" align="left">–/63.9/57.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sulfate/acetate/chloride</td><td class="colsep0 rowsep0" align="left">90.6/45.0/–</td><td class="colsep0 rowsep0" align="left">–/40.6/40.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd bond length (Å)/angles (deg)</td><td class="colsep0 rowsep0" align="left">0.006/1.0</td><td class="colsep0 rowsep0" align="left">0.009/1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ramachandran favored/outliers (%)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">99.2/0.0</td><td class="colsep0 rowsep0" align="left">98.5/0.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">a.u.: asymmetric unit.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Numbers in parentheses are for the outermost bin.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">A measure on agreement among multiple measurements of the same reflections. <i>R</i><sub>merge</sub> is calculated as follows: <i>I</i><sub><i>i</i></sub>(<i>hkl</i>) is the intensity of an individual measurement of the reflection with Miller indices <i>hkl</i>, and <i>I</i>(<i>hkl</i>) is the intensity from multiple observations. <i>R</i><sub>merge</sub> = ∑<sub><i>hkl</i></sub> ∑<sub><i>i</i></sub>|<i>I</i><sub><i>i</i></sub>(<i>hkl</i>) – <i>I</i>(<i>hkl</i>)| /∑<sub><i>hkl</i></sub> ∑<sub><i>i</i></sub>|<i>I</i><sub><i>i</i></sub>(<i>hkl</i>)|.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last"><i>R</i><sub>work</sub> = ∑<sub><i>hkl</i></sub> (||<i>F</i><sub>o</sub>,<sub><i>hkl</i></sub>| – |<i>F</i><sub>c</sub>,<sub>hkl</sub>||)/|<i>F</i><sub>o</sub>,<sub><i>hkl</i></sub>|, where |<i>F</i><sub>o</sub>,<sub><i>hkl</i></sub>| and |<i>F</i><sub>c</sub>,<sub><i>hkl</i></sub>| are the observed and calculated structure factor amplitudes.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last"><i>R</i><sub>free</sub> is equivalent to <i>R</i><sub>work</sub> but calculated with 5% reflections omitted from the refinement process.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">The Ramachandran plots were calculated using PHENIX.</p></div></div></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand binding domain of GluA2 in complex with <b>2e</b>. (A) Cartoon representation of the GluA2-LBD dimer (molA cyan and molB light cyan) with <b>2e</b> (gray space fill representation) bound at the binding site. (B) Zoom on the binding site (molA). Possible hydrogen bonds (up to 3.2 Å) between <b>2e</b> and GluA2, as well as to water molecules and a putative sulfate ion, are displayed as black dashes. Indirect interactions through water and sulfate are shown as red dashes. The electron density map (omit 2m<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) is shown at 1.0 σ and carved around the ligand at 1.6 Å radius. (C) Comparison of the structures of GluA2-LBD with <b>2e</b> (gray) and kainate (light pink; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FW0">1FW0</a>). The structures were superimposed on domain D1 residues. GluA2 residues for complex with kainate are shown in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pyrrolidine-carboxylate group of <b>2e</b> forms a salt bridge to the D1 residue Arg506 (side chain guanidinium group) and a charge-assisted hydrogen bond to Thr501 (backbone NH) as well as to one water molecule (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). The pyrrolidine-nitrogen atom forms a charge-assisted hydrogen bond to the D1 residue Pro499 (backbone carbonyl oxygen) and a salt bridge to the D2 residue Glu726 (side chain carboxylate). Thus, the pyrrolidine-2-carboxylate moiety of <b>2e</b> has similar binding mode as that of kainate (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> However, the orientation of the side chain of Thr501 is different in the two structures. In the structure of GluA2-LBD with kainate, the side chain hydroxyl group forms a hydrogen bond to the carboxylate of Glu726, whereas in the structure with <b>2e</b>, the two side chains are too far apart. Instead, the hydroxyl group makes a hydrogen bond to the side chain of Arg506 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C).</div><div class="NLM_p">The 3-phenyl moiety of <b>2e</b> holds a 3′-carboxylate and a 5′-hydroxyl group both capable of forming polar contacts (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). The 3′-carboxylate of <b>2e</b> forms charge-assisted hydrogen bonds to the D2 residue Thr676 (backbone NH as well as side chain hydroxyl group) and water molecules. These contacts are comparable to those of the distal carboxylate in kainate, but the larger 3-carboxyphenyl moiety of <b>2e</b> leads to a larger domain opening (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C) compared to that in the structure of GluA2-LBD with kainate (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FW0">1FW0</a>, 10.7°). The 5′-hydroxyl group of <b>2e</b> makes only indirect contacts to GluA2-LBD, through a water molecule to Ser673 (backbone carbonyl oxygen) and a putative sulfate ion to Tyr471 (backbone NH) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). The lack of direct contacts from the 5′-hydroxyl group of <b>2e</b> might explain why <b>2e</b> has a similar binding affinity as the parent compound <b>1</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and a lower binding affinity at AMPA receptors compared to compounds containing larger substituents at this position (<b>2b</b>–<b>d</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). When comparing <b>2e</b> with compound <b>2a</b>, the only difference is that the hydroxyl group is positioned in the 4′-position and this leads to an approximately 25-fold better binding affinity at AMPA receptors (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Assuming a similar binding mode of <b>2a</b> and <b>2e</b> in GluA2-LBD, the 4′-hydroxyl group in <b>2a</b> will form a direct hydrogen bond to Ser673, which most likely explains the observed difference in binding affinities. Compound <b>2e</b> was found to possess similar binding affinities at AMPA and kainate receptors (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), in agreement with the fact that the four binding site residues making direct polar contacts to <b>2e</b> are conserved in most AMPA and kainate receptor subunits: the essential Arg506 (GluA2 numbering), Pro499 (except in GluK4 and GluK5 where it is Gly and Ala, respectively), Thr501 (except in GluK2 where it is Ala), and Glu726 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, <b>2e</b> forms polar contacts to backbone atoms only in Pro499 and Thr501.</div><div class="NLM_p">GluK1-LBD was successfully crystallized with the most active compound <b>2f</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), allowing exploration of how substituents on the pyrrolidine-2-carboxylic acid moiety of <b>1</b> affect the binding mode. The complex crystallized with two molecules in the asymmetric unit of the crystal (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) and the structure was determined at 1.9 Å resolution (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The pyrrolidine carboxylate and nitrogen of analogue <b>2f</b> form similar contacts to GluK1 as kainate<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and analogue <b>2e</b> in GluA2, i.e., residues Pro531, Thr533, Arg538, and Glu753 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). However, the <i>n</i>-propyl substituent in analogue <b>2f</b> leads to a different pyrrolidine ring conformation compared to that in kainate (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C), as the <i>n</i>-propyl group would otherwise clash with Glu456. Instead, the <i>n</i>-propyl group is squeezed in between the residues Glu456 and Ser756. A domain opening in the GluK1-LBD structure with analogue <b>2f</b> is calculated to 17.0° (molA) and 17.5° (molB). The carboxylate group in the 3-carboxyphenyl moiety of analogue <b>2f</b> forms charge-assisted hydrogen bonds to the D2 residues Thr705 (side chain hydroxyl group) and Glu753 (backbone NH) as well as water molecules. It is evident that only limited space is available for a substituent in the 4-position as the more bulky benzyl substituent, analogue <b>2g</b>, results in a significant decrease in affinity for all iGluRs compared to <b>2f</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ligand binding domain of GluK1 in complex with <b>2f</b>. (A) Cartoon representation of the GluK1-LBD dimer (mol A forest green; mol B green) with <b>2f</b> (yellow space fill representation) bound at the binding site. (B) Zoom on the binding site (molA). Possible hydrogen bonds (up to 3.2 Å) between <b>2f</b> and GluK1 as well as to water molecules are displayed as black dashes. The electron density map (omit 2m<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) is shown at 1.0 σ and carved around the ligand at 1.6 Å radius. (C) Comparison of the structures of GluK1-LBD with <b>2f</b> and kainate (light pink; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E0X">4E0X</a>). The structures were superimposed on domain D1 residues. GluK1 residues are shown in white for complex with kainate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The structure of GluA2-LBD with <b>2c</b> did unfortunately not allow unambiguous assignment of the ligand despite a resolution of 1.8 Å. The structure of GluA2-LBD in complex with <b>2d</b> was solved at 3.0 Å resolution. The data were processed in space group <i>P</i>1 with 16 molecules in the asymmetric unit of the crystal (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>). After refinement, <i>R</i>/<i>R</i><sub>free</sub> values were high, and therefore space group <i>P</i>2<sub>1</sub> was investigated but resulted in even higher <i>R</i><sub>merge</sub> for low angle reflections and higher <i>R</i>/<i>R</i><sub>free</sub> values. However, the partly refined structure of GluA2-LBD with <b>2d</b> clearly showed the same domain opening (17.1–17.6°) and binding mode of the pyrrolidine-2-carboxylic acid moiety of <b>2d</b> as compound <b>2e</b>. The biphenyl moiety of <b>2d</b> reaches into a new area of the ligand binding cleft, with the biphenyl moiety positioned out of the cleft (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, we have designed and synthesized seven analogues <b>2a</b>–<b>g</b> of the broad-range iGluR antagonist <b>1</b> and characterized them in binding affinity studies as ligands for the iGluRs. Most interestingly, the introduction of a 4′-hydroxyl group (compound <b>2a</b>) induced a 10-fold increase in affinity for GluK3, resulting in a 5-fold preference over the GluK1 subtype. This shift in GluK1/3 affinity ratio is an important step toward the discovery of fully selective GluK3 antagonists. In contrast, the 5′-hydroxyl regioisomer <b>2e</b> did not display an altered affinity profile as compared to lead structure <b>1</b>, underlining that subtle chemical differences induce major changes in the pharmacological profile. Lipophilic substituents in the 5′ position (compounds <b>2b</b>–<b>d</b>) did not induce a remarkable change in the pharmacological profile, whereas a lipophilic substituent in the <i>cis</i>-2,4-position led to an 8-fold higher affinity for GluK1, a 4-fold increase in affinity for GluK3 and a 4-fold reduced affinity for native NMDA receptors (compound <b>2f</b>). A benzyl group in the very same <i>cis</i>-2,4-position (compound <b>2g</b>) reduced the affinity for all iGluRs except for GluK1.</div><div class="NLM_p">X-ray crystal structures of analogue <b>2e</b> in GluA2-LBD and analogue <b>2f</b> in GluK1-LBD were obtained. The pyrrolidine-2-carboxylic acid moiety of analogues <b>2e</b> and <b>2f</b> shows a similar binding mode as in kainate, while the 3-(3-carboxy)-phenyl group in analogues <b>2e</b> and <b>2f</b> induces the change in receptor domain opening (antagonist states). This is in accordance with modeling data during the design phase of lead structure <b>1</b>.</div><div class="NLM_p last">All together, the findings in this study add to the growing pool of insight into the SAR of the iGluRs to facilitate the discovery of new truly subunit selective iGluR antagonists.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p">All reagents were obtained from commercial suppliers and used without further purification. THF was distilled over sodium/benzophenone. Et<sub>2</sub>O was dried over neatly cut sodium. All solvents were analyzed for water content using a Karl Fisher apparatus. Water or air sensitive reactions were conducted in flame-dried glassware under an atmosphere of nitrogen with the syringe–septum cap technique. Purification by DCVC (dry column vacuum chromatography) was performed with silica gel size 25–40 μm (Merck, Silica gel 60). For TLC, Merck TLC Silica gel F<sub>254</sub> with appropriate spray reagents was used: KMnO<sub>4</sub> or molybdenum blue. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained on a Varian Mercury Plus (300 MHz) and a Varian Gemini 2000 instrument (75 MHz), respectively. Preparative HPLC was done using an Agilent Prep HPLC system with consisting of an Agilent 1100 series pump, Agilent 1200 series diode array, multiple wavelength detector (G1365B), connected to an Agilent PrepHT high performance preparative cartridge column (Zorbax, 300 SB-C18 Prep HT, 21.2 mm × 250 mm, 7 μm) with a flow-rate of 20 mL/min. Alternatively, preparative HPLC was performed using Spectraseries UV100 detector with a JASCO 880-PU HPLC pump and a Merck Hitachi D-2000 Chromato Integrator connected to XTerraPrep MS C18 (10 μm, 10 mm × 300 mm) column with a flow-rate of 10 mL/min. LC-MS was performed using an Agilent 1200 series solvent delivery system equipped with an autoinjector coupled to an Agilent 6400 series triple quadrupole mass spectrometer equipped with an electrospray ionization source gradient of the binary solvent system of H<sub>2</sub>O/CH<sub>3</sub>CN/formic acid (A:90/10/0.05, and B: 10/90/0.046) were employed. Optical rotation was measured using a PerkinElmer 241 spectrometer, with Na lamp at 589 nm. Melting points were measured using an automated melting point apparatus, MPA100 OptiMelt (SRS), and are uncorrected. Compounds were dried either under high vacuum or freeze-dried using a Holm & Halby, Heto LyoPro 6000 freeze dryer.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (2<i>S</i>,3<i>R</i>)-3-(3-Carboxy-4-hydroxyphenyl)pyrrolidine-2-carboxylic Acid Trifluoroacidic Acid (<b>2a</b>)</h5><div class="NLM_p last">The carboxylic acid (44 mg, 0.11 mmol, 1.00 equiv) was dissolved in TFA:H<sub>2</sub>O (1:1) (4 mL) and stirred 18 h at rt. The clear, colorless reaction mixture was concentrated in vacuo and afterward azeotropically concentrated using CH<sub>3</sub>CN (5 × 10 mL) and then lyophilized overnight to remove the remaining water. The brownish viscous oil (34 mg, 83%) was trituated with ice-cold Et<sub>2</sub>O (2 × 1 mL) by which the product precipitated. The final product was dried using high vacuum to yield <b>2a</b> (24 mg, 59%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.77 (1H, s), 7.36 (1H, d, <i>J</i> = 8.1 Hz), 6.81 (1H, d, <i>J</i> = 8.6 Hz), 4.10–4.04 (2H, m), 3.42 (2H, t, <i>J</i> = 8.4 Hz), 3.26–3.18 (1H, m), 3.15–3.06 (2H, m), 2.36–2.27 (1H, m), 2.13–2.05 (1H, m), 2.00–1.91 (1H, m). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.6, 171.5, 170.0, 169.7, 160.9, 133.3, 129.4, 129.0, 116.7, 64.6, 60.0, 46.8, 45.5, 45.3, 43.1, 33.5, 26.8. MS (<i>m</i>/<i>z</i>) calcd for C<sub>12</sub>H<sub>14</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 252.1, found 252.1. HPLC (254 nm) >99%; [α]<sup>25</sup><sub>D</sub> −65.7° (<i>c</i> = 0.067, 10% DMSO in H<sub>2</sub>O); mp 172–178 °C (decomp).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (2<i>S</i>,3<i>R</i>)-3-(3-Carboxy-5-propoxyphenyl)pyrrolidine-2-carboxylic Acid Hydrochloride (<b>2b</b>)</h5><div class="NLM_p last">Protected amine <b>10b</b> (180 mg, 0.46 mmol, 1.00 equiv) was dissolved in AcOH (2.5 mL) and 2 M HCl in Et<sub>2</sub>O was added (2.5 mL, 5.0 mmol, 11 equiv). The mixture was left to stir under an atmosphere of nitrogen at rt for 18 h. The mixture was suspended in H<sub>2</sub>O (10 mL), solidified by cooling on a dry ice/acetone bath, and lyophilized to yield <b>2b</b> (149 mg, 99%) as a slightly off-white, crisp solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.51 (1H, m), 7.30 (1H, m), 7.28 (1H, m), 4.17 (1H, m), 3.96 (2H, m), 3.54 (1H, m), 3.41 (1H, m), 3.23 (1H, m), 2.36 (1H, m), 2.01 (1H, m), 1.73 (2H, m), 0.98 (3H, t, <i>J</i> = 7 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.6, 166.8, 158.7, 142.5, 132.2, 120.8, 118.6, 112.9, 69.2, 64.3, 47.3, 45.2, 33.6, 22.1, 10.5. MS: (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 294.1, found: 294.2. HPLC (254 nm) 99.4%; [α]<sup>35</sup><sub>D</sub> +42.1° (<i>c</i> = 0.43, abs EtOH:H<sub>2</sub>O (3:1)).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (2<i>S</i>,3<i>R</i>)-3-(3-(Benzyloxy)-5-carboxyphenyl)pyrrolidine-2-carboxylic Acid Hydrochloride (<b>2c</b>)</h5><div class="NLM_p last">To protected amine <b>10c</b> (302 mg, 0.68 mmol, 1.00 equiv) dissolved in AcOH (4 mL) was added 2 M HCl in Et<sub>2</sub>O (4 mL, 8 mmol, 11.8 equiv). The mixture was left to stir under an atmosphere of nitrogen at rt for 18 h. The mixture was suspended in H<sub>2</sub>O (20 mL), solidified by cooling on a dry ice/acetone bath, and freeze-dried to yield <b>2c</b> (228 mg, 88%) as a slightly off-white, crisp solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.53 (1H, bs), 7.56 (1H, m), 7.49–7.28 (7H, m), 5.15 (2H, s), 4.19 (0.9H, d, <i>J</i> = 8 Hz), 4.04 (0.1H, d, <i>J</i> = 11 Hz), 3.56 (1H, q, <i>J</i> = 9 Hz), 3.48–3.05 (2H, m), 2.37 (1H, m), 2.01 (1H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 166.8, 158.4, 142.5, 136.6, 132.2, 128.3, 127.8, 127.7, 121.2, 119.1, 113.3, 69.5, 64.2, 47.2, 45.3, 33.6. MS (<i>m</i>/<i>z</i>) calcd for C<sub>19</sub>H<sub>20</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 342.1, found: 342.2. HPLC (254 nm) 97%; [α]<sup>35</sup><sub>D</sub> −11.5° (<i>c</i> = 0.41, abs EtOH:DMSO (3:1)).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (2<i>S</i>,3<i>R</i>)-3-(3-([1,1′-Biphenyl]-3-ylmethoxy)-5-carboxyphenyl)pyrrolidine-2-carboxylic Acid Hydrochloride (<b>2d</b>)</h5><div class="NLM_p last">Protected amine <b>10d</b> (247 mg, 0.48 mmol, 1.0 equiv) was dissolved in AcOH (4 mL) and 2 M HCl in Et<sub>2</sub>O was added (4 mL, 8 mmol, 16.7 equiv). The mixture was left to stir under an atmosphere of nitrogen at rt for 18 h. The mixture was suspended in H<sub>2</sub>O (20 mL), solidified by cooling on a dry ice/acetone bath, and lyophilized to yield <b>2d</b> (188 mg, 87%) as a slightly off-white, crisp solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.74 (1H, s), 7.70–7.30 (11H, m), 5.20 (2H, s), 4.15 (1H, d, <i>J</i> = 9 Hz), 3.54 (1H, q, <i>J</i> = 8 Hz), 3.38 (1H, m), 3.22 (1H, m), 2.35 (1H, m), 1.98 (1H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 201.9, 169.5, 166.8, 158.3, 142.8, 140.2, 139.7, 137.3, 132.3, 129.0, 128.9, 127.5, 126.8, 126.6, 126.2, 126.1, 121.2, 119.3, 113.0, 69.4, 64.7, 47.1, 45.2, 33.5. MS: (<i>m</i>/<i>z</i>) calcd for C<sub>25</sub>H<sub>24</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 418.2, found: 418.2. HPLC (254 nm) 99.9%; [α]<sup>35</sup><sub>D</sub> +37.5° (<i>c</i> = 0.40, abs EtOH:DMSO (3:1)).</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (2<i>S</i>,3<i>R</i>)-3-(3-Carboxy-5-hydroxyphenyl)pyrrolidine-2-carboxylic Acid Trifluoroacidic Acid (<b>2e</b>)</h5><div class="NLM_p last">The <i>O</i>-benzyl analogue <b>2c</b> (91 mg, 0.24 mmol, 1.00 equiv) was dissolved in AcOH (7 mL), and an atmosphere of nitrogen was applied. 10% Pd/C (10 mg) was added, followed by purging with hydrogen gas. The reaction was stirred for 6 days, after which HPLC did not show further change in reaction outcome. The mixture was diluted with CH<sub>3</sub>CN (50 mL), filtered through a syringe filter, and concentrated in vacuo. The residue was coevaporated with CH<sub>3</sub>CN (3 × 50 mL), and the crude product was dried in high vacuum overnight, affording a pale-brown glass (57 mg, 83%). The product was purified by preparative HPLC to yield <b>2e</b> (30 mg, 44%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, NaOD): δ 7.47 (1H, t, <i>J</i> = 1 Hz), 7.29 (1H, dd, <i>J</i> = 2, 1 Hz), 7.04 (1H, t, <i>J</i> = 2 Hz), 4.25 (1H, d, <i>J</i> = 9 Hz), 3.64–3.53 (2H, m), 3.51–3.40 (1H, m), 2.53–2.41 (1H, m), 2.24–2.10 (1H, m). <sup>13</sup>C NMR (75 MHz, NaOD): δ 172.1, 170.2, 156.6, 141.5, 132.2, 121.0, 120.4, 116.1, 66.0, 48.5, 46.4, 33.6. MS: (<i>m</i>/<i>z</i>) calcd for C<sub>12</sub>H<sub>14</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 252.1, found: 252.1. HPLC (254 nm) >99.9%; [α]<sup>35</sup><sub>D</sub> +52.6° (<i>c</i> = 0.35, 2 M NaOH).</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-3-(3-Carboxyphenyl)-4-propylpyrrolidine-2-carboxylic Acid Hydrochloride (<b>2f</b>)</h5><div class="NLM_p last">The diacid <b>22a</b> (264 mg, 0.699 mmol, 1.00 equiv) was dissolved in DCM (3 mL), followed by the addition of TFA (3 mL). The reaction mixture was stirred at rt for 2 h. The solvents were removed by evaporation in vacuo and coevaporation with DCM (3 × 25 mL), which afforded an off-white solid (285 mg, quant.). The crude product (143 mg) was dissolved in 1 M HCl (5 mL) and evaporated in vacuo, which was repeated twice. The off-white solid was dried in high vacuum (90 mg, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.07 (1H, bs), 10.51 (1H, bs), 8.99 (1H, bs), 7.95 (1H, s), 7.87 (1H, d, <i>J</i> = 7.8 Hz), 7.69 (1H, d, <i>J</i> = 7.8 Hz), 7.51 (1H, t, <i>J</i> = 7.7 Hz), 4.33 (1H, d, <i>J</i> = 9.8 Hz), 3.58 (1H, dd, <i>J</i> = 11.0, 7.3 Hz), 3.17 (1H, t, <i>J</i> = 10.3 Hz), 2.97 (1H, t, <i>J</i> = 10.9 Hz), 2.47–2.35 (1H, m), 1.37–1.03 (4H, m), 0.72 (3H, t, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 169.6, 167.1, 139.5, 132.6, 131.2, 129.0, 128.9, 128.4, 64.4, 53.4, 49.9, 46.0, 32.2, 20.4, 12.9. MS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 278.1, found 278.2. [α]<sup>25</sup><sub>D</sub> +13.3° (<i>c</i> = 0.33 1 M HCl); mp 240–245 °C.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-Benzyl-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic Acid Hydrochloride (<b>2g</b>)</h5><div class="NLM_p last">Diacid <b>22b</b> (45 mg, 0.11 mmol, 1.00 equiv) in glacial acetic acid (1 mL) was added 2 M HCl/Et<sub>2</sub>O (1.0 mL, 2.0 mmol, 18 equiv). The reaction mixture was stirred at rt under nitrogen overnight. The mixture was concentrated in vacuo. The crude product was purified by preparative HPLC (CH<sub>3</sub>CN:H<sub>2</sub>O (1:1) containing 0.1% TFA) to yield a greenish oil. The crude product was dissolved in 1 M HCl (2 × 40 mL) and concentrated in vacuo. The product was dissolved in H<sub>2</sub>O (40 mL) and then lyophilized, affording <b>2g</b> (26.5 mg, 69%) as a greenish solid. <sup>1</sup>H NMR (300 MHz, (DMSO-<i>d</i><sub>6</sub>): δ 10.55 (1H, bs), 8.00–7.75 (2H, m), 7.48 (1H, m), 7.30–6.80 (5H, m), 4.34 (1H, m), 3.54–2.85 (4H, m), 7.68 (1H, m), 8.96 (1H, bs), 2.57–2.50 (2H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 178.3, 169.3, 166.8, 138.8, 138.4, 132.4, 130.9, 128.94, 128.89, 128.3, 128.2, 126.1, 64.4, 52.7, 49.5, 47.5, 35.5. MS (<i>m</i>/<i>z</i>) calcd for C<sub>19</sub>H<sub>20</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 326.1, found: 326.2. [α]<sup>27</sup><sub>D</sub> +3.1° (<i>c</i> = 0.26, MeOH).</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (2<i>S</i>,3<i>R</i>)-3-(3-Phosphonophenyl)pyrrolidine-2-carboxylic Acid Hydrochloride (<b>2h</b>)</h5><div class="NLM_p">To a solution of NaIO<sub>4</sub> (601 mg, 4.1 equiv) in H<sub>2</sub>O (2.05 mL) and CH<sub>3</sub>CN (1.37 mL) was added RuCl<sub>3</sub>·H<sub>2</sub>O (0.015 mmol; 0.022 equiv), followed by a solution of <b>26</b> (283 mg, 0.685 mmol, 1.00 equiv) previously dissolved in EtOAc (1.37 mL). The reaction mixture was stirred for 2 h at rt and then filtered and washed by EtOAc. The aqueous phase was extracted with EtOAc (3 × 10 mL), and the combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo to give the crude product (240 mg, 82%), which was used directly in the next step to avoid undesired hydrolysis of the diethyl phosphonate group on purification with silica gel.</div><div class="NLM_p last">A solution of the crude product (83 mg, 0.28 mmol, 1.00 equiv) in 2 M HCl (5 mL, 10 mmol, 36 equiv) was stirred at reflux for 3 days. The aqueous solution was then concentrated in vacuo to give a brown solid (75 mg; quant). The crude product (60 mg) was dissolved in aqueous 0.1% TFA (2 mL) and purified by preparative HPLC. Evaporation to dryness followed by lyophilization from a 1 M HCl solution provided <b>2h</b> (32 mg, 47%), as a light-brown crispy solid (hygroscopic). <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O, rotamers) δ 7.70–7.59 (2H, m), 7.55–7.40 (2H, m), 4.35 (1H, d, <i>J</i> = 10 Hz), 3.72–3.55 (2H, m), 3.52–3.39 (1H, m), 2.55–2.43 (1H, m), 2.30–2.10 (1H, m). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O, rotamer and carbon–phosphor coupling) δ 178.7, 171.1, 139.3, 139.1, 133.9, 131.72, 131.70, 131.5, 130.5, 130.4, 130.1, 130.0, 129.8, 78.5, 67.2, 65.4, 48.4, 46.6, 44.0, 33.7, 30.5, 21.5. HPLC (210 nm): >99%. MS (<i>m</i>/<i>z</i>) calcd for C<sub>11</sub>H<sub>14</sub>NO<sub>5</sub>P [M + H]<sup>+</sup> 272.0, found 272.0. [α]<sup>28</sup><sub>D</sub> = +26.8° (<i>c</i> = 0.164, H<sub>2</sub>O).</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>S</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-5-oxopyrrolidine-1-carboxylate (<b>4</b>)</h5><div class="NLM_p last">To a solution of commercially available (<i>S</i>)-pyroglutaminol (<b>3</b>) (1.00 g, 8.69 mmol, 1.0 equiv) in DCM (10 mL) was added imidazole (1.48 g, 21.7 mmol, 2.5 equiv) and TBSCl (1.56 g, 10.4 mmol, 1.2 equiv). The mixture was stirred at rt for 24 h. The solution was diluted with Et<sub>2</sub>O (100 mL), and the organic phase was washed with H<sub>2</sub>O (2 × 100 mL) and brine (2 × 100 mL), respectively. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield a yellow oil (1.90 g). The oil (1.90 g, 8.2 mmol, 10.0 equiv) was dissolved in CH<sub>3</sub>CN (70 mL), cooled to 0 °C, and DMAP (0.11 g, 0.83 mmol, 1.0 equiv) and BOC<sub>2</sub>O (3.60 g, 16.5 mmol, 2.0 equiv) added. The reaction mixture was left to stir at rt overnight. The organic phase was washed with brine (3 × 100 mL) and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated in vacuo to yield a dark, red oil, which was purified using flash chromatography (EtOAc:heptane (1:9)), affording <b>4</b> (2.61 g, 91%) as a thick, yellow oil. <sup>1</sup>H NMR (300 mHz, CDCl<sub>3</sub>): δ 4.16 (1H, m), 3.91 (1H, dd, <i>J</i> = 11, 4 Hz), 3.68 (1H, dd, <i>J</i> = 10, 2 Hz), 2.71 (1H, dt, <i>J</i> = 18, 11 Hz), 2.37 (1H, ddd, <i>J</i> = 18, 9, 2 Hz), 2.20–1.95 (2H, m), 1.54 (9H, s), 0.88 (9H, s), 0.05 (3H, s), 0.04 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.9, 150.0, 82.7, 64.4, 59.0, 32.5, 28.2, 26.0, 21.3, 18.3, −5.3, −5.4. [α]<sup>22</sup><sub>D</sub> −71.6° (<i>c</i> = 0.55, EtOAc); <i>R</i><sub>f</sub> 0.13 (EtOAc:heptane (1:9)).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (<i>S</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxylate (<b>5</b>)</h5><div class="NLM_p">Pyrrolidone <b>4</b> (7.00 g, 21.2 mmol, 1.00 equiv) was dissolved in dry THF (12.5 mL), cooled to −78 °C, and 1 M LHMDS (48.0 mL, 48.0 mmol, 2.26 equiv) added dropwise over the course of 1 h. The mixture was left to stir at −78 °C for 1 h, after which a solution of PhSeCl (5.50 g, 28.7 mmol, 1.35 equiv) in dry THF (8 mL) was added dropwise over the course of 30 min. The mixture was left to stir at −78 °C for 45 min before being quenched with satd NH<sub>4</sub>Cl (10 mL) and stirred for 10 min. The mixture was transferred to a separation funnel containing satd NaHCO<sub>3</sub> (100 mL) and the flask flushed with Et<sub>2</sub>O (2 × 50 mL), which was also transferred to the separation funnel. The organic phase was isolated and filtered through a plug of Celite to remove insoluble material. The aqueous phase was re-extracted with Et<sub>2</sub>O (2 × 75 mL), and the combined organic phases were washed with brine (75 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (7 cm, 75 mL fractions, 0–20% EtOAc in heptane) to yield an orange solid (7.52 g).</div><div class="NLM_p last">The selenyl diastereomers were dissolved in EtOAc (60 mL), cooled to 0 °C, and 30% H<sub>2</sub>O<sub>2</sub> (15 mL) added over the course of 10 min. The mixture was left at 0 °C for 15 min before stirred at rt for 1 h. The mixture was poured into a separation funnel containing satd NaHCO<sub>3</sub> (100 mL). The phases were separated and the aqueous phase extracted with EtOAc (2 × 75 mL). The combined organic phases was washed with brine (75 mL), dried over MgSO<sub>4</sub>, concentrated in vacuo, and purified using DCVC (diameter 7 cm, 75 mL fractions, 0–30% EtOAc in heptane) to yield enone <b>5</b> (4.42 g, 64%) as a white solid. <sup>1</sup>H NMR (300 mHz, CDCl<sub>3</sub>): δ 7.26 (1H, dd, <i>J</i> = 6, 2 Hz), 6.13 (1H, dd, <i>J</i> = 6, 2 Hz), 4.60 (1H, m), 4.16 (1H, dd, <i>J</i> = 10, 4 Hz), 3.72 (1H, dd, <i>J</i> = 10, 7 Hz), 1.57 (9H, s), 0.88 (9H, s), 0.06 (1.5H, s), 0.05 (1.5H, s), 0.01 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 169.4, 149.7, 149.4, 127.0, 82.9, 63.6, 62.4, 28.2, 25.7, 18.1, −5.4, −5.5. MS (<i>m</i>/<i>z</i>) calcd for C<sub>11</sub>H<sub>22</sub>NO<sub>2</sub>Si [M + H]<sup>+</sup> 228.1, found: 228.0. [α]<sup>31</sup><sub>D</sub> −173.4° (<i>c</i> = 0.77, abs EtOH); <i>R</i><sub>f</sub> 0.25 (EtOAc:heptane (1:4)).</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 6-Bromo-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxane (<b>6a</b>)</h5><div class="NLM_p last">A round-bottomed flask was charged with 4-bromo-2-(hydroxymethyl)phenol (5.46 g, 26.9 mmol, 1.00 equiv) and anhydrous ZnCl<sub>2</sub> (9.89 g, 72.6 mmol, 2.70 equiv) under an atmosphere of nitrogen. Dry acetone (40 mL) was added via a syringe, followed by 2,2-dimethoxypropane (16.5 mL, 14.0 g, 135 mmol, 5.00 equiv). The reaction mixture was heated to 40 °C and stirred for 1.5 h and then cooled to ambient temperature. Saturated aqueous Na<sub>2</sub>CO<sub>3</sub> (50 mL) was added to quench the reaction and filtered by suction to remove ZnCO<sub>3</sub>. The solid was washed with EtOAc (40 mL). The biphasic filtrate was transferred to a separating funnel, and the yellow organic layer was separated. The colorless aqueous layer was extracted with EtOAc (2 × 20 mL). The combined organic layers were quickly dried over anhydrous MgSO<sub>4</sub>, filtered, and evaporated in vacuo to dryness. The crude product was purified by DCVC using an isocratic eluent (10% EtOAc in heptane). The purified product was coevaporated with DCM (3 × 25 mL), followed by drying in high vacuum overnight (5.73 g, 88%). The product <b>6a</b> crystallized upon storage in the refrigerator. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.23 (1H, dd, <i>J</i> = 7.4, 1.5 Hz), 7.08 (1H, d, <i>J</i> = 1.5 Hz), 6.68 (1H, d, <i>J</i> = 8.5 Hz), 4.79 (2H, s), 1.52 (6H, s). <i>R</i><sub>f</sub> 0.57 (15% EtOAc in heptane).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> ((3-Bromo-5-propoxybenzyl)oxy)(<i>tert</i>-butyl)dimethylsilane (<b>6b</b>)</h5><div class="NLM_p last">Phenol <b>16</b> (4.00 g, 12.6 mmol, 1.00 equiv) was dissolved in DMF (25 mL) and added K<sub>2</sub>CO<sub>3</sub> (3.48 g, 25.2 mmol, 2.00 equiv) and propyl bromide (2.30 mL, 3.11 g, 25.3 mmol, 2.01 equiv). The mixture was left to stir at rt for 18 h. The mixture was added Et<sub>2</sub>O (200 mL) and washed with water (3 × 100 mL) and brine (75 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by DCVC (diameter = 6 cm, 75 mL fractions, 0–10% EtOAc in heptane) to yield <b>6b</b> (4.09 g, 90%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.02 (1H, s), 6.92 (1H, s), 6.81 (1H, s), 4.67 (2H, s), 3.90 (2H, t, <i>J</i> = 7 Hz), 1.81 (2H, sextet, <i>J</i> = 7 Hz), 1.04 (3H, t, <i>J</i> = 8 Hz), 0.96 (9H, s), 0.12 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.9, 144.7, 122.6, 121.1, 116.2, 111.1, 69.9, 64.4, 26.2, 22.7, 18.7, 10.7, −5.0. <i>R</i><sub>f</sub> 0.77 (EtOAc:heptane (1:10)).</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> ((3-(Benzyloxy)-5-bromobenzyl)oxy)(<i>tert</i>-butyl)dimethylsilane (<b>6c</b>)</h5><div class="NLM_p last">Phenol <b>16</b> (3.50 g, 11.0 mmol, 1.00 equiv) was dissolved in acetone (50 mL) and added K<sub>2</sub>CO<sub>3</sub> (3.10 g, 22.4 mmol, 2.04 equiv) and benzyl bromide (2.10 mL, 3.02 g, 17.7 mmol, 1.61 equiv). The mixture was left to stir at reflux for 24 h. Piperazine (4.75 g, 55.1 mmol, 5.01 equiv) was added and the mixture refluxed for another 2.5 h. The mixture was cooled to rt and concentrated in vacuo. To the mixture was added water (50 mL) and EtOAc (50 mL) and transferred to a separation funnel containing EtOAc (100 mL) and satd NH<sub>4</sub>Cl (100 mL). After separation, the aqueous phase was extracted with EtOAc (50 mL). The combined organic phases were washed with brine (80 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by DCVC (diameter = 7 cm, 75 mL fractions, 0–8% EtOAc in heptane) to yield <b>7</b> (4.25 g, 95%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45–7.30 (5H, m), 7.06 (1H, s), 7.02 (1H, s), 6.90 (1H, s), 5.05 (2H, s), 4.68 (2H, s), 0.96 (9H, s), 0.12 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.5, 144.8, 136.5, 128.6, 128.1, 127.5, 122.6, 121.5, 116.6, 111.3, 70.3, 64.3, 26.2, 18.6, −5.0. <i>R</i><sub>f</sub> 0.65 (EtOAc:heptane (1:10)).</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> ((3-([1,1′-Biphenyl]-3-ylmethoxy)-5-bromobenzyl)oxy)(<i>tert</i>-butyl)dimethylsilane (<b>6d</b>)</h5><div class="NLM_p last">Phenol <b>16</b> (3.00 g, 9.46 mmol, 1.00 equiv) was dissolved in acetone (50 mL) and added K<sub>2</sub>CO<sub>3</sub> (2.61 g, 18.9 mmol, 2.00 equiv) and 3-phenylbenzyl bromide (3.52 g, 14.2 mmol, 1.50 equiv). The mixture was left to stir at reflux for 24 h. Piperazine (4.10 g, 47.6 mmol, 5.0 equiv) was added and the mixture refluxed for another 2.5 h. The mixture was cooled to rt and concentrated in vacuo. To the mixture was added water (50 mL) and EtOAc (50 mL) and transferred to a separation funnel containing EtOAc (100 mL) and satd NH<sub>4</sub>Cl (100 mL). After separation, the aqueous phase was extracted with EtOAc (50 mL). The combined organic phases was washed with brine (80 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified using DCVC (diameter = 7 cm, 75 mL fractions, 0–8% EtOAc in heptane) to yield <b>6d</b> (4.21 g, 92%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.67–7.53 (4H, m), 7.51–7.32 (5H, m), 7.09–7.02 (2H, m), 6.92 (1H, s), 5.11 (2H, s), 4.68 (2H, s), 0.96 (9H, s), 0.11 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 137.0, 129.1, 128.8, 127.5, 127.2, 127.0, 126.4, 126.3, 122.6, 121.6, 116.6, 111.3, 70.3, 64.3, 26.2, 18.6, −5.0. <i>R</i><sub>f</sub> 0.58 (EtOAc:heptane (1:10)).</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> tert-butyl (2S,3R)-2-(((tert-butyldimethylsilyl)oxy)methyl)-3-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-5-oxopyrrolidine-1-carboxylate (<b>7a</b>)</h5><div class="NLM_p last">A dry round-bottomed flask was charged with the bromide (1.86 g, 7.63 mmol, 2.50 equiv), and a nitrogen atmosphere was applied thoroughly. Dry Et<sub>2</sub>O (25 mL) was added via a syringe, and the clear, pale-yellow solution was cooled to −78 °C. <i>tert</i>-BuLi in pentane (10.2 mL, 978 mg, 15.3 mmol, 5.00 equiv, 1.50 M) was added dropwise over the course of 25 min. The reaction mixture became milky due to precipitation. After 10 min of stirring at −78 °C, a suspension of CuCN (342 mg, 3.82 mmol, 1.25 equiv) in dry Et<sub>2</sub>O (2.4 mL) was added portionwise. The resulting suspension was stirred at −78 °C for 5 min and then at −42 °C for 10 min, after which it was recooled to −78 °C. Enone <b>5</b> (1.00 g, 3.05 mmol, 1.00 equiv) was dissolved in dry Et<sub>2</sub>O (3.0 mL) and added dropwise to the cuprate mixture at −78 °C, which resulted in a slight color change to orange. The temperature was raised to −42 °C, and the reaction mixture was stirred at this temperature for 1 h. The dark-brown solution with barely any precipitation was quenched by addition of satd aqueous NH<sub>4</sub>Cl (5 mL), allowed to warm up to ambient temperature, and then transferred to a separating funnel with brine (30 mL) and EtOAc (30 mL). The organic layer was separated, and the blue aqueous layer was extracted with EtOAc (2 × 30 mL). The combined organic layers were dried over anhydrous MgSO<sub>4</sub>, filtered, and evaporated in vacuo to dryness. Purification by DCVC (0–20% EtOAc in heptane) afforded the desired product <b>7a</b> (1.05 g, 70%) as a pale-yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.98 (1H, dd, <i>J</i> = 8.5, 2.2 Hz), 6.78 (2H, dd, <i>J</i> = 5.1, 3.2 Hz), 4.82 (2H, s), 4.05–3.97 (2H, m), 3.80 (1H, dd, <i>J</i> = 9.9, 1.7 Hz), 3.38 (1H, dt, <i>J</i> = 9.4, 2.5), 3.15 (1H, dd, <i>J</i> = 17.7, 9.5 Hz), 2.50 (1H, dd, <i>J</i> = 17.6, 2.5 Hz), 1.56 (6H, s), 1.55 (9H, s), 0.93 (9H, s), 0.10 (3H, s), 0.09 (3H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 174.1, 150.1, 149.8, 136.1, 126.2, 122.2, 119.7, 117.5, 99.9, 99.5, 83.1, 67.0, 63.6, 60.9, 40.1, 38.2, 28.2, 25.9, 24.9, 24.8, 18.3, −5.4. MS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>34</sub>NO<sub>4</sub>Si [M–Boc+H]<sup>+</sup> 392.2, found 392.2. [α]<sup>25</sup><sub>D</sub> −20.7° (<i>c</i> = 0.28, EtOH); <i>R</i><sub>f</sub> 0.40 (25% EtOAc in heptane).</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-3-(3-(((<i>tert</i>-butyldimethylsilyl)oxy)-methyl)-5-propoxyphenyl)-5-oxopyrrolidine-1-carboxylate (<b>7b</b>)</h5><div class="NLM_p last">Solution A: Thiophene (482 mg, 5.74 mmol, 1.57 equiv) was dissolved in dry Et<sub>2</sub>O (6 mL) in a dry vial under an atmostphere of nitrogen and cooled to 0 °C. <i>n</i>-BuLi (2.34 mL, 5.85 mmol, 1.60 equiv, 2.50 M) was added dropwise over 15 min and the mixture left to stir at 0 °C for 15 min, then at rt for 2 h (a white, colloid precipitate was formed). Bromide <b>6b</b> (1.65 g, 4.59 mmol, 1.25 equiv) was dissolved in dry Et<sub>2</sub>O (50 mL) in a dry flask under an atmosphere of nitrogen and cooled to −78 °C. <i>tert</i>-BuLi (5.76 mL, 9.22 mmol, 2.52 equiv, 1.60 M) was added dropwise over the course of 20 min. The mixture was left to stir at −78 °C for 45 min (the solution became slightly colored and unclear) before a suspension of CuCN (410 mg, 4.58 mmol, 1.25 equiv) in dry Et<sub>2</sub>O (4 mL) was added dropwise over the course of 6 min. The mixture was left to stir at −78 °C for 10 min, then 10 min at −42 °C before being recooled to −78 °C. The mixture was added dropwise to solution A (7.1 mL, 4.6 mmol, 1.25 equiv) over the course of 20 min and left to stir at −78 °C for 10 min, then at −42 °C for 10 min before being recooled to −78 °C. A solution of enone <b>5</b> (1.20 g, 3.66 mmol, 1.00 equiv) dissolved in Et<sub>2</sub>O (10 mL) was dropwise added over the course of 25 min. The mixture instantly turned highly yellow and was left to stir at −78 °C for 10 min, then at −42 °C for 45 min before being quenched using satd NH<sub>4</sub>Cl (8 mL). The mixture was transferred to a separation funnel containing satd NaHCO<sub>3</sub> (50 mL) and EtOAc (50 mL). The phases were separated and the aqueous phase extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by DCVC (0–12% EtOAc in heptane and 0–5% EtOAc in PhMe) yielded <b>7b</b> (1.38 mg, 62%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 6.80 (1H, m), 6.68 (1H, s), 6.60 (1H, m), 4.68 (2H, s), 4.07 (1H, m), 4.00 (1H, dd, <i>J</i> = 10, 4 Hz), 3.91 (2H, t, <i>J</i> = 7 Hz), 3.79 (1H, dd, <i>J</i> = 11, 2 Hz), 3.40 (1H, dt, <i>J</i> = 10, 2 Hz), 3.12 (1H, dd, <i>J</i> = 18, 10 Hz), 2.54 (1H, dd, <i>J</i> = 18, 3 Hz), 1.81 (2H, d, <i>J</i> = 7 Hz), 1.54 (9H, s), 1.04 (3H, t, <i>J</i> = 8 Hz), 0.96 (9H, s), 0.92 (9H, s), 0.12 (6H, s), 0.10 (3H, s), 0.08 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.1, 159.7, 149.8, 145.6, 143.9, 116.0, 111.6, 110.5, 83.0, 69.6, 66.8, 64.9, 63.8, 40.0, 38.9, 28.3, 26.2, 26.1, 22.8, 18.6, 18.4, 10.7, −5.0, −5.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>27</sub>H<sub>50</sub>NO<sub>4</sub>Si<sub>2</sub> [M + H – Boc]<sup>+</sup> 508.3, found 508.1. <i>R</i><sub>f</sub> 0.49 (EtOAc:toluene (1:10)); [α]<sup>23</sup><sub>D</sub> −22.3° (<i>c</i> = 0.30, abs EtOH).</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-(Benzyloxy)-5-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)phenyl)-2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-5-oxopyrrolidine-1-carboxylate (<b>7c</b>)</h5><div class="NLM_p last">Bromide <b>6c</b> (2.01 g, 4.93 mmol, 1.25 equiv) was dissolved in dry Et<sub>2</sub>O (60 mL) in a dry flask under an atmosphere of nitrogen and cooled to −78 °C. <i>tert</i>-BuLi (6.18 mL, 9.89 mmol, 2.51 equiv, 1.60 M) was added dropwise over the course of 15 min, and the mixture was left to stir at −78 °C for 30 min. The solution became slightly yellow colored and unclear before a suspension of CuCN (440 mg, 4.91 mmol, 1.25 equiv) in dry Et<sub>2</sub>O (4 mL) was added dropwise over the course of 5 min. The mixture was left to stir at −78 °C for 10 min, then 10 min at −42 °C before being recooled to −78 °C. To the mixture was added dropwise solution A (9.0 mL, 4.9 mmol, 1.34 equiv) over the course of 15 min and left to stir at −78 °C for 10 min, then at −42 °C for 10 min before being recooled to −78 °C. A solution of enone <b>5</b> (1.29 g, 3.94 mmol, 1.00 equiv) dissolved in Et<sub>2</sub>O (4 mL) was dropwise added over the course of 15 min, and the mixture instantly turned bright yellow. The mixture was left to stir at −78 °C for 15 min, then at −42 °C for 40 min before quenched using satd NH<sub>4</sub>Cl (10 mL). The mixture was transferred to a separation funnel containing satd NaHCO<sub>3</sub> (75 mL) and EtOAc (75 mL). The phases were separated, and the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (75 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by DCVC (diameter = 7, 75 mL fractions, 0–10% EtOAc in heptane) to yield <b>7c</b> (1.11 g, 43%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45–7.28 (5H, m), 6.89 (1H, s), 6.73–6.67 (2H, m), 5.05 (2H, s), 4.69 (2H, s), 4.07 (1H, m), 4.00 (1H, dd, <i>J</i> = 11, 4 Hz), 3.79 (1H, dd, <i>J</i> = 11, 2 Hz), 3.31 (1H, d, <i>J</i> = 9 Hz), 3.13 (1H, dd, <i>J</i> = 18, 10 Hz), 2.53 (1H, dd, <i>J</i> = 18, 2 Hz), 1.54 (9H, s), 0.95 (9H, s), 0.93 (9H, s), 0.11 (6H, s), 0.10 (3H, s), 0.09 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.1, 159.5, 150.0, 145.8, 144.2, 137.0, 128.8, 128.2, 127.7, 116.6, 112.2, 111.0, 83.2, 70.2, 67.0, 65.1, 64.0, 40.2, 39.1, 28.5, 26.4, 26.3, 18.8, 18.6, −4.8, −5.0. MS (<i>m</i>/<i>z</i>) calcd for C<sub>31</sub>H<sub>50</sub>NO<sub>4</sub>Si<sub>2</sub> [M + H – Boc]<sup>+</sup> 556.3, found: 556.3. <i>R</i><sub>f</sub> 0.44 (EtOAc:heptane (1:4)); [α]<sup>35</sup><sub>D</sub> −22.2° (<i>c</i> = 0.89, abs EtOH).</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-([1,1′-Biphenyl]-3-ylmethoxy)-5-(((<i>tert</i>-butyldimethylsilyl)oxy)-methyl)phenyl)-2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-5-oxopyrrolidine-1-carboxylate (<b>7d</b>)</h5><div class="NLM_p last">Bromide <b>6d</b> (3.17 g, 6.56 mmol, 1.24 equiv) was dissolved in dry Et<sub>2</sub>O (80 mL) in a dry flask under an atmosphere of nitrogen and cooled to −78 °C. <i>tert</i>-BuLi (8.28 mL, 13.25 mmol, 2.51 equiv, 1.60 M) was then added dropwise over the course of 30 min. The mixture was left to stir at −78 °C for 45 min (the solution became yellow colored) before a suspension of CuCN (590 mg, 6.59 mmol, 1.25 equiv) in dry Et<sub>2</sub>O (4 mL) was added dropwise over the course of 15 min. The mixture was left to stir at −78 °C for 10 min (mixture turned wine red), then 15 min at −42 °C before recooled to −78 °C over the course of 10 min. The mixture was dropwise added to solution A (9.9 mL, 6.6 mmol, 1.25 equiv) over the course of 30 min and left to stir at −78 °C for 10 min, then at −42 °C for 10 min before being recooled to −78 °C. A solution of enone <b>5</b> (1.73 g, 5.28 mmol, 1.00 equiv) dissolved in Et<sub>2</sub>O (4 mL) was dropwise added over the course of 15 min (the mixture turned slightly yellow). The mixture was left to stir at −78 °C for 15 min, then at −42 °C for 90 min before being quenched using satd NH<sub>4</sub>Cl (12 mL). The mixture was transferred to a separation funnel containing satd NaHCO<sub>3</sub> (75 mL) and EtOAc (75 mL). The phases were separated and the aqueous phase extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (75 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by DCVC (0–10% EtOAc in heptane and 0–4% EtOAc in toluene) yielded <b>7d</b> (1.62 g, 42%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.70–7.53 (4H, m), 7.52–7.33 (5H, m), 6.94 (1H, m), 6.74 (2H, m), 5.13 (2H, s), 4.71 (2H, s), 4.10 (1H, m), 4.02 (1H, dd, <i>J</i> = 10, 4 Hz), 3.81 (1H, dd, <i>J</i> = 10, 2 Hz), 3.44 (1H, dm, <i>J</i> = 10 Hz), 3.16 (1H, dd, <i>J</i> = 18, 9 Hz), 2.57 (1H, dd, <i>J</i> = 18, 3 Hz), 1.55 (9H, s), 0.96 (9H, s), 0.94 (9H, s), 0.12 (6H, s), 0.11 (3H, s), 0.10 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.3, 149.8, 145.7, 144.0, 141.6, 140.8, 137.3, 129.1, 128.8, 127.4, 127.2, 126.9, 126.4, 126.3, 116.4, 112.1, 110.6, 83.1, 70.1, 66.8, 64.9, 63.8, 40.1, 38.9, 28.3, 26.2, 26.1, 18.6, 18.4, −5.0, −5.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>37</sub>H<sub>54</sub>NO<sub>4</sub>Si<sub>2</sub> [M + H – Boc]<sup>+</sup> 632.4, found: 632.4. <i>R</i><sub>f</sub> 0.38 (EtOAc:heptane (1:4)); [α]<sup>31</sup><sub>D</sub> −22.7° (<i>c</i> = 0.71, abs EtOH).</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-3-(2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]-dioxin-6-yl)pyrrolidine-1-carboxylate (<b>8a</b>)</h5><div class="NLM_p last">A round-bottomed flask was charged with lactam <b>7a</b> (558 mg, 1.14 mmol, 1.00 equiv) and equipped with a condenser, and an atmosphere of nitrogen was applied. Through the septum, dry THF (15 mL) and 1 M BH<sub>3</sub>·THF (7.5 mL, 648 mg, 7.54 mmol, 6.00 equiv) were added via syringes, and the colorless reaction mixture was heated to reflux (80 °C) for 3.5 h, then cooled to 0 °C and THF (10 mL), H<sub>2</sub>O (1 mL), 2 M NaOH (13 mL), and 30% H<sub>2</sub>O<sub>2</sub> (4 mL) were added sequentially. The mixture was stirred for 3.5 h at rt and then quenched by addition of satd aqueous NaHCO<sub>3</sub> (30 mL) and extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over anhydrous MgSO<sub>4</sub>, filtered, and evaporated in vacuo to dryness. Purification by DCVC (0–15% EtOAc in heptane) afforded the desired product <b>8a</b> (248 mg, 46%) as a colorless, viscous oil. <i>R</i><sub>f</sub> 0.47 (25% EtOAc in heptane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.05–6.96 (1H, m), 6.81–6.75 (2H, m), 4.83 (2H, s), 4.01 (1H, dd, <i>J</i> = 10.3, 3.7 Hz), 3.79–3.60 (4H, m), 3.45 (1H, td, <i>J</i> = 7.2, 5.4 Hz), 3.37–3.26 (1H, m), 2.30–2.16 (1H, m), 1.94–1.79 (1H, m), 1.56 (6H, s), 1.50 (9H, s), 0.91 (9H, s), 0.06 (6H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ (rotamers) 154.2, 149.6, 135.7, 135.1, 127.0, 126.8, 123.2, 123.1, 119.2, 117.0, 99.4, 79.4, 65.7, 65.5, 62.8, 61.4, 61.0, 47.0, 46.4, 46.0, 44.9, 33.0, 31.8, 28.7, 26.0, 24.9, 18.3, −5.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>36</sub>NO<sub>3</sub>Si [M – Boc + H]<sup>+</sup> 378.3, found 378.2. [α]<sup>25</sup><sub>D</sub> +9.7° (<i>c</i> = 0.68, abs. EtOH).</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-3-(3-(((<i>tert</i>-butyldimethylsilyl)oxy)-methyl)-5-propoxyphenyl)pyrrolidine-1-carboxylate (<b>8b</b>)</h5><div class="NLM_p last">Lactam <b>7c</b> (1.43 g, 2.35 mmol, 1.0 equiv) was dissolved in dry THF (25 mL) and 1 M BH<sub>3</sub>·THF complex (25 mL, 25 mmol, 10.6 equiv) added over the course of 5 min. The mixture was refluxed under an atmosphere of nitrogen for 20 h. The mixture was cooled to 0 °C and H<sub>2</sub>O (5 mL) added dropwise over the course of 10 min, NaOH (2 M, 25 mL) dropwise over the course of 20 min, and H<sub>2</sub>O<sub>2</sub> (30%, 5 mL) over the course of 5 min (organic/aqueous ratio important). After 5 min, the mixture was remove from the ice bath and left to stir at rt for 1 h. The mixture was poured into satd NaHCO<sub>3</sub> (100 mL) and EtOAc (75 mL). After separation, the aqueous phase was extracted with EtOAc (2 × 75 mL), and the combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 4 cm, 30 mL fractions, 0–5% EtOAc in toluene) to yield <b>8b</b> (820 mg, 59%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 6.75 (1H, m), 6.73 (1H, s), 6.66 (1H, m), 4.07–3.98 (0.5H, m), 3.91 (2H, t, <i>J</i> = 6 Hz), 3.80–3.55 (3H, m), 3.87–3.80 (0.5H, m), 3.49 (1H, m), 3.42–3.25 (1H, m), 2.32–2.17 (1H, m), 1.95–1.82 (1H, m), 1.81 (2H, h, <i>J</i> = 7 Hz), 1.49 (9H, s), 1.04 (3H, t, <i>J</i> = 7 Hz), 0.96 (9H, s), 0.91 (9H, s), 0.12 (6H, s), 0.06 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.4, 154.3, 154.2, 145.4, 144.9, 143.2, 143.1, 117.4, 117.1, 112.3, 110.2, 109.9, 79.5, 79.1, 69.5, 65.7, 65.5, 65.1, 62.9, 61.5, 47.2, 46.7, 45.7, 32.8, 31.8, 28.8, 26.2, 26.1, 22.8, 18.7, 18.4, 10.8, −4.9, −5.1. MS (<i>m</i>/<i>z</i>) calcd for C<sub>27</sub>H<sub>52</sub>NO<sub>3</sub>Si<sub>2</sub> [M – Boc + H]<sup>+</sup> 494.4, found 494.4. <i>R</i><sub>f</sub> 0.44 (EtOAc:toluene (1:20)); [α]<sup>23</sup><sub>D</sub> +11.5° (<i>c</i> = 0.30, abs EtOH).</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-(Benzyloxy)-5-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)phenyl)-2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carboxylate (<b>8c</b>)</h5><div class="NLM_p last">Lactam <b>7c</b> (1.66 g, 2.53 mmol, 1.00 equiv) was dissolved in dry THF (20 mL) and 1 M BH<sub>3</sub>·THF complex (25 mL, 25 mmol, 9.88 equiv) added over the course of 5 min. The mixture was refluxed under an atmosphere of nitrogen for 20 h. The mixture was cooled to 0 °C, THF (40 mL) added, and H<sub>2</sub>O (6 mL) added dropwise over the course of 15 min. NaOH (2 M, 30 mL) was added dropwise over the course of 15 min and H<sub>2</sub>O<sub>2</sub> (30%, 10 mL) over the course of 15 min (organic/aqueous ratio important). After 5 min, the mixture was removed from the ice bath and left to stir at rt for 1 h. The mixture was poured into satd NaHCO<sub>3</sub> (100 mL) and EtOAc (75 mL). After separation, the aqueous phase was extracted with EtOAc (2 × 75 mL) and the combined organic phases were washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 4 cm, 30 mL fractions, 0–2% EtOAc in toluene) to yield <b>8c</b> (976 mg, 60%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.47–7.30 (5H, m), 6.86 (1H, m), 6.80–6.71 (2H, m), 5.06 (2H, s), 4.71 (2H, s), 4.05 (0.5H, dd, <i>J</i> = 10, 4 Hz), 3.86 (0.5H, m), 3.80–3.58 (3H, m), 3.55–3.46 (1H, m), 3.43–3.27 (1H, m), 2.35–2.18 (1H, m), 2.00–1.85 (1H, m), 1.51 (9H, s), 0.97 (9H, s), 0.93 (9H, s), 0.12 (6H, s), 0.08 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.1, 154.2, 154.1, 145.4, 145.0, 143.3, 143.2, 137.03, 136.99, 128.6, 127.9, 127.5, 117.7, 117.5, 112.7, 110.4, 110.2, 79.5, 79.2, 77.6, 77.2, 76.7, 70.0, 65.6, 65.5, 65.0, 62.8, 61.5, 47.2, 46.7, 45.7, 32.8, 31.8, 28.8, 26.2, 26.1, 18.7, 18.4, −4.9, −5.1. MS (<i>m</i>/<i>z</i>) calcd for C<sub>31</sub>H<sub>52</sub>NO<sub>3</sub>Si<sub>2</sub> [M – Boc + H]<sup>+</sup> 542.4, found 542.4 (−Boc). <i>R</i><sub>f</sub> 0.20 (EtOAc:toluene (1:40)); [α]<sup>35</sup><sub>D</sub> +3.2° (<i>c</i> = 0.50, abs EtOH).</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-([1,1′-Biphenyl]-3-ylmethoxy)-5-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-phenyl)-2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carboxylate (<b>8d</b>)</h5><div class="NLM_p last">Lactam <b>7d</b> (1.77 g, 2.42 mmol, 1.00 equiv) was dissolved in dry THF (20 mL) and 1 M BH<sub>3</sub>·THF complex (25 mL, 25 mmol, 10.3 equiv) added over the course of 5 min. The mixture was refluxed under an atmosphere of nitrogen for 20 h. The mixture was cooled to 0 °C, THF (40 mL) added, and H<sub>2</sub>O (6 mL) added dropwise over the course of 15 min. NaOH (2 M, 30 mL) was added dropwise over the course of 15 min and H<sub>2</sub>O<sub>2</sub> (30%, 10 mL) over the course of 15 min (organic/aqueous ratio important). After 5 min, the mixture was removed from the ice bath and left to stir at rt for 1 h. The mixture was poured into satd NaHCO<sub>3</sub> (100 mL) and EtOAc (75 mL). After separation, the aqueous phase was extracted with EtOAc (2 × 75 mL) and the combined organic phases were washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 4 cm, 30 mL fractions, 0–2% EtOAc in PhMe) to yield <b>8d</b> (887 mg, 51%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.72–7.55 (4H, m), 7.52–7.33 (5H, m), 6.91 (1H, m), 6.84–6.78 (2H, m), 5.14 (2H, s), 4.74 (2H, s), 4.08 (0.5H, dd, <i>J</i> = 10, 4 Hz), 3.90 (0.5H, m), 3.86–3.62 (3H, m), 3.55 (1H, m), 3.38 (1H, m), 2.28 (1H, m), 1.94 (1H, m), 1.53 (9H, s), 0.99 (9H, s), 0.95 (9H, s), 0.14 (6H, s), 0.10 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.1, 154.23, 154.15, 145.4, 145.0, 143.34, 143.26, 141.6, 140.9, 137.54, 137.49, 129.0, 128.8, 127.4, 127.2, 126.8, 126.44, 126.35, 117.8, 117.6, 112.8, 110.3, 110.1, 79.5, 79.2, 70.0, 65.6, 65.5, 65.0, 62.8, 61.5, 47.2, 46.7, 45.7, 32.8, 31.8, 28.8, 26.2, 26.1, 18.6, 18.4, −4.9, −5.1. MS (<i>m</i>/<i>z</i>) calcd for C<sub>37</sub>H<sub>56</sub>NO<sub>3</sub>Si<sub>2</sub> [M – Boc + H]<sup>+</sup> 618.4, found 618.4. <i>R</i><sub>f</sub> 0.21 (EtOAc:toluene (1:40)); [α]<sup>35</sup><sub>D</sub> +1.9° (<i>c</i> = 0.67, abs EtOH).</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(2,2-Dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-6-yl)-2-(hydroxymethyl)-pyrrolidine-1-carboxylate (<b>9a</b>)</h5><div class="NLM_p last">The protected alcohol (448 mg, 0.94 mmol, 1.0 equiv) was dissolved in dry THF (9 mL) under an atmosphere of nitrogen and 1 M TBAF in THF (2.8 mL, 736 mg, 2.81 mmol, 3.0 equiv) was added at rt. The reaction mixture was stirred for 2 h, whereafter H<sub>2</sub>O (20 mL) and satd NaHCO<sub>3</sub> (20 mL) were added, and following extracted with EtOAc (3 × 30 mL). The combined organic phases were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo to dryness. Purified by DCVC (15–35% EtOAc in heptane), followed by drying in high vacuum overnight, afforded the desired alcohol as a colorless, viscous oil, which crystallized to a white solid (295 mg, 87%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.02 (1H, dd, <i>J</i> = 8.4, 2.3 Hz), 6.84 (1H, bs), 6.76 (1H, d, <i>J</i> = 8.3 Hz), 5.13 (1H, bd, <i>J</i> = 8.0 Hz), 4.82 (2H, s), 3.86 (1H, t, <i>J</i> = 7.8 Hz), 3.73 (2H, t, <i>J</i> = 9.4 Hz), 3.64–3.57 (1H, m), 3.33 (1H, dt, <i>J</i> = 10.6, 6.3 Hz), 2.84–2.76 (1H, m), 2.15–2.08 (1H, m), 1.99–1.85 (1H, m), 1.55 (6H, s), 1.51 (9H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 156.7, 150.1, 132.2, 127.2, 123.5, 119.4, 117.2, 99.5, 80.5, 67.2, 66.0, 60.9, 47.3, 47.1, 33.1, 28.5, 24.8, 24.7. MS (<i>m</i>/<i>z</i>) calcd for C<sub>16</sub>H<sub>22</sub>NO<sub>5</sub> [M – <sup><i>t</i></sup>Bu + H]<sup>+</sup> 308.2, found 308.1. [α]<sup>25</sup><sub>D</sub> +14.2° (<i>c</i> = 0.86, EtOH); mp 110–112 °C.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 2-(Hydroxymethyl)-3-(3-(hydroxymethyl)-5-propoxyphenyl)pyrrolidine-1-carboxylate (<b>9b</b>)</h5><div class="NLM_p last">Pyrrolidine <b>8b</b> (1.30 g, 2.19 mmol, 1.00 equiv) was dissolved in dry THF (12 mL) in a dry vial and 1 M TBAF (8.80 mL, 8.80 mmol, 4.02 equiv) added. The mixture was left to stir at rt for 18 h. The mixture was quenched using 50% satd NaHCO<sub>3</sub> (50 mL) and transferred to a separation funnel containing EtOAc (25 mL). The aqueous phase was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 3 cm, 25 mL fractions, 0–90% EtOAc in heptane) to yield diol <b>9b</b> (736 mg, 92%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 6.84–6.78 (2H, m), 6.70 (1H, m), 5.07 (1H, m), 4.65 (2H, s), 3.92 (2H, t, <i>J</i> = 7 Hz), 3.90–3.68 (3H, m), 3.62 (1H, dd, <i>J</i> = 11, 7 Hz), 3.35 (1H, m), 2.86 (1H, m), 2.15 (1H, m), 2.07–1.90 (2H, m), 1.81 (2H, h, <i>J</i> = 7 Hz), 1.51 (9H, s), 1.05 (3H, t, <i>J</i> = 7 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.7, 156.8, 142.9, 142.5, 118.2, 113.6, 111.3, 80.7, 69.7, 67.2, 66.2, 65.4, 48.1, 47.4, 33.1, 28.7, 22.8, 10.8. MS (<i>m</i>/<i>z</i>) calcd for C<sub>16</sub>H<sub>24</sub>NO<sub>5</sub> [M – <sup><i>t</i></sup>Bu + H]<sup>+</sup> 310.2, found 310.2. <i>R</i><sub>f</sub> 0.37 (EtOAc:heptane (3:1)); [α]<sup>23</sup><sub>D</sub> +23.9° (<i>c</i> = 0.31, abs EtOH).</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-(Benzyloxy)-5-(hydroxymethyl)phenyl)-2-(hydroxymethyl)pyrrolidine-1-carboxylate (<b>9c</b>)</h5><div class="NLM_p last">Pyrrolidine <b>8c</b> (967 g, 1.51 mmol, 1.00 equiv) was dissolved in dry THF (15 mL) in a dry vial and 1 M TBAF (6 mL, 6 mmol, 3.97 equiv) added. The mixture was left to stir at rt for 18 h. The mixture was quenched using 50% satd NaHCO<sub>3</sub> (50 mL) and transferred to a separation funnel containing EtOAc (50 mL). The aqueous phase was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with brine (75 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 4 cm, 30 mL fractions, 0–100% EtOAc in heptane) to yield diol <b>9c</b> (572 mg, 92%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45–7.28 (5H, m), 6.88 (1H, m), 6.85 (1H, m), 6.79 (1H, m), 5.09 (1H, m), 5.06 (2H, s), 4.65 (2H, s), 3.95 (1H, m), 3.90–3.67 (3H, m), 3.61 (1H, dd, <i>J</i> = 11, 7 Hz), 3.34 (1H, m), 2.87 (1H, m), 2.14 (1H, m), 2.08–1.89 (2H, m), 1.51 (9H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 158.3, 153.6, 153.2, 145.0, 144.8, 144.2, 137.0, 128.3, 127.7, 127.5, 117.4, 111.8, 110.4, 78.5, 78.4, 69.0, 65.5, 62.8, 60.8, 60.7, 46.0, 45.8, 45.3, 44.5, 31.2, 30.5, 28.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>20</sub>H<sub>24</sub>NO<sub>5</sub> [M – <sup><i>t</i></sup>Bu + H]<sup>+</sup> 358.2, found: 358.2. <i>R</i><sub>f</sub> 0.42 (EtOAc:heptane (3:1)); [α]<sup>35</sup><sub>D</sub> +12.3° (<i>c</i> = 0.44, abs EtOH).</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-([1,1′-Biphenyl]-3-ylmethoxy)-5-(hydroxymethyl)phenyl)-2-(hydroxymethyl)-pyrrolidine-1-carboxylate (<b>9d</b>)</h5><div class="NLM_p last"><b>8d</b> (800 g, 1.11 mmol, 1.00 equiv) was dissolved in dry THF (15 mL) in a dry vial and 1 M TBAF (5.00 mL, 5.00 mmol, 4.50 equiv) added. The mixture was left to stir at rt for 18 h. The mixture was quenched using phosphate buffer (50 mL, pH 7) and transferred to a separation funnel containing EtOAc (50 mL). The aqueous phase was extracted with EtOAc (2 × 50 mL), and the combined organic phases was washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 4 cm, 30 mL fractions, 0–90% EtOAc in heptane) to yield diol <b>9d</b> (512 mg, 94%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.60–7.53 (4H, m), 7.50–7.32 (5H, m), 6.91 (1H, m), 6.86 (1H, s), 6.81 (1H, m), 5.24 (1H, m), 5.10 (2H, s), 4.63 (2H, s), 3.96 (1H, m), 3.65 (2H, m), 3.63 (1H, dd, <i>J</i> = 11, 7 Hz), 3.34 (1H, m), 3.00–2.60 (2H, m), 2.14 (1H, m), 1.97 (1H, m), 1.51 (9H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.2, 156.7, 143.2, 142.5, 141.5, 140.8, 137.3, 129.0, 128.8, 127.4, 127.2, 126.8, 126.5, 126.4, 118.5, 113.7, 111.3, 80.7, 70.1, 67.0, 65.9, 64.9, 47.9, 47.2, 32.9, 28.6. MS (<i>m</i>/<i>z</i>) calcd for C<sub>26</sub>H<sub>28</sub>NO<sub>5</sub> [M – <sup><i>t</i></sup>Bu + H]<sup>+</sup> 434.2, found 434.2. <i>R</i><sub>f</sub> 0.39 (EtOAc:heptane (3:1)); [α]<sup>35</sup><sub>D</sub> +10.2° (<i>c</i> = 0.53, abs EtOH).</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (2<i>S</i>,3<i>R</i>)-1-(<i>tert</i>-Butoxycarbonyl)-3-(2,2-dimethyl-4-oxo-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-6-yl)pyrrolidine-2-carboxylic Acid (<b>10a</b>) and (2<i>S</i>,3<i>R</i>)-1-(<i>tert</i>-Butoxycarbonyl)-3-(2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-6-yl)pyrrolidine-2-carboxylic Acid (<b>11</b>)</h5><div class="NLM_p last">To an ice-cooled mixture of the protected alcohol <b>9a</b> (150 mg, 0.413 mmol, 1.0 equiv) dissolved in CH<sub>3</sub>CN (2.5 mL) and EtOAc (2.5 mL) was added dropwise NaIO<sub>4</sub> (883 mg, 4.13 mmol, 10.0 equiv) and RuCl<sub>3</sub>·H<sub>2</sub>O (4 mg, 0.02 mmol, 0.04 equiv) dissolved in H<sub>2</sub>O (4 mL). The reaction was stirred at 0 °C for 1.5 h. The brownish reaction mixture was filtered through a plug of Celite and washed with EtOAc (15 mL). The filtrates were transferred to a separating funnel, and the organic layer was isolated. The aqueous layer was extracted with EtOAc (2 × 15 mL), and the combined organic phases were washed with brine (25 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude product was isolated as a dark-brown oil by evaporation in vacuo (179 mg). Purification by DCVC (5–25% EtOAc in heptane containing 1% AcOH) afforded compound <b>10a</b> and <b>11</b>, respectively. For <b>10a</b>: White foam (36 mg, 22%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.88–7.84 (1H, m), 7.49 (1H, t, <i>J</i> = 7.7 Hz), 6.98–6.94 (1H, m), 4.36 (0.5H, d, <i>J</i> = 5.9 Hz), 4.25 (0.5H, d, <i>J</i> = 7.0 Hz), 3.86–3.73 (2H, m), 3.64–3.45 (1H, m), 2.40–2.30 (1H, m), 2.13–2.02 (1H, m), 1.76 (6H, s), 1.54 (5H, s), 1.45 (4H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 196.3, 183.3, 174.9, 174.4, 173.7, 172.8, 161.1, 155.6, 154.9, 153.6, 135.5, 135.2, 134.9, 127.8, 127.5, 117.6, 113.3, 106.5, 81.1, 80.8, 65.6, 65.3, 61.4, 61.2, 49.8, 49.0, 48.1, 47.3, 46.3, 45.9, 45.4, 32.6, 32.4, 29.7, 28.4, 28.2, 25.8 (rotamers). MS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>18</sub>NO<sub>5</sub> [M – Boc + H]<sup>+</sup> 292.1, found 292.1. <i>R</i><sub>f</sub> 0.25 (50% EtOAc in heptane +1% AcOH); [α]<sup>25</sup><sub>D</sub> +21.8° (<i>c</i> 0.21 abs. EtOH); mp 200 °C (decomp.). For <b>11</b>: White solid (62 mg, 40%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 10.77 (1H, bs), 7.04 (1H, d, <i>J</i> = 8.0 Hz), 6.85 (1H, s), 6.78 (1H, d, <i>J</i> = 8.3 Hz), 4.84 (2H, s), 4.36 (0.5H, bs), 4.21 (0.5H, d, <i>J</i> = 6.1 Hz), 3.81–3.41 (3H, m), 2.38–2.22 (1H, m), 2.04–1.94 (1H, m), 1.55 (6H, s), 1.51 (4H, s), 1.44 (5H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 178.1, 155.3, 153.6, 150.2, 132.5, 132.0, 126.6, 126.5, 123.1, 123.0, 119.4, 117.2, 99.5, 81.1, 80.7, 65.8, 60.8, 49.3, 47.3, 46.3, 46.0, 33.0, 32.6, 28.5, 28.3, 24.8 (rotamers present). MS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>4</sub> [M – Boc + H]<sup>+</sup> 278.1, found 278.0. <i>R</i><sub>f</sub> 0.35 (50% EtOAc in heptane + 1% AcOH, KMnO<sub>4</sub> staining); [α]<sup>25</sup><sub>D</sub> +49.4° (<i>c</i> = 0.23, abs EtOH); mp 128–130 °C.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (2<i>S</i>,3<i>R</i>)-1-(<i>tert</i>-Butoxycarbonyl)-3-(3-carboxy-5-propoxyphenyl)pyrrolidine-2-carboxylic Acid (<b>10b</b>)</h5><div class="NLM_p last">Suspension A: NaIO<sub>4</sub> (1.92 g, 8.98 mmol, 9.98 equiv) was suspended in H<sub>2</sub>O (6 mL), and after stirring at rt for 5 min, RuCl<sub>3</sub>·H<sub>2</sub>O (8 mg, 0.035 mmol, 0.04 equiv) was added. The black suspension was stirred for 1 min at rt prior to use. Diol <b>9b</b> (276 mg, 0.90 mmol, 1.00 equiv) was dissolved in CH<sub>3</sub>CN (5 mL) and EtOAc (5 mL), cooled to 0 °C, and suspension A added dropwise. The flask containing suspension A was washed with H<sub>2</sub>O (2 mL), which was added the mixture. The mixture was left to stir at 0 °C for 1.5 h. The mixture was filtered through a plug of Celite, and the plug was afterward washed with EtOAc (2 × 5 mL). The organic phases were pooled in a separation funnel and H<sub>2</sub>O (20 mL) added. After separation of the two phases, the aqueous phase was extracted with EtOAc (2 × 20 mL). The pooled organic phases was washed with brine (20 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 3 cm, 30 mL fractions, 0–50% EtOAc in heptane containing 2% AcOH) to yield diacid <b>10b</b> (196 mg, 66%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 11.0 (2H, bs), 7.59 (1H, m), 7.49 (1H, m), 7.06 (1H, m), 4.46 (0.4H, d, <i>J</i> = 6 Hz), 4.30 (0.6H, d, <i>J</i> = 7 Hz), 3.97 (2H, t, <i>J</i> = 7 Hz), 3.86–3.50 (3H, m), 2.35 (1H, m), 2.09 (1H, m), 1.83 (2H, h, <i>J</i> = 7 Hz), 1.52 (4H, s), 1.44 (5H, s), 1.06 (3H, t, <i>J</i> = 7 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 178.3, 176.7, 171.5, 171.4, 159.4, 155.0, 153.8, 142.6, 142.1, 131.0, 130.9, 121.1, 121.0, 119.9, 119.7, 113.8, 113.7, 81.3, 81.2, 69.9, 65.7, 65.2, 49.8, 48.1, 46.4, 46.2, 33.1, 32.7, 28.6, 28.4. MS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>5</sub> [M – Boc + H]<sup>+</sup> 294.1, found 294.1. <i>R</i><sub>f</sub> 0.36 (EtOAc:heptane:AcOH (40:20:1)).</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (2<i>S</i>,3<i>R</i>)-3-(3-(Benzyloxy)-5-carboxyphenyl)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic Acid (<b>10c</b>)</h5><div class="NLM_p last">Suspension A: NaIO<sub>4</sub> (2.40 g, 11.22 mmol, 10.0 equiv) and RuCl<sub>3</sub>·H<sub>2</sub>O (10 mg, 0.044 mmol, 0.04 equiv) were suspended in H<sub>2</sub>O (7.5 mL) and stirred at rt for 1 min prior to use. Diol <b>9c</b> (462 mg, 1.12 mmol, 1.00 equiv) was dissolved in CH<sub>3</sub>CN (10 mL) and EtOAc (10 mL), cooled to 0 °C, and suspension A added dropwise over the course of 15 min. The flask containing suspension A was washed with H<sub>2</sub>O (7.5 mL), to which was added the mixture over the course of 5 min. The mixture was left to stir at 0 °C for 2 h. The mixture was filtered through a plug of Celite, and the plug was afterward washed with EtOAc (2 × 20 mL). The organic phases were pooled in a separation funnel and H<sub>2</sub>O (40 mL) added. After separation of the two phases, the aqueous phase was extracted with EtOAc (2 × 50 mL). The pooled organic phases were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 3 cm, 30 mL fractions, 0–50% EtOAc in heptane containing 2% AcOH) to yield diacid <b>10c</b> (410 mg, 83%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.40–7.75 (2H, bs), 7.64–7.57 (2H, m), 7.47–7.30 (5H, m), 7.14 (1H, t, <i>J</i> = 7 Hz), 5.10 (2H, s), 4.44 (0.5H, d, <i>J</i> = 6 Hz), 4.28 (0.5H, d, <i>J</i> = 7 Hz), 3.85–3.45 (3H, m), 2.34 (1H, m), 2.06 (1H, m), 1.52 (4.5H, s), 1.44 (4.5H, s). <sup>13</sup>C NMR (75 MHz, DMSO): δ 173.3, 172.8, 166.8, 158.4, 153.2, 152.7, 143.1, 142.7, 136.6, 132.2, 128.3, 127.8, 127.7, 120.7, 120.6, 118.7, 118.5, 113.3, 79.1, 69.4, 65.4, 65.1, 49.1, 48.0, 46.0, 32.6, 32.1, 28.2, 28.0. MS (<i>m</i>/<i>z</i>) calcd for C<sub>19</sub>H<sub>20</sub>NO<sub>5</sub> [M – Boc + H]<sup>+</sup> 342.1, found 342.2. <i>R</i><sub>f</sub> 0.36 (EtOAc:heptane:AcOH (10:5:0.1)); [α]<sup>35</sup><sub>D</sub> +49.7° (<i>c</i> = 0.39, abs EtOH).</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (2<i>S</i>,3<i>R</i>)-3-(3-([1,1′-Biphenyl]-3-ylmethoxy)-5-carboxyphenyl)-1-(<i>tert</i>-butoxycarbonyl)-pyrrolidine-2-carboxylic Acid (<b>10d</b>)</h5><div class="NLM_p last">Suspension A: NaIO<sub>4</sub> (1.71 g, 11.46 mmol, 16.4 equiv) and RuCl<sub>3</sub>·H<sub>2</sub>O (8 mg, 0.035 mmol, 0.05 equiv) were suspended in H<sub>2</sub>O (6 mL) and stirred at rt for 1 min prior to use. Diol <b>9d</b> (342 mg, 0.699 mmol, 1.00 equiv) was dissolved in CH<sub>3</sub>CN (8 mL) and EtOAc (8 mL), cooled to 0 °C, and suspension A added dropwise over the course of 15 min. The flask containing suspension A was washed with H<sub>2</sub>O (6 mL), to which was added the mixture over the course of 5 min. The mixture was left to stir at 0 °C for 2 h. The mixture was filtered through a plug of Celite, and the plug was afterward washed with EtOAc (2 × 15 mL). The organic phases were pooled in a separation funnel and H<sub>2</sub>O (40 mL) added. After separation of the two phases, the aqueous phase was extracted with EtOAc (2 × 50 mL). The pooled organic phases was washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 3 cm, 30 mL fractions, 0–45% EtOAc in heptane containing 2% AcOH) to yield diacid <b>10d</b> (250 mg, 69%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.69–7.54 (6H, m), 7.50–7.31 (5H, m), 7.17 (1H, t, <i>J</i> = 2 Hz), 5.16 (2H, s), 4.45 (0.5H, d, <i>J</i> = 6 Hz), 4.29 (0.5H, d, <i>J</i> = 8 Hz), 3.86–3.45 (3H, m), 2.35 (1H, m), 2.07 (1H, m), 1.52 (4.5H, s), 1.44 (4.5H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 178.3, 177.4, 175.5, 171.3, 159.2, 155.6, 153.7, 142.9, 142.3, 141.8, 140.8, 136.8, 131.1, 129.2, 128.9, 127.6, 127.3, 127.2, 126.7, 126.6, 122.0, 121.7, 120.3, 114.1, 81.8, 81.3, 70.5, 65.7, 65.4, 50.0, 47.8, 46.6, 46.3, 33.1, 32.8, 28.7, 28.5. MS (<i>m</i>/<i>z</i>) calcd for C<sub>25</sub>H<sub>24</sub>NO<sub>5</sub> [M – Boc + H]<sup>+</sup> 418.2, found: 418.2. <i>R</i><sub>f</sub> 0.40 (EtOAc:heptane:AcOH (10:5:0.1)); [α]<sup>35</sup><sub>D</sub> +42.7° (<i>c</i> = 0.33, abs EtOH).</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 3-Bromo-5-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)phenol (<b>16</b>)</h5><div class="NLM_p">Commercially available acid <b>15</b> (10.0 g, 46.8 mmol, 1.00 equiv) was dissolved in dry THF (60 mL) under an atmosphere of nitrogen and cooled to 0 °C. To this solution was added BH<sub>3</sub>·THF complex (70 mL, 70 mmol, 1.50 equiv) over the course of 30 min (gas formation). After stirring at 0 °C for 15 min, the reaction mixture was left to stir at rt overnight. The mixture was transferred to a separation funnel containing phosphate buffer (100 mL, pH 7) and added Et<sub>2</sub>O (100 mL). The phases were separated and the aqueous phase extracted with EtOAc (2 × 75 mL). The combined organic phases was washed with brine (80 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield a white solid.</div><div class="NLM_p last">The solid was dissolved in DMF (20 mL) and cooled 0 °C under an atmosphere of nitrogen. Imidazole (4.13 g, 60.7 mmol, 1.30 equiv) was added followed by portionwise addition of TBSCl (7.95 g, 52.7 mmol, 1.13 equiv) over the course of 1 min. The mixture was left to stir at 0 °C for 15 min and then 10 min at rt before DMF (10 mL) was added due to extensive formation of solid material. The mixture was left to stir at rt overnight. The mixture was transferred to a separation funnel containing Et<sub>2</sub>O (100 mL), EtOAc (100 mL), and satd NaHCO<sub>3</sub> (100 mL). The organic phase was washed with water (3 × 100 mL) and brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by DCVC (diameter = 6 cm, 50 mL fractions, 0–30% EtOAc in heptane) to yield <b>16</b> (10.4 g, 71%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.01 (1H, s), 6.86 (1H, s), 6.74 (1H, s), 6.66 (2H, s), 5.64 (1H, s), 0.96 (9H, s), 0.13 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 156.3, 144.8, 122.6, 121.5, 117.4, 112.0, 64.3, 26.2, 18.7, −5.0. <i>R</i><sub>f</sub> 0.20 (EtOAc:heptane (1:10)).</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (3<i>S</i>,4<i>R</i>,5<i>S</i>)-<i>tert</i>-Butyl 3-Allyl-5-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(3-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)phenyl)-2-oxopyrrolidine-1-carboxylate (<b>19a</b>)</h5><div class="NLM_p last">Compound <b>18</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (2.76 g, 5.02 mmol, 1.00 equiv) was dissolved in dry THF (20 mL) and cooled to −78 °C. A solution of LHMDS in THF (6.02 mL, 6.02 mmol, 1.20 equiv) was added dropwise over the course of 20 min. The solution was stirred at −78 °C for 1 h before adding allyl bromide (1.70 mL, 2.43 g, 20.1 mmol, 4.0 equiv) dropwise over the course of 15 min. After stirring at −78 °C for 15 min, the solution was transferred to an acetone bath cooled to −52 °C (the temperature was maintained at this temperature by use of a cryostat) and stirred at this temperature for 20 h. The reaction mixture was quenched with satd NH<sub>4</sub>Cl (5 mL) over the course of 5 min and transferred to a separation funnel with EtOAc (75 mL) and satd NaHCO<sub>3</sub> (75 mL). The aqueous phase was extracted with EtOAc (75 mL), and the combined organic phases were washed with brine (60 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by DCVC (diameter 7 cm, 75 mL fractions, 0–2.5% EtOAc in toluene) to yield <b>19a</b> (1.44 g, 49%) as a viscous, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.29 (1H, t, <i>J</i> = 8 Hz), 7.23–7.16 (2H, m), 7.09 (1H, dm, <i>J</i> = 8 Hz), 5.68 (1H, m), 5.10–4.98 (2H, m), 4.13 (1H, dd, <i>J</i> = 10, 3 Hz), 3.98 (1H, ddd, <i>J</i> = 7, 3, 2 Hz), 3.54 (1H, dd, <i>J</i> = 11, 2 Hz), 3.34 (1H, dd, <i>J</i> = 10, 7 Hz), 2.74 (1H, m), 2.58–2.37 (2H, m), 1.56 (9H, s), 0.95 (9H, s), 0.91 (9H, s), 0.11 (6H, s), 0.06 (3H, s), 0.05 (3H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 150.1, 142.2, 141.8, 134.8, 128.8, 126.4, 125.6, 124.9, 117.7, 83.1, 65.0, 64.9, 60.6, 50.4, 42.9, 34.0, 28.3, 26.1, 26.0, 18.6, 18.4, −5.0, −5.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>27</sub>H<sub>48</sub>NO<sub>3</sub>Si [M – Boc + H]<sup>+</sup> 490.3, found 490.3. <i>R</i><sub>f</sub> 0.41 (EtOAc:toluene (1:20)); [α]<sup>22</sup><sub>D</sub> −2.7° (<i>c</i> = 0.49, EtOAc).</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (3<i>S</i>,4<i>R</i>,5<i>R</i>)-<i>tert</i>-Butyl 3-Benzyl-5-((<i>tert</i>-butyldimethylsilyloxy)methyl)-4-(3-((<i>tert</i>-butyldimethylsilyloxy)methyl)phenyl)-2-oxocyclopentanecarboxylate (<b>19b</b>)</h5><div class="NLM_p last">Compound <b>18</b> (1.20 g, 2.18 mmol, 1.00 equiv) was dissolved in dry THF (4.7 mL) and cooled to −78 °C. A 1 M solution of LHMDS in THF (2.60 mmol, 2.60 mL, 1.19 equiv) was added dropwise over the course of 20 min. The solution was stirred at −78 °C for 1 h before adding benzyl bromide (1.3 mL, 1.9 g, 11 mmol, 5.0 equiv) dropwise over the course of 15 min. After stirring at −78 °C for 15 min, the solution was transferred to an CH<sub>3</sub>CN/dry ice bath (−42 °C) and stirred at this temperature for 5 h. The reaction mixture was quenched with satd NH<sub>4</sub>Cl (5 mL) and transferred to a separation funnel with EtOAc (30 mL) and satd NaHCO<sub>3</sub> (15 mL). The aqueous phase was extracted with EtOAc (2 × 30 mL), and the combined organic phases were washed with brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by flash chromatography (2.5% EtOAc in toluene) to afford <b>19b</b> (1.00 g, 72%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45–7.06 (7H, m), 6.92 (1H, s), 6.84 (1H, dm, <i>J</i> = 7 Hz), 4.65 (2H, s), 4.02 (1H, dd, <i>J</i> = 10, 4 Hz), 3.95 (1H, m), 3.52 (1H, dd, <i>J</i> = 11, 2 Hz), 3.22 (1H, m), 3.15–2.95 (3H, m), 1.57 (9H, s), 0.96 (9H, s), 0.87 (9H, s), 0.11 (6H, s), 0.02 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.8, 150.1, 142.02, 141.97, 138.2, 137.9, 129.6, 129.1, 128.7, 128.32, 128.25, 126.4, 126.1, 125.3, 125.2, 124.7, 83.1, 65.2, 64.9, 60.9, 52.6, 43.0, 35.6, 28.3, 26.2, 26.1, 21.7, 18.7, 18.5, −4.9, −5.12, −5.15. MS (<i>m</i>/<i>z</i>) calcd for C<sub>31</sub>H<sub>50</sub>NO<sub>3</sub>Si<sub>2</sub> [M – Boc + H]<sup>+</sup> 540.3, found 540.4. <i>R</i><sub>f</sub> 0.34 (EtOAc:toluene (1:19)); [α]<sup>20</sup><sub>D</sub> +4.6° (<i>c</i> = 0.56, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-<i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-4-propyl-3-(<i>m</i>-tolyl)pyrrolidine-1-carboxylate (<b>20a</b>)</h5><div class="NLM_p last">Compound <b>19a</b> (1.24 g, 2.10 mmol, 1.00 equiv) was dissolved in dry THF (6 mL) and dry EtOH (32 mL) added. The mixture was thoroughly purged with nitrogen, followed by thoroughly purging with hydrogen gas. The mixture was stirred under an atmosphere of hydrogen (1 atm) for 18 h. The mixture was filtered through a plug of Celite, which was afterward washed with EtOAc (5 × 5 mL). The mixture was concentrated in vacuo to yield a colorless but slightly milky oil. (b) The colorless oil was dissolved in dry THF (15 mL) and 1 M BH<sub>3</sub>·THF complex (20 mL, 20 mmol, 9.52 equiv) added and stirred at reflux for 1.5 h and afterward 18 h at rt. The mixture was cooled to 0 °C, and THF (32 mL) was added. Afterward, H<sub>2</sub>O (6 mL) was added dropwise over the course of 2 h, 2 M NaOH (25 mL) over the course of 30 min, and 30% H<sub>2</sub>O<sub>2</sub> (10 mL) over the course of 15 min. After being stirred for 5 min at 0 °C, the mixture was removed from the ice bath and left to stir at rt for 1 h. The reaction mixture was quenched with satd NaHCO<sub>3</sub> (75 mL) and transferred to a separation funnel with EtOAc (50 mL). The aqueous phase was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with brine (75 mL), dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo. The crude product was purified using DCVC (diameter 4 cm, 30 mL fractions, 0–6% EtOAc in heptanes) to yield <b>20a</b> (551 mg, 59%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.24–7.16 (1H, m), 7.08–6.99 (3H, m), 4.19 (0.5H, dd, <i>J</i> = 11, 3 Hz), 4.08 (0.5H, dd, <i>J</i> = 11, 7 Hz), 3.98–3.84 (1H, m), 3.77 (0.5H, dm, <i>J</i> = 9 Hz), 3.66 (0.5H, dm, <i>J</i> = 9 Hz), 3.52 (0.5H, d, <i>J</i> = 10 Hz), 3.41 (0.5H, d, <i>J</i> = 10 Hz), 3.15–3.02 (1H, m), 2.89 (1H, t, <i>J</i> = 11 Hz), 2.36 (3H, m), 2.30–2.05 (1H, m), 1.51 (4.5H, s), 1.49 (4.5H, s), 1.45–1.08 (4H, m), 0.91 (4.5H, s), 0.90 (4.5H, s), 0.83 (3H, t, <i>J</i> = 7 Hz), 0.04 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.1, 154.0, 141.7, 141.4, 138.1, 129.1, 128.44, 128.35, 127.5, 125.7, 125.3, 79.4, 79.1, 66.8, 61.6, 59.9, 53.72, 53.65, 53.0, 52.2, 45.6, 45.2, 34.1, 28.8, 26.1, 21.7, 21.6, 18.4, 14.6, −5.1, −5.2. MS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>38</sub>NOSi [M – Boc – TBS-O + H]<sup>+</sup> 348.3, found 348.3. <i>R</i><sub>f</sub> 0.37 (EtOAc:heptane (1:10)); [α]<sup>22</sup><sub>D</sub> −29.8° (<i>c</i> = 0.43, EtOAc).</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-<i>tert</i>-Butyl 4-Benzyl-2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-3-(3-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)phenyl)pyrrolidine-1-carboxylate (<b>20b</b>)</h5><div class="NLM_p last">Compound <b>19b</b> (370 mg, 0.58 mmol, 1.00 equiv) was dissolved in dry THF (2.5 mL) and a solution of 1 M BH<sub>3</sub>·THF (3.5 mL, 3.5 mmol, 6.0 equiv) added and stirred at reflux for 21 h. The mixture was cooled to 0 °C, and THF (7.4 mL) was added dropwise. Afterward, H<sub>2</sub>O (0.3 mL), 2 M NaOH (4.7 mL), and H<sub>2</sub>O<sub>2</sub> (30%, 1.7 mL) were added dropwise in that particular order. After being stirred for 5 min at 0 °C, the mixture was removed from the ice bath and left to stir at rt for 1.5 h. The reaction mixture was quenched with satd NaHCO<sub>3</sub> (5 mL) and transferred to a separation funnel with EtOAc (20 mL). The aqueous phase was extracted with EtOAc (2 × 30 mL), and the combined organic phases were washed with brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified using flash chromatography (5% EtOAc in heptane) to afford <b>20b</b> (108 mg, 30%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.10 (7H, m), 7.08–7.00 (2H, m), 4.78 (2H, s), 4.22 (0.44H, dm, <i>J</i> = 11 Hz), 4.00–3.85 (1H, m), 3.84–3.67 (1.55H, m), 3.53 (0.55H, d, <i>J</i> = 10 Hz), 3.43 (0.45H, d, <i>J</i> = 11 Hz), 3.27 (1H, t, <i>J</i> = 10 Hz), 3.01 (1H, t, <i>J</i> = 11 Hz), 2.76 (1H, dm, <i>J</i> = 12 Hz), 2.57–2.33 (2H, m), 1.46 (9H, s), 0.98 (9H, s), 0.92 (9H, s), 0.15 (6H, s), 0.05 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.0, 153.9, 141.9, 141.8, 141.0, 140.8, 140.1, 139.9, 128.7, 128.6, 128.3, 127.1, 126.4, 126.1, 126.0, 124.7, 79.5, 79.2, 66.8, 65.1, 61.5, 59.8, 53.04, 52.98, 52.7, 51.5, 47.3, 37.6, 28.8, 26.2, 26.1, 18.7, 18.4, −4.9, −5.1. MS (<i>m</i>/<i>z</i>) calcd for C<sub>31</sub>H<sub>52</sub>NO<sub>2</sub>Si<sub>2</sub> [M – Boc + H]<sup>+</sup> 526.4, found 526.4. <i>R</i><sub>f</sub> 0.48 (EtOAc:heptane (1:4)); [α]<sup>20</sup><sub>D</sub> −15.3° (<i>c</i> = 0.51, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-<i>tert</i>-Butyl 2-(Hydroxymethyl)-4-propyl-3-(<i>m</i>-tolyl)pyrrolidine-1-carboxylate (<b>21a</b>)</h5><div class="NLM_p last">Compound <b>20a</b> (515 mg, 1.11 mmol, 1.00 equiv) was dissolved in dry THF (10 mL) in a dry flask and 1 M TBAF (4.8 mL, 4.8 mmol, 4.32 equiv) added. The mixture was left to stir at rt for 18 h. The mixture was quenched using satd NaHCO<sub>3</sub> (40 mL) and transferred to a separation funnel containing EtOAc (40 mL). The aqueous phase was extracted with EtOAc (2 × 40 mL), and the combined organic phases were washed with brine (75 mL), dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified using DCVC (dia = 3 cm, 25 mL fractions, 0–18% EtOAc in toluene) to yield <b>21a</b> (340 mg, 89%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (1H, t, <i>J</i> = 8 Hz), 7.08–6.95 (3H, m), 5.31 (0.7H, dm, <i>J</i> = 8 Hz), 4.00–3.70 (2H, m), 3.70–3.45 (2H, m), 2.96 (1H, t, <i>J</i> = 11 Hz), 2.35 (3H, s), 2.35–2.10 (2H, m), 1.51 (9H, s), 1.40–1.20 (2H, m), 1.20–1.05 (2H, m), 0.81 (3H, t, <i>J</i> = 7 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 156.8, 139.2, 138.3, 128.9, 128.6, 128.1, 125.5, 80.6, 68.5, 66.0, 54.8, 53.2, 44.8, 33.8, 28.7, 21.7, 21.4, 14.5. MS (<i>m</i>/<i>z</i>) calcd for C<sub>16</sub>H<sub>24</sub>NO<sub>3</sub> [M – O<sup><i>t</i></sup>Bu + H]<sup>+</sup> 278.2, found 278.2. <i>R</i><sub>f</sub> 0.22 (EtOAc:toluene (2:15)); [α]<sup>22</sup><sub>D</sub> −48.2° (<i>c</i> = 0.53, EtOAc).</div></div><div id="sec4_1_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-<i>tert</i>-Butyl 4-Benzyl-2-(hydroxymethyl)-3-(3-(hydroxymethyl)phenyl)pyrrolidine-1-carboxylate (<b>21b</b>)</h5><div class="NLM_p last">Compound <b>20b</b> (453 mg, 0.73 mmol, 1.00 equiv) was dissolved in dry THF (4 mL) and 1 M TBAF in THF (2.2 mL, 2.2 mmol, 3.0 equiv) added. The solution was stirred at rt for 21 h under an atmosphere of nitrogen. The mixture was quenched with satd NaHCO<sub>3</sub> (1 mL) and H<sub>2</sub>O (1 mL). The mixture was transferred to a separation funnel containing EtOAc (10 mL) and brine (10 mL). The aqueous phase was extracted with EtOAc (2 × 20 mL), and the combined organic phases were washed with brine (10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The mixture was purified by flash chromatography (33% heptane in EtOAc) to afford <b>21b</b> as a white foam (252 mg, 79%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.13 (7H, m), 7.04–6.99 (2H, m), 5.31 (1H, dm, <i>J</i> = 8 Hz), 4.67 (2H, m), 4.00–3.45 (4H, m), 3.07 (1H, m), 2.75–2.65 (1H, m), 2.60–2.30 (4H, m), 1.47 (9H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 156.5, 141.8, 139.4, 139.0, 128.9, 128.5, 128.3, 127.4, 126.7, 126.1, 126.0, 80.8, 68.3, 65.5, 64.9, 54.1, 52.6, 46.3, 37.4, 28.6. MS (<i>m</i>/<i>z</i>) calcd for C<sub>20</sub>H<sub>24</sub>NO<sub>4</sub> [M −<sup><i>t</i></sup>Bu + H]<sup>+</sup> 342.2, found 342.1. <i>R</i><sub>f</sub> 0.38 (EtOAc:heptane (2:1)); [α]<sup>20</sup><sub>D</sub> −28.3 (<i>c</i> = 0.57, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-1-(<i>tert</i>-Butoxycarbonyl)-3-(3-carboxyphenyl)-4-propylpyrrolidine-2-carboxylic Acid (<b>22a</b>)</h5><div class="NLM_p last">The diol <b>21a</b> (303 mg, 0.87 mmol, 1.00 equiv) was dissolved in CH<sub>3</sub>CN (5 mL) and EtOAc (5 mL), cooled to 0 °C, and a suspension of NaIO<sub>4</sub> (1.86 g, 8.70 mmol, 10.00 equiv) and RuCl<sub>3</sub>·H<sub>2</sub>O (8.0 mg, 0.035 mmol, 0.04 equiv) in H<sub>2</sub>O (4 mL) added dropwise. Additional H<sub>2</sub>O (4 mL) was used to rinse the flask for efficient transfer of reagents. The reaction mixture was stirred at 0 °C for approximately 1.5 h, followed by filtration through a plug of Celite, which was washed with EtOAc (3 × 10 mL). To the filtrate was added H<sub>2</sub>O (40 mL) and brine (5 mL), and the organic layer was separated. The aqueous layer was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried over anhydrous MgSO<sub>4</sub>, filtered, and evaporated in vacuo to dryness. The crude product was purified by DCVC, which afforded the diacid <b>22a</b> as a white solid (304 mg, 93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.04–7.97 (2H, m), 7.54–7.43 (2H, m), 4.39 (0.5H, d, <i>J</i> = 9.0 Hz), 4.26 (0.5H, d, <i>J</i> = 9.5 Hz), 4.04 (0.5H, dd, <i>J</i> = 10.5, 7.3 Hz), 3.96 (0.5H, dd, <i>J</i> = 10.7, 7.4 Hz), 3.22–3.03 (2H, m), 2.41–2.30 (1H, m), 1.52 (4H, s), 1.43 (5H, s), 1.30–1.18 (4H, m), 0.83–0.79 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 178.3, 177.0, 175.4, 171.5, 155.4, 153.4, 139.6, 139.1, 133.7, 133.1, 130.0, 129.7, 129.6, 129.5 (2 peaks), 129.2, 129.1, 81.6, 81.0, 66.9, 66.6, 56.7, 55.0, 52.5, 51.9, 46.1, 45.6, 33.3, 33.2, 28.4, 28.3, 21.2, 20.7, 14.1 (rotamers). MS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>4</sub> [M – Boc + 2H]<sup>+</sup> 278.1, found 278.2. mp. 130–135 °C; [α]<sup>25</sup><sub>D</sub> +3.0° (<i>c</i> = 0.33, EtOH).</div></div><div id="sec4_1_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-Benzyl-1-(<i>tert</i>-butoxycarbonyl)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic Acid (<b>22b</b>)</h5><div class="NLM_p last">Suspension A: NaIO<sub>4</sub> (451 mg, 2.11 mmol, 8.22 equiv) and RuCl<sub>3</sub>·H<sub>2</sub>O (1.1 mg, 0.005 mmol, 0.02 equiv) were suspended in H<sub>2</sub>O (3 mL) and stirred at rt for 1 min prior to use. Diol <b>21b</b> (102 mg, 0.26 mmol, 1.00 equiv) was dissolved in CH<sub>3</sub>CN (2 mL) and EtOAc (2 mL). Suspension A was dropwise added to the reaction mixture over the course of 5 min and stirred at rt for 30 min. The mixture was filtered through a plug of Celite, and the plug was afterward washed with EtOAc (2 × 5 mL). The aqueous phase was extracted with EtOAc (2 × 10 mL), and the combined organic phases were washed with brine (10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by DCVC (0–25% EtOAc in heptane containing 2% AcOH) to afford <b>22b</b> (50 mg, 45%) as white foam. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 11.31 (2H, bs), 8.06–7.97 (2H, m), 7.56–7.41 (2H, m), 7.27–7.08 (3H, m), 7.06–6.96 (2H, m), 4.42 (0.39H, d, <i>J</i> = 9 Hz), 4.28 (0.61H, d, <i>J</i> = 9 Hz), 3.99–3.71 (1H, m), 3.37–3.13 (2H, m), 2.78–2.57 (2H, m), 2.57–2.42 (1H, m), 1.47 (3.3H, s), 1.42 (5.7H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 177.9, 176.3, 171.3, 154.8, 153.3, 139.2, 139.0, 138.9, 138.7, 133.5, 133.2, 130.2, 129.65, 129.58, 129.2, 128.5, 126.4, 81.4, 81.1, 66.7, 67.0, 56.2, 54.9, 52.2, 51.8, 48.1, 47.5, 37.4, 37.2, 28.6, 28.4. MS (<i>m</i>/<i>z</i>) calcd for C<sub>19</sub>H<sub>20</sub>NO<sub>4</sub> [M – Boc + H]<sup>+</sup> 326.1, found 326.2. <i>R</i><sub>f</sub> 0.47 (EtOAc:heptane:AcOH (32:16:1)); [α]<sup>20</sup><sub>D</sub> +28.0° (<i>c</i> = 0.10, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> (4<i>R</i>,5<i>S</i>)-<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-5-[[(<i>tert</i>-butyl)dimethylsilyloxy]methyl]-4-(3-bromophenyl)pyrrolidin-2-one (<b>23</b>)</h5><div class="NLM_p last">To a solution of 1,3-dibromobenzene (5.4 g, 22.9 mmol) in dry THF (37 mL) at −78 °C was added <i>n</i>-BuLi (22.9 mmol; 3 equiv). After stirring for 20 min, a slurry of CuCN (1.025 g, 11.45 mmol) in THF (5 mL) was added. The reaction mixture was allowed to warm to −50 °C for 20 min. The flask was recooled to −78 °C for 25 min, and a solution of enone <b>5</b> (2.5 g; 7.63 mmol) in THF (8.25 mL) was added followed by addition of TMSCl (2.07 g; 2.42 mL; 19.05 mmol). The flask was allowed to warm to −50 °C and then stirred at this temperature 80 min. The reaction was quenched by satd NH<sub>4</sub>Cl (20 mL), and the organic layer was extracted by EtOAc (2 × 200 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification by flash column chromatography (EtOAc/heptane 1:9) gave <b>23</b> (2.13 g, 58%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.76–6.82 (4H, m), 4.06 (1H, m), 4.00 (1H, dd, <i>J =</i> 10.5, 3.8 Hz), 3.81 (1H, dd, <i>J =</i> 10.5, 2.1 Hz), 3.43 (1H, d, <i>J =</i> 9.4 Hz), 3.16 (1H, dd, <i>J =</i> 17.8, 9.6 Hz), 2.51 (1H, dd, <i>J =</i> 17.8, 2.5 Hz), 1.55 (9H, s), 0.92 (9H, s), 0.09 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 149.7, 146.4, 130.6, 130.2, 129.7, 124.8, 123.0, 83.2, 66.4, 63.6, 39.8, 38.5, 28.0, 25.8, 18.2, −5.5. mp. 87.3 °C; [α] <sub>D</sub><sup>25</sup> −26.6° (<i>c</i> = 0.51, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (2<i>S</i>,3<i>R</i>)-<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-2-[[(<i>tert</i>-butyl)dimethylsilyloxy]methyl]-3-(3-bromophenyl)pyrrolidine (<b>24</b>)</h5><div class="NLM_p last">To a solution of <b>23</b> (180 mg; 0.37 mmol) in THF (1.6 mL) was added a solution of BH<sub>3</sub>·THF (2.47 mmol; 1N solution), and the reaction mixture was stirring under reflux for 20 h. The flask was cooled to 0 °C for 20 min and the solution diluted with THF (4.5 mL). H<sub>2</sub>O (0.2 mL) was added, followed by NaOH (3.04 mL; 6.08 mmol; 2 N solution) and H<sub>2</sub>O<sub>2</sub> (0.95 mL; 10.97 mmol; 35% in water). The reaction mixture was allowed to warm up to rt for 80 min and quenched by saturated NaHCO<sub>3</sub> (3 mL). The aqueous phase was extracted with EtOAc (3 × 15 mL), and the combined organic layers were washed with brine (3 × 30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. Purification by flash column chromatography (EtOAc:heptane (1:9)) gave <b>24</b> (127 mg, 73%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, two rotamers): δ 7.30 (2H, m), 7.23–7.05 (2H, m), 4.04–3.57 (4H, m), 3.54–3.44 (1H, m), 3.34 (1H, dd, <i>J =</i> 14.4, 8.7 Hz), 2.27 (1H, dd, <i>J =</i> 12.4, 6.5 Hz), 1.96–1.80 (1H, m), 1.48 (9H, s), 0.90 (9H, s), 0.06 (6H, d, <i>J =</i> 10.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, two rotamers): δ 154.1, 146.3, 145.9, 130.4, 130.3, 130.1, 129.5, 128.5, 127.3, 127.1, 126.4, 125.9, 125.8, 122.6, 79.6, 79.2, 65.3, 65.2, 62.9, 61.5, 46.8, 46.4, 46.2, 45.3, 32.6, 31.5, 28.5, 25.8, 18.1, −5.4. [α]<sup>24</sup><sub>D</sub> +1.9° (<i>c</i> = 0.62, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> (2<i>S</i>,3<i>R</i>)-<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-2-[[(<i>tert</i>-butyl)dimethylsilyloxy]methyl]-3-(3-diethylphosphonate)pyrrolidine (<b>25</b>)</h5><div class="NLM_p last">To a solution of <b>24</b> (0.217 mmol; 102 mg) in dry THF (5 mL) at −78 °C was added <i>n</i>-BuLi (0.16 mL, 1.4 M solution, 1.00 equiv) over 10 min. After stirring for 15 min at −78 °C, ClPO<sub>3</sub>Et<sub>2</sub> (37 μL, 1.2 equiv) was added, and the reaction mixture was stirred at −78 °C for 1 h and then quenched by addition of satd NaHCO<sub>3</sub> (1.5 mL). The aqueous phase was extracted by EtOAc (3 × 30 mL), and the combined organic phases were washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. Purification by flash column chromatography (EtOAc:heptane 2:8, then EtOAc:heptane (1:1)) gave <b>25</b> (75.4 mg, 66%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, two rotamers): δ 7.75–7.58 (2H, m), 7.45–7.32 (2H, m), 4.22–3.95 (4H, m), 3.90–3.50 (5H, m), 3.45–3.29 (1H, m), 2.38–2.21 (1H, m), 2.00–1.81 (1H, m), 1.47 (9H, s) 1.35 (6H, t, <i>J =</i> 7.1 Hz), 0.90 (9H, s) 0.04 (6H, s). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, two rotamers and carbon–phosphor coupling): δ 154.0, 131.3, 131.2, 130.7, 130.5, 130.4, 129.9, 129.7, 128.9, 128.6, 127.4, 79.6, 79.2, 65.3, 62.8, 62.1, 62.0, 61.4, 46.9, 46.6, 46.3, 45.5, 32.6, 31.7, 28.5, 25.8, 18.1, 16.4, 16.3, −5.4. <i>R</i><sub>f</sub> 0.18 (EtOAc:heptane (1:1)); [α]<sup>24</sup><sub>D</sub> +0.8° (<i>c</i> = 0.58, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_1_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (2<i>S</i>,3<i>R</i>)-<i>tert</i>-Butyl 3-(3-(Diethoxyphosphoryl)phenyl)-2-(hydroxymethyl)pyrrolidine-1-carboxylate (<b>26</b>)</h5><div class="NLM_p last">To a solution of <b>25</b> (468 mg, 0.849 mmol, 1.00 equiv) in dry THF (8 mL) was added TBAF (2.66 mL, 1 M solution in THF, 3.00 equiv). The reaction mixture was stirred for 1 h at rt and then quenched by addition of satd NaHCO<sub>3</sub>:H<sub>2</sub>O (1:1) (8 mL). The aqueous phase was extracted with EtOAc (3 × 100 mL), and the combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. Purification by flash column chromatography (EtOAc) gave <b>26</b> (253 mg, 65%) as a colorless oil. <i>R</i><sub>f</sub> 0.21 (EtOAc 100%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, two rotamers): δ 7.74–7.61 (2H, m), 7.46–7.37 (2H, m), 5.05 (1H, br s), 4.24–4.00 (1H, m), 3.99–3.88 (1H, m), 3.86–3.56 (4H, m), 3.43–3.28 (1H, m), 3.01–2.88 (1H, m), 2.25–2.08 (1H, m), 2.08–1.91 (1H, m), 1.50 (9H, s), 1.33 (6H, t, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, two rotamers and carbon–phosphor coupling): δ 156.9, 142.0, 141.8, 132.0, 131.6, 131.4, 130.8, 130.5, 129.4, 129.2, 128.0, 80.9, 67.4, 65.9, 65.8, 62.6, 47.9, 47.4, 33.2, 28.8, 16.8, 16.7. [α]<sup>24</sup><sub>D</sub> −2.8° (<i>c</i> = 0.61, CH<sub>2</sub>Cl<sub>2</sub>).</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Pharmacology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Binding Affinity at Native iGluRs</h4><div class="NLM_p last">Affinities for AMPA, KA, and NMDA receptors in rat cortical synaptosomes were determined using 5 nM [<sup>3</sup>H]AMPA, 5 nM [<sup>3</sup>H]KA, and 2 nM [<sup>3</sup>H]CGP39653, respectively, with minor modifications as previously described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Competition radioligand binding to native and cloned rat iGluR was carried out as previously detailed.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> X-ray Structures</h3><div class="NLM_p">Rat GluA2-LBD,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> comprising segment S1 residues 413–527, a GT linker, and segment S2 residues 653–797 (numbering including signal peptide), was expressed and purified in the presence of <span class="smallcaps smallerCapital">l</span>-Asp as previously reported.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Rat GluK1 LBD (GRIK1_RAT, UNP P22756, segment S1 residues 445–559, a GT linker, and segment S2 residues 682–820) was expressed and purified in the presence of Glu as previously described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Crystallization of GluA2-LBD with <b>2e</b></h4><div class="NLM_p last">GluA2-LBD in complex with <b>2e</b> was crystallized using the hanging drop vapor diffusion method at 7 °C. The crystals containing <b>2e</b> were obtained by coincidence when attempting to crystallize GluA2-LBD with <b>2d</b>. This implies that <b>2d</b> to some extent has been degraded into <b>2e</b> or that compound <b>2d</b> contains minor amounts of <b>2e</b>. The protein solution consisted of 5.0 mg/mL GluA2-LBD in 10 mM HEPES, pH 7.0, 20 mM NaCl, and 1 mM EDTA. Solid <b>2d</b> was added to the diluted protein solution and left to equilibrate overnight. Precipitation was removed before setting up the drops. The drop contained 1 μL of the complex solution and 1 μL of reservoir solution (20% PEG4000, 0.1 M lithium sulfate, and 0.1 M phosphate citrate buffer, pH 4.5). Reservoir volume was 0.5 mL. The crystals were flash cooled in liquid nitrogen after soaking in cryobuffer consisting of the reservoir solution with 20% glycerol added. Flash-cooled crystals were stored in liquid nitrogen until data collection.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Crystallization of GluK1-LBD with <b>2f</b></h4><div class="NLM_p last">GluK1-LBD in complex with <b>2f</b> was crystallized using the hanging drop vapor diffusion method at 7 °C. The drop contained 1 μL of the complex solution (5.5 mg/mL GluK1-LBD and 12.5 mM <b>2f</b> in 10 mM HEPES, pH 7.0, 20 mM NaCl, and 1 mM EDTA) and 1 μL of reservoir solution (20% PEG8000, 0.3 M lithium sulfate, and 0.1 M Tris pH 8.0). Reservoir volume was 0.5 mL. The crystals were flash cooled in liquid nitrogen after soaking in cryobuffer consisting of the reservoir solution with 20% glycerol added.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Data Collection and Structure Determination</h3><div class="NLM_p">X-ray data of the GluA2-LBD in complex with <b>2e</b> and GluK1-LBD in complex with <b>2f</b> were collected at the I911-3 (MX) beamline (MaxLab, Lund, Sweden).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Data processing was performed using MOSFLM<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> within the CCP4i suite of programs<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (<b>2e</b> complex) or XDS<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (<b>2f</b> complex). The data were scaled and merged using SCALA<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> within the CCP4i suite of programs.</div><div class="NLM_p">Structure determinations were carried out using molecular replacement and the program PHASER<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> implemented in CCP4i. The GluA2-LBD with an antagonist (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TZA">3TZA</a>, molA<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>) was used as a search model for solving the structure of GluA2-LBD with <b>2e</b>, including protein atoms only. The search model was divided into two domains: D1 (411–514, 749–791) and D2 (515–527+GT+653–748). A solution was found, showing electron density for two molecules in the asymmetric unit of the crystal for the complex with <b>2e</b>. Missing residues, <b>2e</b>, and other ions and molecules from the crystallization buffer were gradually built into the structure using the program COOT.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Ligand coordinates were created in Maestro (Maestro version 9.5, Schrödinger, LLC, New York, NY, 2013), whereas topology and parameter files for the ligand <b>2e</b> were obtained using eLBOW.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The structures were refined in PHENIX<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> using individual isotropic <i>B</i>-factors and TLS. Between refinement steps, the structure was inspected and corrected in COOT. For statistics on data collection and refinements, see <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_p">The structure of GluK1-LBD with <b>2f</b> was solved by molecular replacement using PHASER within CCP4i, and the structure of GluK1-LBD with an antagonist (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DLD">4DLD</a>, molA; protein atoms only)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> was used as a search model. The search model was defined as two domains: D1 (446–552, 780–820) and D2 (553–559+GT+682–779). Two molecules were found in the asymmetric unit of the crystal. Subsequently, the amino acid residues of the GluK1 LBD complex were automatically built using AutoBuild within Phenix except for a few residues, which were manually built using COOT. Visual inspection of the structure in COOT revealed clear density corresponding to the ligand <b>2f</b>. The ligand coordinates were created in Maestro (Maestro version 9.8, Schrödinger, LLC, New York, NY, 2014) and fitted into the electron density. Topology and parameter files for <b>2f</b> were obtained using eLBOW. The structure was refined in PHENIX with isotropic <i>B</i> factors, TLS, and riding H atoms. Between refinement steps, the structure was inspected and corrected in COOT. Gradually, acetate and chloride ions, as well as water, ethylene glycol, and PEG molecules, were manually modeled into the electron densities. For statistics on data collection and refinements, see <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Structure Validation and Analysis</h4><div class="NLM_p last">The structures were validated using tools in PHENIX and COOT. Domain openings of GluA2-LBD were calculated relative to the structure of GluA2-LBD with glutamate (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTJ">1FTJ</a>, molB),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> using the DynDom Server.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Domain openings of GluK1-LBD in complex with <b>2f</b> were determined relative to the structure of GluK1-LBD with glutamate (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F36">2F36</a>, molA).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Figures were prepared in PyMOL (The PyMOL Molecular Graphics System, version 1.3, and version 1.5.0.5, Schrödinger, LLC).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> In Silico Study</h4><div class="NLM_p last">The modeling study was performed using the software package MOE 2013.08 (Molecular Operating Environment, Chemical Computing Group) using the built-in mmff94x force field and the GB/SA continuum solvation model. Docking: The receptor proteins were prepared for docking by running the algorithm Protonate 3D. Docking studies were performed using the <i>Induced Fit</i> algorithm under standard setup with the mmff94x force field, solvation set to distance, and <i>ligand atoms</i> selected as docking site. Explicit water molecules in the binding site were excluded during the docking process.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00750">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Crystal data and data collection statistics of GluA2-LBD in complex with <b>2d</b> and the ligand binding domain of GluA2 in complex with <b>2d</b>(PDF). SMILES data (CSV). The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00750" class="ext-link">10.1021/acs.jmedchem.5b00750</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00750/suppl_file/jm5b00750_si_001.pdf">jm5b00750_si_001.pdf (369.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00750/suppl_file/jm5b00750_si_002.csv">jm5b00750_si_002.csv (3.89 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors have been deposited in the Protein Data Bank: GluA2-LBD with <b>2e</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMA">4YMA</a>) and GluK1-LBD with <b>2f</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMB">4YMB</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b00750" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karla Frydenvang</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#98f3f9eaf4f9b6feeae1fcfdf6eef9f6ffd8ebedf6fcb6f3edb6fcf3"><span class="__cf_email__" data-cfemail="c2a9a3b0aea3eca4b0bba6a7acb4a3aca582b1b7aca6eca9b7eca6a9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lennart Bunch</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2a464f485f6a595f444e04415f044e41"><span class="__cf_email__" data-cfemail="fe929b9c8bbe8d8b909ad0958bd09a95">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niels Krogsgaard-Larsen</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morten Storgaard</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charlotte Møller</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles S. Demmer</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeanette Hansen</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liwei Han</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rune N. Monrad</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birgitte Nielsen</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Tapken</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darryl S. Pickering</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jette S. Kastrup</span> - <span class="hlFld-Affiliation affiliation">†Chemical Neuroscience Group, ‡Biostructural Research
Group, §Medicinal
Chemistry Group, ∥Molecular, Cellular Pharmacology Group, Department of Drug Design and Pharmacology, Faculty of Health and
Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.K.-L. and M.S. contributed equally to this work</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d829e7326-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank the Danish Research Council (FSS), the Lundbeck Foundation, The Carlsberg Foundation, GluTarget, Danscatt, and the European Community’s Seventh Framework Programme (FP7/2007-2013) BioStruct-X under grant agreement no. 283570 for financial support. Heidi Peterson is thanked for help with expression and purification of GluA2-LBD, and MAX-Lab, Lund, Sweden, is thanked for providing beam time.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COSY</td><td class="NLM_def"><p class="first last">homonuclear correlation spectroscopy</p></td></tr><tr><td class="NLM_term">D1</td><td class="NLM_def"><p class="first last">domain 1 of the LBD</p></td></tr><tr><td class="NLM_term">D2</td><td class="NLM_def"><p class="first last">domain 2 of the LBD</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DCVC</td><td class="NLM_def"><p class="first last">dry column vacuum chromatography</p></td></tr><tr><td class="NLM_term">KA</td><td class="NLM_def"><p class="first last">kainic acid (kainate at pH = 7)</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">(<i>S</i>)-glutamate</p></td></tr><tr><td class="NLM_term">GluA2-LBD</td><td class="NLM_def"><p class="first last">ligand binding domain of GluA2</p></td></tr><tr><td class="NLM_term">HMQC</td><td class="NLM_def"><p class="first last">heteronuclear multiple-bond correlation</p></td></tr><tr><td class="NLM_term">iGluR</td><td class="NLM_def"><p class="first last">ionotropic Glu receptor</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domain</p></td></tr><tr><td class="NLM_term">LHMDS</td><td class="NLM_def"><p class="first last">lithium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">mGluR</td><td class="NLM_def"><p class="first last">metabotropic Glu receptor</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TBSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TMSCl</td><td class="NLM_def"><p class="first last">trimethylsilyl chloride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Meldrum, B. S.</span><span> </span><span class="NLM_article-title">Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology</span> <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007S</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015S</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1093%2Fjn%2F130.4.1007S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10736372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1eiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1007S-1015S&author=B.+S.+Meldrum&title=Glutamate+as+a+Neurotransmitter+in+the+Brain%3A+Review+of+Physiology+and+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate as a neurotransmitter in the brain: review of physiology and pathology</span></div><div class="casAuthors">Meldrum, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4S</span>),
    <span class="NLM_cas:pages">1007S-1015S</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">A review with 107 refs.  Glutamate is the principal excitatory neurotransmitter in brain.  The knowledge of the glutamatergic synapse has advanced enormously in the last 10 yr, primarily through application of mol. biol. techniques to the study of glutamate receptors and transporters.  There are three families of ionotropic receptors with intrinsic cation permeable channels [N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate].  There are three groups of metabotropic, G protein-coupled glutamate receptors (mGluR) that modify neuronal and glial excitability through G protein subunits acting on membrane ion channels and second messengers such as diacylglycerol and cAMP.  There are also two glial glutamate transporters and three neuronal transporters in the brain.  Glutamate is the most abundant amino acid in the diet.  There is no evidence for brain damage in humans resulting from dietary glutamate.  A kainate analog, domoate, is sometimes ingested accidentally in blue mussels; this potent toxin causes limbic seizures, which can lead to hippocampal and related pathol. and amnesia.  Endogenous glutamate, by activating NMDA, AMPA or mGluR1 receptors, may contribute to the brain damage occurring acutely after status epilepticus, cerebral ischemia or traumatic brain injury.  It may also contribute to chronic neurodegeneration in such disorders as amyotrophic lateral sclerosis and Huntington's chorea.  In animal models of cerebral ischemia and traumatic brain injury, NMDA and AMPA receptor antagonists protect against acute brain damage and delayed behavioral deficits.  Such compds. are undergoing testing in humans, but therapeutic efficacy has yet to be established.  Other clin. conditions that may respond to drugs acting on glutamatergic transmission include epilepsy, amnesia, anxiety, hyperalgesia and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKb4ZXcCmp-7Vg90H21EOLACvtfcHk0lj92L33TIMi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1eiu7c%253D&md5=01ad34f6a1483ea6dd2766e15d73bd01</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F130.4.1007S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F130.4.1007S%26sid%3Dliteratum%253Aachs%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DGlutamate%2520as%2520a%2520Neurotransmitter%2520in%2520the%2520Brain%253A%2520Review%2520of%2520Physiology%2520and%2520Pathology%26jtitle%3DJ.%2520Nutr.%26date%3D2000%26volume%3D130%26spage%3D1007S%26epage%3D1015S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Anggono, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huganir, R. L.</span><span> </span><span class="NLM_article-title">Regulation of AMPA Receptor Trafficking and Synaptic Plasticity</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1016/j.conb.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.conb.2011.12.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=461-469&author=V.+Anggonoauthor=R.+L.+Huganir&title=Regulation+of+AMPA+Receptor+Trafficking+and+Synaptic+Plasticity&doi=10.1016%2Fj.conb.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DAnggono%26aufirst%3DV.%26aulast%3DHuganir%26aufirst%3DR.%2BL.%26atitle%3DRegulation%2520of%2520AMPA%2520Receptor%2520Trafficking%2520and%2520Synaptic%2520Plasticity%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2012%26volume%3D22%26spage%3D461%26epage%3D469%26doi%3D10.1016%2Fj.conb.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lovinger, D. M.</span><span> </span><span class="NLM_article-title">Neurotransmitter Roles in Synaptic Modulation, Plasticity and Learning in the Dorsal Striatum</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2010.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20096294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVektrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=951-961&author=D.+M.+Lovinger&title=Neurotransmitter+Roles+in+Synaptic+Modulation%2C+Plasticity+and+Learning+in+the+Dorsal+Striatum&doi=10.1016%2Fj.neuropharm.2010.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum</span></div><div class="casAuthors">Lovinger, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-961</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dorsal striatum is a large forebrain region involved in action initiation, timing, control, learning and memory.  Learning and remembering skilled movement sequences requires the dorsal striatum, and striatal subregions participate in both goal-directed (action-outcome) and habitual (stimulus-response) learning.  Modulation of synaptic transmission plays a large part in controlling input to as well as the output from striatal medium spiny projection neurons (MSNs).  Synapses in this brain region are subject to short-term modulation, including allosteric alterations in ion channel function and prominent presynaptic inhibition.  Two forms of long-term synaptic plasticity have also been obsd. in striatum, long-term potentiation (LTP) and long-term depression (LTD).  LTP at glutamatergic synapses onto MSNs involves activation of NMDA-type glutamate receptors and D1 dopamine or A2A adenosine receptors.  Expression of LTP appears to involve postsynaptic mechanisms.  LTD at glutamatergic synapses involves retrograde endocannabinoid signaling stimulated by activation of metabotropic glutamate receptors (mGluRs) and D2 dopamine receptors.  While postsynaptic mechanisms participate in LTD induction, maintained expression involves presynaptic mechanisms.  A similar form of LTD has also been obsd. at GABAergic synapses onto MSNs.  Studies have just begun to examine the roles of synaptic plasticity in striatal-based learning.  Findings to date indicate that mols. implicated in induction of plasticity participate in these forms of learning.  Neurotransmitter receptors involved in LTP induction are necessary for proper skill and goal-directed instrumental learning.  Interestingly, receptors involved in LTP and LTD at glutamatergic synapses onto MSNs of the "indirect pathway" appear to have important roles in habit learning.  More work is needed to reveal if and when synaptic plasticity occurs during learning and if so what mols. and cellular processes, both short- and long-term, contribute to this plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGote-5gnOPC57Vg90H21EOLACvtfcHk0lh3WDP2SXBBXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVektrg%253D&md5=7ce322f4b31795632446b3417c014ab3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DLovinger%26aufirst%3DD.%2BM.%26atitle%3DNeurotransmitter%2520Roles%2520in%2520Synaptic%2520Modulation%252C%2520Plasticity%2520and%2520Learning%2520in%2520the%2520Dorsal%2520Striatum%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D951%26epage%3D961%26doi%3D10.1016%2Fj.neuropharm.2010.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Cocaine and Amphetamine-like Psychostimulants: Neurocircuitry and Glutamate Neuroplasticity</span> <span class="citation_source-journal">Dialogues Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18286799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ivVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=389-397&author=P.+W.+Kalivas&title=Cocaine+and+Amphetamine-like+Psychostimulants%3A+Neurocircuitry+and+Glutamate+Neuroplasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity</span></div><div class="casAuthors">Kalivas Peter W</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-97</span>
        ISSN:<span class="NLM_cas:issn">1294-8322</span>.
    </div><div class="casAbstract">Although the pharmacology of amphetamine-like psychostimulants at dopamine transporters is well understood, addiction to this class of drugs has proven difficult to deal with.  The reason for this disconnection is that while the molecular mechanism of amphetamine action is critical to reinforce drug use, it is only the first step in a sequence of widespread neuroplastic events in brain circuitry.  This review outlines the affect of psychostimulants on mesocorticolimbic dopamine projections that mediate their reinforcing effect, and how this action ultimately leads to enduring pathological neuroplasticity in glutamatergic projections from the prefrontal cortex to the nucleus accumbens.  Molecular neuroadaptations induced by psychostimulant abuse are described in glutamate neurotransmission, and from this information potential pharmacotherapeutic targets are identified, based upon reversing or countermanding psychostimulant-induced neuroplasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQD9KXpjMZxgHp3bfzSLaX5fW6udTcc2eZ323QhaT9EJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ivVegtw%253D%253D&md5=612056ab28b3c50a5e1033dd2e3f9963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DCocaine%2520and%2520Amphetamine-like%2520Psychostimulants%253A%2520Neurocircuitry%2520and%2520Glutamate%2520Neuroplasticity%26jtitle%3DDialogues%2520Clin.%2520Neurosci.%26date%3D2007%26volume%3D9%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ruiz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullmann, D. M.</span><span> </span><span class="NLM_article-title">Ionotropic Receptors at Hippocampal Mossy Fibers: Roles in Axonal Excitability, Synaptic Transmission, and Plasticity</span> <span class="citation_source-journal">Front. Neural Circuits</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="refDoi"> DOI: 10.3389/fncir.2012.00112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.3389%2Ffncir.2012.00112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23316138" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=112&author=A.+J.+Ruizauthor=D.+M.+Kullmann&title=Ionotropic+Receptors+at+Hippocampal+Mossy+Fibers%3A+Roles+in+Axonal+Excitability%2C+Synaptic+Transmission%2C+and+Plasticity&doi=10.3389%2Ffncir.2012.00112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffncir.2012.00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncir.2012.00112%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DA.%2BJ.%26aulast%3DKullmann%26aufirst%3DD.%2BM.%26atitle%3DIonotropic%2520Receptors%2520at%2520Hippocampal%2520Mossy%2520Fibers%253A%2520Roles%2520in%2520Axonal%2520Excitability%252C%2520Synaptic%2520Transmission%252C%2520and%2520Plasticity%26jtitle%3DFront.%2520Neural%2520Circuits%26date%3D2013%26volume%3D6%26spage%3D112%26doi%3D10.3389%2Ffncir.2012.00112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mellor, J. R.</span><span> </span><span class="NLM_article-title">Synaptic Plasticity of Kainate Receptors</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.1042/BST0340949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1042%2FBST0340949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17052234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=949-951&author=J.+R.+Mellor&title=Synaptic+Plasticity+of+Kainate+Receptors&doi=10.1042%2FBST0340949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic plasticity of kainate receptors</span></div><div class="casAuthors">Mellor, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">949-951</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Synaptic plasticity of ionotropic glutamate receptors has been extensively studied with a particular focus on the role played by NMDA (N-methyl-D-aspartate) receptors in the induction of synaptic plasticity and the subsequent movement of AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors.  The third subtype of ionotropic glutamate receptor, kainate receptors, has not been studied to the same extent, but recent evidence shows that these receptors also exhibit synaptic plasticity in response to activity.  There is also a growing body of data on the mechanisms underlying kainate receptor trafficking and the proteins they interact with.  This review summarizes the current state of knowledge on this topic, focusing on the evidence for the removal or insertion of functional kainate receptors in response to synaptic activity and the cellular mechanisms that underlie this regulation of neuronal kainate receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEQGzAejuFB7Vg90H21EOLACvtfcHk0lhJDhb46GjeTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb3O&md5=e8301e7e3fc20c1af6d49a8dae2c7b72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBST0340949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340949%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DJ.%2BR.%26atitle%3DSynaptic%2520Plasticity%2520of%2520Kainate%2520Receptors%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D949%26epage%3D951%26doi%3D10.1042%2FBST0340949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span> </span><span class="NLM_article-title">Kainate Receptors: Pharmacology, Function and Therapeutic Potential</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2008.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18793656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FkvVantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=90-113&author=D.+E.+Janeauthor=D.+Lodgeauthor=G.+L.+Collingridge&title=Kainate+Receptors%3A+Pharmacology%2C+Function+and+Therapeutic+Potential&doi=10.1016%2Fj.neuropharm.2008.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Kainate receptors: pharmacology, function and therapeutic potential</span></div><div class="casAuthors">Jane David E; Lodge David; Collingridge Graham L</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-113</span>
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    </div><div class="casAbstract">Compared to the other glutamate receptors, progress in the understanding of the functions of kainate receptors (KARs) has lagged behind, due mainly to the relative lack of specific pharmacological tools.  Over the last decade subunit selective agonists (e.g.  ATPA and 5-iodowillardiine) and orthosteric (e.g.  LY382884 and ACET) and allosteric antagonists for KARs that contain GluK1 (GluR5) subunits have been developed.  However, no selective ligands for the other KAR subunits have been identified.  The use of GluK1 antagonists has enabled several functions of KARs, that contain this subunit, to be identified.  Thus, KARs have been shown to regulate excitatory and inhibitory synaptic transmission.  In the case of the regulation of L-glutamate release, they can function as facilitatory autoreceptors or inhibitory autoreceptors during repetitive synaptic activation and can respond to ambient levels of L-glutamate to provide a tonic regulation of L-glutamate release.  KARs also contribute a component of excitatory synaptic transmission at certain synapses.  They can also act as triggers for both long-term potentiation (LTP) and long-term depression (LTD) and rapid alterations in their trafficking can result in altered synaptic transmission during both synaptic plasticity and neuronal development.  KARs also contribute to synchronised rhythmic activity in the brain and are involved in forms of learning and memory.  With respect to therapeutic indications, antagonists for GluK1 have shown positive activity in animal models of pain, migraine, epilepsy, stroke and anxiety.  This potential has now been confirmed in dental pain and migraine in initial studies in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR1K3JQEA6lWyYR5VtavbzfW6udTcc2eYr9KtRZ4xdwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FkvVantA%253D%253D&md5=bd4bbdccdf7b3178730e63167476188a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DKainate%2520Receptors%253A%2520Pharmacology%252C%2520Function%2520and%2520Therapeutic%2520Potential%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26spage%3D90%26epage%3D113%26doi%3D10.1016%2Fj.neuropharm.2008.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Sanacora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treccani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, M.</span><span> </span><span class="NLM_article-title">Towards a Glutamate Hypothesis of Depression: An Emerging Frontier of Neuropsychopharmacology for Mood Disorders</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2011.07.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=63-77&author=G.+Sanacoraauthor=G.+Treccaniauthor=M.+Popoli&title=Towards+a+Glutamate+Hypothesis+of+Depression%3A+An+Emerging+Frontier+of+Neuropsychopharmacology+for+Mood+Disorders&doi=10.1016%2Fj.neuropharm.2011.07.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DSanacora%26aufirst%3DG.%26aulast%3DTreccani%26aufirst%3DG.%26aulast%3DPopoli%26aufirst%3DM.%26atitle%3DTowards%2520a%2520Glutamate%2520Hypothesis%2520of%2520Depression%253A%2520An%2520Emerging%2520Frontier%2520of%2520Neuropsychopharmacology%2520for%2520Mood%2520Disorders%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D63%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2011.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanacora, G.</span><span> </span><span class="NLM_article-title">Glutamate-Based Depression GBD</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span><span class="refDoi"> DOI: 10.1016/j.mehy.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.mehy.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22391030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XltlantLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=675-681&author=D.+J.+McCarthyauthor=R.+Alexanderauthor=M.+A.+Smithauthor=S.+Pathakauthor=S.+Kanesauthor=C.-M.+Leeauthor=G.+Sanacora&title=Glutamate-Based+Depression+GBD&doi=10.1016%2Fj.mehy.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate-based depression GBD</span></div><div class="casAuthors">McCarthy, Dennis J.; Alexander, Robert; Smith, Mark A.; Pathak, Sanjeev; Kanes, Stephen; Lee, Chi-Ming; Sanacora, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">675-681</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  We describe a new term: glutamate-based depression (GBD).  GBD is defined as a chronic depressive illness assocd. with environmental stress and diseases assocd. with altered glutamate neurotransmission.  We hypothesize that glutamate-induced over-activation of extrasynaptic NMDA receptors in the subgenual cingulate area called Brodmann's 25 plays an important role in the etiol. of depression and may be responsible for the high incidence of co-morbid depression assocd. in diseases with glutamate etiol.  While depression is a syndrome with multiple possible etiologies, we propose that a disruption in glutamatergic neurotransmission may underline a substantial proportion of clin. obsd. depression.  The high rates of depressive symptoms assocd. with various disorders in which altered glutamatergic functions have been identified, may suggest a common pathophysiol. mechanism is underlying the diverse clin. presentations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprR_HdGR4iL7Vg90H21EOLACvtfcHk0lgfWcFwCbKK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltlantLg%253D&md5=15ac8bdcb7de0cbe4157e21e4d4c7376</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DKanes%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.-M.%26aulast%3DSanacora%26aufirst%3DG.%26atitle%3DGlutamate-Based%2520Depression%2520GBD%26jtitle%3DMed.%2520Hypotheses%26date%3D2012%26volume%3D78%26spage%3D675%26epage%3D681%26doi%3D10.1016%2Fj.mehy.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Riaza Bermudo-Soriano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Rodriguez, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero-Lorenzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca-Garcia, E.</span><span> </span><span class="NLM_article-title">New Perspectives in Glutamate and Anxiety</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.pbb.2011.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.pbb.2011.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2012&pages=752-774&author=C.+Riaza+Bermudo-Sorianoauthor=M.+M.+Perez-Rodriguezauthor=C.+Vaquero-Lorenzoauthor=E.+Baca-Garcia&title=New+Perspectives+in+Glutamate+and+Anxiety&doi=10.1016%2Fj.pbb.2011.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2011.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2011.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DRiaza%2BBermudo-Soriano%26aufirst%3DC.%26aulast%3DPerez-Rodriguez%26aufirst%3DM.%2BM.%26aulast%3DVaquero-Lorenzo%26aufirst%3DC.%26aulast%3DBaca-Garcia%26aufirst%3DE.%26atitle%3DNew%2520Perspectives%2520in%2520Glutamate%2520and%2520Anxiety%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2012%26volume%3D100%26spage%3D752%26epage%3D774%26doi%3D10.1016%2Fj.pbb.2011.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lea, P. M. th</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptor Subtype 5 Antagonists MPEP and MTEP</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2006.00149.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Fj.1527-3458.2006.00149.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=149-166&author=P.+M.+th+Leaauthor=A.+I.+Faden&title=Metabotropic+Glutamate+Receptor+Subtype+5+Antagonists+MPEP+and+MTEP&doi=10.1111%2Fj.1527-3458.2006.00149.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2006.00149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2006.00149.x%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DP.%2BM.%2Bth%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DMetabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Antagonists%2520MPEP%2520and%2520MTEP%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D149%26epage%3D166%26doi%3D10.1111%2Fj.1527-3458.2006.00149.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vikelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsikostas, D. D.</span><span> </span><span class="NLM_article-title">The Role of Glutamate and Its Receptors in Migraine</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.2174/187152707781387279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.2174%2F187152707781387279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17691981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=251-257&author=M.+Vikelisauthor=D.+D.+Mitsikostas&title=The+Role+of+Glutamate+and+Its+Receptors+in+Migraine&doi=10.2174%2F187152707781387279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glutamate and its receptors in migraine</span></div><div class="casAuthors">Vikelis, Michail; Mitsikostas, Dimos D.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-257</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate (Glu) is the principal excitatory neurotransmitter in the central nervous system.  Its receptors are classified into ionotropic receptors, which are ion channels and include NMDA, AMPA and kainate receptors, named after the agonists that selectively bind to them, and metabotropic receptors, which are G-protein coupled receptors.  The trigeminal system is considered to play a key role in migraine pathophysiol., trafficking pain signals from the head and face to the trigeminal nucleus caudalis.  The role of glutamate in the pathophysiol. of migraine is implicated by data from animal and human studies.  Animal studies include expts. of cortical spreading depression, studies of c-fos protein expression in trigeminal nucleus caudalis, studies of plasma protein extravasation and electrophysiol. studies.  Human studies investigating the role of Glu in migraine pathogenesis measured the levels of Glu in plasma, platelets and cerebrospinal fluid, studied its effect on migraine symptoms and examd. the effect of Glu in modulating sensitization.  Findings from both the animal and the human studies suggest a link between glutamate and migraine and further suggest that glutamate plays a key role in migraine mechanisms.  In the future, efforts should be made to further investigate the role of glutamate in migraine pathogenesis and, subsequently, in migraine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VOPUyFebWrVg90H21EOLACvtfcHk0li2tgre-7HpGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehsLfO&md5=5a05c3ccc1aa945cb2ab018b470f4c36</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F187152707781387279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707781387279%26sid%3Dliteratum%253Aachs%26aulast%3DVikelis%26aufirst%3DM.%26aulast%3DMitsikostas%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Role%2520of%2520Glutamate%2520and%2520Its%2520Receptors%2520in%2520Migraine%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D251%26epage%3D257%26doi%3D10.2174%2F187152707781387279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Weiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieckman, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens-Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkalla, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">772</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span><span class="refDoi"> DOI: 10.1124/jpet.106.101428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1124%2Fjpet.106.101428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16690725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=772-781&author=B.+Weissauthor=A.+Altauthor=A.+M.+Ogdenauthor=M.+Gatesauthor=D.+K.+Dieckmanauthor=A.+Clemens-Smithauthor=K.+H.+Hoauthor=K.+Jarvieauthor=G.+Rizkallaauthor=R.+A.+Wright&title=Pharmacological+Characterization+of+the+Competitive+GLUK5+Receptor+Antagonist+Decahydroisoquinoline+LY466195+in+Vitro+and+in+Vivo&doi=10.1124%2Fjpet.106.101428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo</span></div><div class="casAuthors">Weiss, Brianne; Alt, Andrew; Ogden, Ann Marie; Gates, Mary; Dieckman, Donna K.; Clemens-Smith, Amy; Ho, Ken H.; Jarvie, Keith; Rizkalla, Geihan; Wright, Rebecca A.; Calligaro, David O.; Schoepp, Darryle; Mattiuz, Edward L.; Stratford, Robert E.; Johnson, Bryan; Salhoff, Craig; Katofiasc, Mary; Phebus, Lee A.; Schenck, Kathryn; Cohen, Marlene; Filla, Sandra A.; Ornstein, Paul L.; Johnson, Kirk W.; Bleakman, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">772-781</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The excitatory neurotransmitter glutamate has been implicated in both migraine and persistent pain.  The identification of the kainate receptor GLUK5 in dorsal root ganglia, the dorsal horn, and trigeminal ganglia makes it a target of interest for these indications.  We examd. the in vitro and in vivo pharmacol. of the competitive GLUK5-selective kainate receptor antagonist LY466195, the most potent GLUK5 antagonist described to date.  Comparisons were made to the competitive GLUK5/α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonist LY293558 [(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid], other decahydroisoquinoline GLUK5 receptor antagonists, and the noncompetitive AMPA receptor antagonist LY300168 [1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodi-azepine].  When characterized electrophysiol. in rat dorsal root ganglion neurons, LY466195 antagonized kainate (30 μM)-induced currents with an IC50 value of 0.045 ± 0.011 μM.  In HEK293 cells transfected with GLUK5, GLUK2/GLUK5, or GLUK5/GLUK6 receptors, LY466195 produced IC50 values of 0.08 ± 0.02, 0.34 ± 0.17, and 0.07 ± 0.02 μM, resp.  LY466195 was efficacious in a dural plasma protein extravasation (PPE) model of migraine with an ID100 value of 100 μg/kg i.v.  LY466195 was also efficacious in the c-fos migraine model, with a dose of 1 μg/kg i.v. significantly reducing the no. of Fos-pos. cells in the rat nucleus caudalis after elec. stimulation of the trigeminal ganglion.  Furthermore, LY466195 showed no contractile activity in the rabbit saphenous vein in vitro.  The di-Et ester prodrug of LY466195 was also efficacious in the same PPE and c-fos models after oral administration at doses of 10 and 100 μg/kg, resp. while having no N-methyl-D-aspartate antagonist-like behavioral effects at oral doses up to 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwe6dtAoo61bVg90H21EOLACvtfcHk0li2tgre-7HpGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOltro%253D&md5=decb91d0148d7a4049f15e1c4622925a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101428%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DB.%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DOgden%26aufirst%3DA.%2BM.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DDieckman%26aufirst%3DD.%2BK.%26aulast%3DClemens-Smith%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DK.%2BH.%26aulast%3DJarvie%26aufirst%3DK.%26aulast%3DRizkalla%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DR.%2BA.%26atitle%3DPharmacological%2520Characterization%2520of%2520the%2520Competitive%2520GLUK5%2520Receptor%2520Antagonist%2520Decahydroisoquinoline%2520LY466195%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D772%26epage%3D781%26doi%3D10.1124%2Fjpet.106.101428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">De Bartolomeis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarappa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iasevoli, F.</span><span> </span><span class="NLM_article-title">Targeting Glutamate System for Novel Antipsychotic Approaches: Relevance for Residual Psychotic Symptoms and Treatment Resistant Schizophrenia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">682</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.ejphar.2012.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22387855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=682&publication_year=2012&pages=1-11&author=A.+De+Bartolomeisauthor=C.+Sarappaauthor=S.+Magaraauthor=F.+Iasevoli&title=Targeting+Glutamate+System+for+Novel+Antipsychotic+Approaches%3A+Relevance+for+Residual+Psychotic+Symptoms+and+Treatment+Resistant+Schizophrenia&doi=10.1016%2Fj.ejphar.2012.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia</span></div><div class="casAuthors">de Bartolomeis, Andrea; Sarappa, Chiara; Magara, Salvatore; Iasevoli, Felice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">682</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antipsychotics are the mainstay of schizophrenia treatment.  However, approx. one third of schizophrenic patients do not respond or respond poorly to antipsychotics.  Therefore, there is a need for new approaches that can improve schizophrenia treatment significantly.  Promising strategies arise from the modulation of glutamatergic system, according to its proposed involvement in schizophrenia pathogenesis.  In this review, we critically updated preclin. and clin. data on the modulation of glutamate N-methyl-D-aspartate (NMDA) receptor activity by NMDA-Rs co-agonists, glycine transporters inhibitors, AMPAkines, mGluR5 agonists, NMDA-Rs partial agonists.  We focused on: 1) preclin. results in animal models mimicking the pathophysiol. of psychosis, mainly believed to be responsible of neg. and cognitive symptoms, and predicting antipsychotic-like activity of these compds.; and 2) clin. efficacy in open-label and double-blind trials.  Albeit promising preclin. findings for virtually all compds., clin. efficacy has not been confirmed for D-cycloserine.  Contrasting evidence has been reported for glycine and D-serine, that may however have a role as add-on agents.  More promising results in humans have been found for glycine transporter inhibitors.  AMPAkines appear to be beneficial as pro-cognitive agents, while pos. allosteric modulators of mGluR5 have not been tested in humans.  Memantine has been proposed in early stages of schizophrenia, as it may counteract the effects of glutamate excitotoxicity correlated to high glutamate levels, slowing the progression of neg. symptoms assocd. to more advanced stages of the illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGEDAptXZnLVg90H21EOLACvtfcHk0lgkddDNQT1p2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggtb8%253D&md5=1f192ddf1f7dc0eb73a7f994c0f41bdf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBartolomeis%26aufirst%3DA.%26aulast%3DSarappa%26aufirst%3DC.%26aulast%3DMagara%26aufirst%3DS.%26aulast%3DIasevoli%26aufirst%3DF.%26atitle%3DTargeting%2520Glutamate%2520System%2520for%2520Novel%2520Antipsychotic%2520Approaches%253A%2520Relevance%2520for%2520Residual%2520Psychotic%2520Symptoms%2520and%2520Treatment%2520Resistant%2520Schizophrenia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D682%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.ejphar.2012.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benneyworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopaske, G.</span><span> </span><span class="NLM_article-title">Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1007/978-3-642-25758-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1007%2F978-3-642-25758-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23027419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=267-295&author=J.+T.+Coyleauthor=A.+Basuauthor=M.+Benneyworthauthor=D.+Baluauthor=G.+Konopaske&title=Glutamatergic+Synaptic+Dysregulation+in+Schizophrenia%3A+Therapeutic+Implications&doi=10.1007%2F978-3-642-25758-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications</span></div><div class="casAuthors">Coyle, Joseph T.; Basu, Alo; Benneyworth, Michael; Balu, Darrick; Konopaske, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">267-295</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Schizophrenia affects approx. 1% of the population and continues to be assocd. with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications.  An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clin. observations that NMDA receptor antagonists, the dissociative anesthetics like ketamine, can replicate in normal individuals the full range of symptoms of schizophrenia including psychosis, neg. symptoms, and cognitive impairments.  Low dose ketamine can also re-create a no. of physiol. abnormalities characteristic of schizophrenia.  Postmortem studies have revealed abnormalities in endogenous modulators of NMDA receptors in schizophrenia as well as components of a postsynaptic d. where NMDA receptors are localized.  Gene assocn. studies have revealed several genes that affect NMDA receptor function whose allelic variants are assocd. with increased risk for schizophrenia including genes encoding D-amino acid oxidase, its modulator G72, dysbindin, and neuregulin.  The parvalbumin-pos., fast-firing GABAergic interneurons that provide recurrent inhibition to cortical-limbic pyramidal neurons seem to be most sensitive to NMDA receptor hypofunction.  As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and neg. symptoms, and drives subcortical dopamine release, resulting in psychosis.  Drugs designed to correct the cortical-limbic dysregulated glutamatergic neurotransmission show promise for reducing neg. and cognitive symptoms of schizophrenia as well as its pos. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUOYchIYYK7Vg90H21EOLACvtfcHk0ljIgZGOBaDiVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D&md5=1cda996ff05ed79c6ff89bc9cac0d050</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBenneyworth%26aufirst%3DM.%26aulast%3DBalu%26aufirst%3DD.%26aulast%3DKonopaske%26aufirst%3DG.%26atitle%3DGlutamatergic%2520Synaptic%2520Dysregulation%2520in%2520Schizophrenia%253A%2520Therapeutic%2520Implications%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26spage%3D267%26epage%3D295%26doi%3D10.1007%2F978-3-642-25758-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Glutamatergic Theories of Schizophrenia</span> <span class="citation_source-journal">Isr. J. Psychiatry Relat. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20686195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BC3cjis1Glug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=4-16&author=D.+C.+Javitt&title=Glutamatergic+Theories+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic theories of schizophrenia</span></div><div class="casAuthors">Javitt Daniel C</div><div class="citationInfo"><span class="NLM_cas:title">The Israel journal of psychiatry and related sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia is a serious mental disorder that affects up to 1% of the population worldwide.  Traditional models of schizophrenia have emphasized dopaminergic dysfunction.  Over the last 20 years, however, limitations of the dopamine model have become increasingly apparent, necessitating development of alternative models.  Glutamatergic models are based upon the observation that the psychotomimetic agents such as phencyclidine (PCP) and ketamine induce psychotic symptoms and neurocognitive disturbances similar to those of schizophrenia by blocking neurotransmission at N-methyl-D-aspartate (NMDA)-type glutamate receptors.  Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of NMDA receptors throughout the brain.  Further, NMDA receptors are located on brain circuits that regulate dopamine release, suggesting that dopaminergic deficits in schizophrenia may also be secondary to underlying glutamatergic dysfunction.  Agents that stimulate NMDA receptor-mediated neurotransmission, including glycine-site agonists and glycine transport inhibitors, have shown encouraging results in preclinical studies and are currently undergoing clinical development.  Encouraging results have been observed as well with agents such as metabotropic 2/3 agonists that decrease resting glutamate levels, reversing potential disruption in firing patterns within prefrontal cortex and possibly other brain regions.  Overall, these findings suggest that glutamatergic theories may lead to new conceptualizations and treatment approaches that would not be possible based upon dopaminergic models alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN9-HE38_eScAKB7Fa-xrUfW6udTcc2ebggsLb4J6HQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjis1Glug%253D%253D&md5=d55be824c89af674880f2269514c7a3c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlutamatergic%2520Theories%2520of%2520Schizophrenia%26jtitle%3DIsr.%2520J.%2520Psychiatry%2520Relat.%2520Sci.%26date%3D2010%26volume%3D47%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Almeida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. M.</span><span> </span><span class="NLM_article-title">Glutamate Neurotoxicity Is Associated with Nitric Oxide-Mediated Mitochondrial Dysfunction and Glutathione Depletion</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">790</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S0006-8993(98)00064-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS0006-8993%2898%2900064-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=9593899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=790&publication_year=1998&pages=209-216&author=A.+Almeidaauthor=S.+J.+Healesauthor=J.+P.+Bolanosauthor=J.+M.+Medina&title=Glutamate+Neurotoxicity+Is+Associated+with+Nitric+Oxide-Mediated+Mitochondrial+Dysfunction+and+Glutathione+Depletion&doi=10.1016%2FS0006-8993%2898%2900064-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion</span></div><div class="casAuthors">Almeida, Angeles; Heales, Simon J. R.; Bolanos, Juan P.; Medina, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">790</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The role of mitochondrial energy metab. in glutamate mediated neurotoxicity was studied in rat neurons in primary culture.  A brief (15 min) exposure of the neurons to glutamate caused a dose-dependent (0.01-1 mM) increase in cGMP levels together with delayed (24 h) neurotoxicity and ATP depletion.  These effects were prevented by either the nitric oxide (·NO) synthase (NOS) inhibitor Nω-nitro-L-arginine Me ester (NAME; 1 mM) or by the N-methyl-D-aspartate (NMDA) glutamate-subtype receptor antagonist d-(-)-2-amino-5-phosphonopentanoate (APV; 0.1 mM).  Glutamate exposure (0.1 mM and 1 mM) followed by 24 h of incubation caused the inhibition of succinate-cytochrome c reductase (20-25%) and cytochrome c oxidase (31%) activities in the surviving neurons, without affecting NADH-coenzyme-Q1 reductase activity.  The rate of oxygen consumption was impaired in neurons exposed to 1 mM glutamate, either with glucose (by 26%) or succinate (by 39%) as substrates.  These effects on the mitochondrial respiratory chain and neuronal respiration, together with the obsd. glutathione depletion (20%) by glutamate exposure were completely prevented by NAME or APV.  The results suggest that mitochondrial dysfunction and impairment of antioxidant status may account for glutamate-mediated neurotoxicity via a mechanism involving ·NO biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbRvzupIizbVg90H21EOLACvtfcHk0ljIgZGOBaDiVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVGrt7g%253D&md5=c3c7699550f0fc2845a1a5261c7c5628</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900064-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900064-X%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DA.%26aulast%3DHeales%26aufirst%3DS.%2BJ.%26aulast%3DBolanos%26aufirst%3DJ.%2BP.%26aulast%3DMedina%26aufirst%3DJ.%2BM.%26atitle%3DGlutamate%2520Neurotoxicity%2520Is%2520Associated%2520with%2520Nitric%2520Oxide-Mediated%2520Mitochondrial%2520Dysfunction%2520and%2520Glutathione%2520Depletion%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D790%26spage%3D209%26epage%3D216%26doi%3D10.1016%2FS0006-8993%2898%2900064-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takarada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, Y.</span><span> </span><span class="NLM_article-title">Possible Protection by Notoginsenoside R1 against Glutamate Neurotoxicity Mediated by N-Methyl-D-Aspartate Receptors Composed of an NR1/NR2B Subunit Assembly</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span><span class="refDoi"> DOI: 10.1002/jnr.22021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fjnr.22021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19224577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2rsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=2145-2156&author=B.+Guauthor=N.+Nakamichiauthor=W.-S.+Zhangauthor=Y.+Nakamuraauthor=Y.+Kambeauthor=R.+Fukumoriauthor=K.+Takumaauthor=K.+Yamadaauthor=T.+Takaradaauthor=H.+Taniuraauthor=Y.+Yoneda&title=Possible+Protection+by+Notoginsenoside+R1+against+Glutamate+Neurotoxicity+Mediated+by+N-Methyl-D-Aspartate+Receptors+Composed+of+an+NR1%2FNR2B+Subunit+Assembly&doi=10.1002%2Fjnr.22021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly</span></div><div class="casAuthors">Gu, Bin; Nakamichi, Noritaka; Zhang, Wen-Sheng; Nakamura, Yukary; Kambe, Yuki; Fukumori, Ryo; Takuma, Kazuhiro; Yamada, Kiyofumi; Takarada, Takeshi; Taniura, Hideo; Yoneda, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2145-2156</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Notoginsenoside R1 (NTR1) is the main active ingredient in Panax notoginseng, a herbal medicine widely used in Asia for years.  The purpose of this study was to investigate pharmacol. properties of NTR1 on neurotoxicity of glutamate (Glu) in primary cultured mouse cortical neurons along with its possible mechanism of action.  It was found that NTR1 significantly protected neurons from the loss of cellular viability caused by brief exposure to 10 μM Glu for 1 h in a dose-dependent manner at concns. from 0.1 to 10 μM, without affecting the viability alone.  NTR1 significantly inhibited the increased no. of cells pos. to propidium iodide (PI) staining, increase of intracellular free Ca2+ ions, overprodn. of intracellular reactive oxygen species, and depolarization of mitochondrial membrane potential in cultured neurons exposed to Glu, in addn. to blocking decreased Bcl-2 and increased Bax expression levels.  The target site at which NTR1 protects neurons from Glu toxicity was further evaluated by using the acquired expression strategy of N-methyl-D-aspartate (NMDA) receptor subunits in human embryonic kidney 293 cells.  It was found that 10 μM NTR1 protected NR1/NR2B subunit expressing cells from cell death by 100 μM NMDA, but not cells expressing NR1/NR2A subunits, when detd. by PI staining.  These results suggest that NTR1 may preferentially protect neurons from Glu excitotoxicity mediated by NMDA receptor composed of an NR1/NR2B subunit assembly in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbk7iwgM7TKLVg90H21EOLACvtfcHk0ljwppVAoWguJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2rsbo%253D&md5=aedd5ccd363d8fd1e6621da8f2b2da0b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22021%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DB.%26aulast%3DNakamichi%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.-S.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKambe%26aufirst%3DY.%26aulast%3DFukumori%26aufirst%3DR.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakarada%26aufirst%3DT.%26aulast%3DTaniura%26aufirst%3DH.%26aulast%3DYoneda%26aufirst%3DY.%26atitle%3DPossible%2520Protection%2520by%2520Notoginsenoside%2520R1%2520against%2520Glutamate%2520Neurotoxicity%2520Mediated%2520by%2520N-Methyl-D-Aspartate%2520Receptors%2520Composed%2520of%2520an%2520NR1%252FNR2B%2520Subunit%2520Assembly%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D2145%26epage%3D2156%26doi%3D10.1002%2Fjnr.22021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, G. N.</span><span> </span><span class="NLM_article-title">Cell Death Mechanisms in the Early Stages of Acute Glutamate Neurotoxicity</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.1016/j.neures.2009.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neures.2009.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19944120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=271-278&author=A.+Kumarauthor=R.+L.+Singhauthor=G.+N.+Babu&title=Cell+Death+Mechanisms+in+the+Early+Stages+of+Acute+Glutamate+Neurotoxicity&doi=10.1016%2Fj.neures.2009.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death mechanisms in the early stages of acute glutamate neurotoxicity</span></div><div class="casAuthors">Kumar, Alok; Singh, Ram Lakhan; Babu, G. Nagesh</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-278</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study focused on the early stages of acute glutamate (L-Glu)-induced neurotoxic mechanisms, both biochem., e.g. intracellular reactive oxygen species (ROS) and assocd. parameters as well as gene expression of cell survival/death pathways, i.e. Bcl-2 and caspases.  Stereotactic intracortical injections of L-Glu (1 μmol/1 μl) resulted in decreased size of pyramidal neurons in rat after 1 h.  We also obsd. that intracellular ROS, calcium (Ca2+) and peroxynitrite (ONOO-) prodn. were significantly elevated, whereas, mitochondrial transmembrane potential (ΔΨm) and total glutathione were significantly decreased by L-Glu bolus.  The Bcl-2/Bax ratio in the L-Glu-injected rats was found to be significantly lower than the controls.  Moreover, acute L-Glu significantly induced mRNA expression of nNOS, iNOS, caspase-3 and caspase-9.  It may be concluded from the present study that acute L-Glu administration, at an early stage, increases intracellular ROS accumulation, Ca2+ levels and peroxynitrite prodn. and decreases glutathione pool.  Furthermore, it appears that decreased mitochondrial Bcl-2/Bax ratio might have upregulated the mRNA expression of caspase-3 and caspase-9 which launch cell death cascade.  Regarding the chronol. of the events, we presume that acute L-Glu increases ROS and decreases ΔΨm and glutathione rapidly and it is more likely that these events precede gene expression changes, ultimately resulting in neuronal damage/death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQriJiaH5O1bVg90H21EOLACvtfcHk0linJJnJTHJhJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVaqu7s%253D&md5=7850c711ce9c9c4222e282a8cdff482f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2009.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2009.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%2BL.%26aulast%3DBabu%26aufirst%3DG.%2BN.%26atitle%3DCell%2520Death%2520Mechanisms%2520in%2520the%2520Early%2520Stages%2520of%2520Acute%2520Glutamate%2520Neurotoxicity%26jtitle%3DNeurosci.%2520Res.%26date%3D2010%26volume%3D66%26spage%3D271%26epage%3D278%26doi%3D10.1016%2Fj.neures.2009.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, C. G.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease, β-Amyloid, Glutamate, NMDA Receptors and Memantine--Searching for the Connections</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02057.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Fj.1476-5381.2012.02057.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22646481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=324-352&author=W.+Danyszauthor=C.+G.+Parsons&title=Alzheimer%E2%80%99s+Disease%2C+%CE%B2-Amyloid%2C+Glutamate%2C+NMDA+Receptors+and+Memantine%2D%2DSearching+for+the+Connections&doi=10.1111%2Fj.1476-5381.2012.02057.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections</span></div><div class="casAuthors">Danysz, Wojciech; Parsons, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-352</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Amyloid (Aβ) is widely accepted to be one of the major pathomechanisms underlying Alzheimer's disease (AD), although there is presently lively debate regarding the relative roles of particular species/forms of this peptide.  Most recent evidence indicates that sol. oligomers rather than plaques are the major cause of synaptic dysfunction and ultimately neurodegeneration.  Sol. oligomeric Aβ has been shown to interact with several proteins, for example glutamatergic receptors of the NMDA type and proteins responsible for maintaining glutamate homeostasis such as uptake and release.  As NMDA receptors are critically involved in neuronal plasticity including learning and memory, we felt that it would be valuable to provide an up to date review of the evidence connecting Aβ to these receptors and related neuronal plasticity.  Strong support for the clin. relevance of such interactions is provided by the NMDA receptor antagonist memantine.  This substance is the only NMDA receptor antagonist used clin. in the treatment of AD and therefore offers an excellent tool to facilitate translational extrapolations from in vitro studies through in vivo animal expts. to its ultimate clin. utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQTCiAIwYyrVg90H21EOLACvtfcHk0linJJnJTHJhJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShurfN&md5=fbf694fc7ef433aa83c13b48244d3e8e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02057.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02057.x%26sid%3Dliteratum%253Aachs%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DParsons%26aufirst%3DC.%2BG.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%252C%2520%25CE%25B2-Amyloid%252C%2520Glutamate%252C%2520NMDA%2520Receptors%2520and%2520Memantine--Searching%2520for%2520the%2520Connections%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D324%26epage%3D352%26doi%3D10.1111%2Fj.1476-5381.2012.02057.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">McKeage, K.</span><span> </span><span class="NLM_article-title">Memantine: A Review of Its Use in Moderate to Severe Alzheimer’s Disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.2165/11201020-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.2165%2F11201020-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=881-897&author=K.+McKeage&title=Memantine%3A+A+Review+of+Its+Use+in+Moderate+to+Severe+Alzheimer%E2%80%99s+Disease&doi=10.2165%2F11201020-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2165%2F11201020-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11201020-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeage%26aufirst%3DK.%26atitle%3DMemantine%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520Moderate%2520to%2520Severe%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2009%26volume%3D23%26spage%3D881%26epage%3D897%26doi%3D10.2165%2F11201020-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Francis, P. T.</span><span> </span><span class="NLM_article-title">Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1159/000113713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1159%2F000113713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18322401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Whtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=241-243&author=P.+T.+Francis&title=Glutamatergic+Approaches+to+the+Treatment+of+Cognitive+and+Behavioural+Symptoms+of+Alzheimer%E2%80%99s+Disease&doi=10.1159%2F000113713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer's Disease</span></div><div class="casAuthors">Francis, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">241-243</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The glutamatergic system has long been recognized for its role in learning and memory and recent studies indicate an early loss of glutamatergic synapses in Alzheimer's disease (AD).  Efforts to produce drugs which address changes in the glutamatergic system in AD are well advanced (e.g. memantine and drugs in development such as ampakines).  Much less is known about the possible role of glutamate in non-cognitive behavioral changes; however, recent data from clin. trials suggest that memantine reduces agitation and aggressive behavior in AD patients.  In this context, it is important to help identify new treatment approaches to replace the use of antipsychotics in this vulnerable population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcEQTfIARvlbVg90H21EOLACvtfcHk0lg3_bfELORSsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Whtbk%253D&md5=20bfea2875be1f69ad6a7286dec1fd2a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1159%2F000113713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113713%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26atitle%3DGlutamatergic%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Cognitive%2520and%2520Behavioural%2520Symptoms%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D241%26epage%3D243%26doi%3D10.1159%2F000113713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fan, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, L. A.</span><span> </span><span class="NLM_article-title">N-Methyl-D-Aspartate (NMDA) Receptor Function and Excitotoxicity in Huntington’s Disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.pneurobio.2006.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17188796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=272-293&author=M.+M.+Fanauthor=L.+A.+Raymond&title=N-Methyl-D-Aspartate+%28NMDA%29+Receptor+Function+and+Excitotoxicity+in+Huntington%E2%80%99s+Disease&doi=10.1016%2Fj.pneurobio.2006.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease</span></div><div class="casAuthors">Fan, Mannie M. Y.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">272-293</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence support a role for neuronal damage arising as a result of excessive activation of glutamate receptors by excitatory amino acids in the pathogenesis of Huntington disease.  The N-methyl-D-aspartate subclass of inotropic glutamate receptors (NMDARs) is more selective and effective than the other subclasses in mediating this damage.  As well, neurons expressing high levels of NMDARs are lost early from the striatum of individuals affected with Huntington's disease (HD), and injection of NMDAR agonists into the striatum of rodents or non-human primates recapitulates the pattern of neuronal damage obsd. in HD.  Altered NMDAR function has been reported in corticostriatal synapses in one mouse model of HD, and NMDAR-mediated current and/or toxicity have been found to be potentiated in striatal neurons from several HD mouse models as well as heterologous cells expressing the mutant huntington protein.  Changes in NMDAR activity have been correlated with altered calcium homeostasis, mitochondrial membrane depolarization and caspase activation.  NMDAR stimulation is also closely linked to mitochondrial activity, as treatment with mitochondrial toxins has been demonstrated to produce striatal damage that can be reversed by the addn. of NMDAR antagonists.  Recent efforts have focused on the elucidation of mol. pathways linking huntington to NMDARs, as well as the mechanisms which underlie the enhancement of NMDAR activity by mutant huntington.  Here, we review the literature to date and recent findings concerning the role of NMDARs in HD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmSAU9WE51bVg90H21EOLACvtfcHk0lg3_bfELORSsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D&md5=d6ed0834cf6cf86a2134887e459e6991</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DM.%2BM.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DN-Methyl-D-Aspartate%2520%2528NMDA%2529%2520Receptor%2520Function%2520and%2520Excitotoxicity%2520in%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D272%26epage%3D293%26doi%3D10.1016%2Fj.pneurobio.2006.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Corona, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar-y-Romo, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia, R.</span><span> </span><span class="NLM_article-title">Glutamate Excitotoxicity and Therapeutic Targets for Amyotrophic Lateral Sclerosis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.1517/14728222.11.11.1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1517%2F14728222.11.11.1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18028007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1415-1428&author=J.+C.+Coronaauthor=L.+B.+Tovar-y-Romoauthor=R.+Tapia&title=Glutamate+Excitotoxicity+and+Therapeutic+Targets+for+Amyotrophic+Lateral+Sclerosis&doi=10.1517%2F14728222.11.11.1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis</span></div><div class="casAuthors">Corona, Juan C.; Tovar-y-Romo, Luis B.; Tapia, Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1415-1428</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Two forms of amyotrophic lateral sclerosis (ALS) are known, the familial (FALS), due in part to mutations in superoxide dismutase 1 (SOD1), and the sporadic (SALS), which accounts for > 90% of all cases.  The cause of SALS is not known, but excitotoxicity due to overactivation of glutamate receptors may mediate the motor neuron degeneration in the spinal cord, which is the hallmark of this disease.  Overactivation of calcium-permeable α-amino-3-hydroxy-5-isoxazole propionate receptors lacking the subunit glutamate receptor 2, leading to an increase in calcium cytoplasmic concn., seems to play an important role in the mechanism of neuronal death.  The knowledge of this mechanism, in addn. to other factors, provides several possible targets for therapeutic strategies that are reviewed in this article.  Some of these strategies have proven to be partially effective in both human mutant superoxide dismutase 1 transgenic rodents (FALS model) and the few existing in vivo models of spinal motor neurodegeneration induced by excitotoxicity (SALS models), although observable benefits are still to be shown in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqei-EMokx_ZrVg90H21EOLACvtfcHk0lgDyoOsozQxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnI&md5=e5ff781db6a38f272e70602cbab67553</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1415%26sid%3Dliteratum%253Aachs%26aulast%3DCorona%26aufirst%3DJ.%2BC.%26aulast%3DTovar-y-Romo%26aufirst%3DL.%2BB.%26aulast%3DTapia%26aufirst%3DR.%26atitle%3DGlutamate%2520Excitotoxicity%2520and%2520Therapeutic%2520Targets%2520for%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1415%26epage%3D1428%26doi%3D10.1517%2F14728222.11.11.1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Muir, K. W.</span><span> </span><span class="NLM_article-title">Glutamate-Based Therapeutic Approaches: Clinical Trials with NMDA Antagonists</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/j.coph.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.coph.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16359918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=53-60&author=K.+W.+Muir&title=Glutamate-Based+Therapeutic+Approaches%3A+Clinical+Trials+with+NMDA+Antagonists&doi=10.1016%2Fj.coph.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists</span></div><div class="casAuthors">Muir, Keith W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The majority of clin. trials of N-Me D-aspartate antagonists were conducted in the fields of stroke, traumatic brain injury (TBI), and dementia.  Stroke and TBI trials have involved more than 9000 patients, but have yielded no therapeutically useful agents, with the possible exception of magnesium for treatment of subarachnoid hemorrhage.  Several of the synthetic N-Me -aspartate antagonist development programs were abandoned owing to concerns about drug toxicity, particularly in stroke.  Systematic reviews in stroke and TBI have shown that definitive conclusions cannot be drawn for most agents owing to early termination of trials.  In dementia, memantinec has shown some benefit in moderate-to-severe Alzheimer's disease, with no clear benefit to date for milder stages of Alzheimer's disease or for vascular dementia.  Other therapeutic areas of promise remain inadequately explored at present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGNYjrNzhI7Vg90H21EOLACvtfcHk0lgDyoOsozQxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVygtg%253D%253D&md5=1fd02215bb9125304666f8db06d624c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMuir%26aufirst%3DK.%2BW.%26atitle%3DGlutamate-Based%2520Therapeutic%2520Approaches%253A%2520Clinical%2520Trials%2520with%2520NMDA%2520Antagonists%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.coph.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Alexander, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, D. W.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors as a Strategic Target for the Treatment of Epilepsy</span> <span class="citation_source-journal">Epilepsy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.eplepsyres.2006.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.eplepsyres.2006.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16787741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVOgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1-22&author=G.+M.+Alexanderauthor=D.+W.+Godwin&title=Metabotropic+Glutamate+Receptors+as+a+Strategic+Target+for+the+Treatment+of+Epilepsy&doi=10.1016%2Fj.eplepsyres.2006.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy</span></div><div class="casAuthors">Alexander, Georgia M.; Godwin, Dwayne W.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsy Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">EPIRE8</span>;
        ISSN:<span class="NLM_cas:issn">0920-1211</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Epilepsy is a chronic neurol. disorder that has many known types, including generalized epilepsies that involve cortical and subcortical structures.  A proportion of patients have seizures that are resistant to traditional anti-epilepsy drugs, which mainly target ion channels or postsynaptic receptors.  This resistance to conventional therapies makes it important to identify novel targets for the treatment of epilepsy.  Given the involvement of the neurotransmitter glutamate in the etiol. of epilepsy, targets that control glutamatergic neurotransmission are of special interest.  The metabotropic glutamate receptors (mGluRs) are of a family of eight G-protein-coupled receptors that serve unique regulatory functions at synapses that use the neurotransmitter glutamate.  Their distribution within the central nervous system provides a platform for both presynaptic control of glutamate release, as well as postsynaptic control of neuronal responses to glutamate.  In recent years, substantial efforts have been made towards developing selective agonists and antagonists which may be useful for targeting specific receptor subtypes in an attempt to harness the therapeutic potential of these receptors.  We examine the possibility of intervening at these receptors by considering the specific example of absence seizures, a form of generalized, non-convulsive seizure that involves the thalamus.  Views of the etiol. of absence seizures have evolved over time from the "centerncephalic" concept of a diffuse subcortical pacemaker toward the "cortical focus" theory in which cortical hyperexcitability leads the thalamus into the 3-4 Hz rhythms that are characteristic of absence seizures.  Since the cortex communicates with the thalamus via a massive glutamatergic projection, ionotropic glutamate receptor (iGluR) blockade has held promise, but the global nature of iGluR intervention has precluded the clin. effectiveness of drugs that block iGluRs.  In contrast, mGluRs, because they modulate iGluRs at glutamatergic synapses only under certain conditions, may quell seizure activity by selectively reducing hyperactive glutamatergic synaptic communication within the cortex and thalamus without significantly affecting normal response rates.  In this article, we review the circuitry and events leading to absence seizure generation within the corticothalamic network, we present a comprehensive review of the synaptic location and function of mGluRs within the thalamus and cerebral cortex, and review the current knowledge of mGluR modulation and seizure generation.  We conclude by reviewing the potential advantages of Group II mGluRs, specifically mGluR2, in the treatment of both convulsive and non-convulsive seizures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLBqc6wcG5bVg90H21EOLACvtfcHk0lgDyoOsozQxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVOgsb0%253D&md5=939bcf760fa9b900da11e71cbffc10c5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.eplepsyres.2006.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eplepsyres.2006.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DG.%2BM.%26aulast%3DGodwin%26aufirst%3DD.%2BW.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%2520as%2520a%2520Strategic%2520Target%2520for%2520the%2520Treatment%2520of%2520Epilepsy%26jtitle%3DEpilepsy%2520Res.%26date%3D2006%26volume%3D71%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.eplepsyres.2006.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Subtype Selective Kainic Acid Receptor Agonists: Discovery and Approaches to Rational Design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1002/med.20133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fmed.20133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18623169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=3-28&author=L.+Bunchauthor=P.+Krogsgaard-Larsen&title=Subtype+Selective+Kainic+Acid+Receptor+Agonists%3A+Discovery+and+Approaches+to+Rational+Design&doi=10.1002%2Fmed.20133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype selective kainic acid receptor agonists: discovery and approaches to rational design</span></div><div class="casAuthors">Bunch, Lennart; Krogsgaard-Larsen, Povl</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  (S)-Glutamic acid (Glu) is the major excitatory neurotransmitter in the mammalian central nervous system, activating the plethora of glutamate receptors (GluRs).  In broad lines, the GluRs are divided into two major classes: the ionotropic Glu receptors (iGluRs) and the metabotropic Glu receptors (mGluRs).  Within the iGluRs, five subtypes (KA1, KA2, iGluR5-7) show high affinity and express full agonist activity upon binding of the naturally occurring amino acid kainic acid (KA).  Thus these receptors have been named the KA receptors.  This review describes all-to our knowledge-published KA receptor agonists.  In total, over 100 compds. are described by means of chem. structure and available pharmacol. data.  With this perspective review, it is our intention to ignite and stimulate inspiration for future design and synthesis of novel subtype selective KA receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYYXqBUFL8bVg90H21EOLACvtfcHk0ljiQD6toUCV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SrtLk%253D&md5=a2440ac0304aaf563bcc8ae9689b0b40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fmed.20133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20133%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DSubtype%2520Selective%2520Kainic%2520Acid%2520Receptor%2520Agonists%253A%2520Discovery%2520and%2520Approaches%2520to%2520Rational%2520Design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D3%26epage%3D28%26doi%3D10.1002%2Fmed.20133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation, and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation%2C+and+Function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljiQD6toUCV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%252C%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Vaidya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashaw, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, R. K.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors: A Review on Perspectives and Therapeutic Aspects</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1967-1981&author=A.+Vaidyaauthor=S.+Jainauthor=A.+K.+Jainauthor=A.+Agrawalauthor=S.+K.+Kashawauthor=S.+K.+Jainauthor=R.+K.+Agrawal&title=Metabotropic+Glutamate+Receptors%3A+A+Review+on+Perspectives+and+Therapeutic+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaidya%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DKashaw%26aufirst%3DS.%2BK.%26aulast%3DJain%26aufirst%3DS.%2BK.%26aulast%3DAgrawal%26aufirst%3DR.%2BK.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%253A%2520A%2520Review%2520on%2520Perspectives%2520and%2520Therapeutic%2520Aspects%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1967%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Larsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valadés, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of a New Class of Ionotropic Glutamate Receptor Antagonists by the Rational Design of (2<i>S</i>,3<i>R</i>)-3-(3-Carboxyphenyl)-Pyrrolidine-2-Carboxylic Acid</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1021/cn100093f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100093f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWhsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=107-114&author=A.+M.+Larsenauthor=R.+Venskutonyt%C4%97author=E.+A.+Valad%C3%A9sauthor=B.+Nielsenauthor=D.+S.+Pickeringauthor=L.+Bunch&title=Discovery+of+a+New+Class+of+Ionotropic+Glutamate+Receptor+Antagonists+by+the+Rational+Design+of+%282S%2C3R%29-3-%283-Carboxyphenyl%29-Pyrrolidine-2-Carboxylic+Acid&doi=10.1021%2Fcn100093f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Class of Ionotropic Glutamate Receptor Antagonists by the Rational Design of (2S,3R)-3-(3-Carboxyphenyl)-pyrrolidine-2-carboxylic Acid</span></div><div class="casAuthors">Larsen, Ann M.; Venskutonyte, Raminta; Valades, Elena Anton; Nielsen, Birgitte; Pickering, Darryl S.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The kainic acid (KA) receptors belong to the class of glutamate (Glu) receptors in the brain and constitute a promising target for the treatment of neurol. and/or psychiatric diseases such as schizophrenia, major depression, and epilepsy.  Five KA subtypes have been identified and named GluK1-5.  In this article, we present the discovery of (2S,3R)-3-(3-carboxyphenyl)-pyrrolidine-2-carboxylic acid (1) based on a rational design process.  Target compd. 1 was synthesized by a stereoselective strategy in 10 steps from com. available starting materials.  Binding affinities of 1 at native ionotropic Glu receptors were detd. to be in the micromolar range (AMPA, 51 μM; KA, 22 μM; NMDA 6 μM), with the highest affinity for cloned homomeric KA receptor subtypes GluK1,3 (3.0 and 8.1 μM, resp.).  Functional characterization of 1 by two electrode voltage clamp (TEVC) electrophysiol. at a nondesensitizing mutant of GluK1 showed full competitive antagonistic behavior with a Kb of 11.4 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe72VGdj51HrVg90H21EOLACvtfcHk0ljJVqmYQ3hPxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWhsbvE&md5=dfe53691cb11fa493b0aaaec96a60909</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn100093f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100093f%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BM.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DValad%25C3%25A9s%26aufirst%3DE.%2BA.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Class%2520of%2520Ionotropic%2520Glutamate%2520Receptor%2520Antagonists%2520by%2520the%2520Rational%2520Design%2520of%2520%25282S%252C3R%2529-3-%25283-Carboxyphenyl%2529-Pyrrolidine-2-Carboxylic%2520Acid%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D107%26epage%3D114%26doi%3D10.1021%2Fcn100093f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Møller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brehm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Resolution, Absolute Stereochemistry, and Enantiopharmacology of the GluR1–4 and GluR5 Antagonist 2-Amino-3-[5-Tert-Butyl-3-(phosphonomethoxy)-4-Isoxazolyl]propionic Acid</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1002/(SICI)1520-636X(1999)11:10<752::AID-CHIR3>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=752-759&author=E.+H.+M%C3%B8llerauthor=J.+Egebjergauthor=L.+Brehmauthor=T.+B.+Stensb%C3%B8lauthor=T.+N.+Johansenauthor=U.+Madsenauthor=P.+Krogsgaard-Larsen&title=Resolution%2C+Absolute+Stereochemistry%2C+and+Enantiopharmacology+of+the+GluR1%E2%80%934+and+GluR5+Antagonist+2-Amino-3-%5B5-Tert-Butyl-3-%28phosphonomethoxy%29-4-Isoxazolyl%5Dpropionic+Acid&doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-636X%25281999%252911%253A10%253C752%253A%253AAID-CHIR3%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8ller%26aufirst%3DE.%2BH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DBrehm%26aufirst%3DL.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DResolution%252C%2520Absolute%2520Stereochemistry%252C%2520and%2520Enantiopharmacology%2520of%2520the%2520GluR1%25E2%2580%25934%2520and%2520GluR5%2520Antagonist%25202-Amino-3-%255B5-Tert-Butyl-3-%2528phosphonomethoxy%2529-4-Isoxazolyl%255Dpropionic%2520Acid%26jtitle%3DChirality%26date%3D1999%26volume%3D11%26spage%3D752%26epage%3D759%26doi%3D10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dolman, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troop, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knauss, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nistico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolotto, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacology of Willardiine Derivatives Acting as Antagonists of Kainate Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7867</span><span class="NLM_x">–</span> <span class="NLM_lpage">7881</span><span class="refDoi"> DOI: 10.1021/jm050584l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050584l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7867-7881&author=N.+P.+Dolmanauthor=H.+M.+Troopauthor=J.+C.+Moreauthor=A.+Altauthor=J.+L.+Knaussauthor=R.+Nisticoauthor=S.+Jackauthor=R.+M.+Morleyauthor=Z.+A.+Bortolottoauthor=P.+J.+Roberts&title=Synthesis+and+Pharmacology+of+Willardiine+Derivatives+Acting+as+Antagonists+of+Kainate+Receptors&doi=10.1021%2Fjm050584l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm050584l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050584l%26sid%3Dliteratum%253Aachs%26aulast%3DDolman%26aufirst%3DN.%2BP.%26aulast%3DTroop%26aufirst%3DH.%2BM.%26aulast%3DMore%26aufirst%3DJ.%2BC.%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DKnauss%26aufirst%3DJ.%2BL.%26aulast%3DNistico%26aufirst%3DR.%26aulast%3DJack%26aufirst%3DS.%26aulast%3DMorley%26aufirst%3DR.%2BM.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520Pharmacology%2520of%2520Willardiine%2520Derivatives%2520Acting%2520as%2520Antagonists%2520of%2520Kainate%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7867%26epage%3D7881%26doi%3D10.1021%2Fjm050584l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pøhlsgaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Lessons from More than 80 Structures of the GluA2 Ligand-Binding Domain in Complex with Agonists, Antagonists and Allosteric Modulators</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20713069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=135-150&author=J.+P%C3%B8hlsgaardauthor=K.+Frydenvangauthor=U.+Madsenauthor=J.+S.+Kastrup&title=Lessons+from+More+than+80+Structures+of+the+GluA2+Ligand-Binding+Domain+in+Complex+with+Agonists%2C+Antagonists+and+Allosteric+Modulators&doi=10.1016%2Fj.neuropharm.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators</span></div><div class="casAuthors">Pohlsgaard, Jacob; Frydenvang, Karla; Madsen, Ulf; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-150</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system.  These receptors play an important role for the development and function of the nervous system, and are essential in learning and memory.  However, iGluRs are also implicated in or have causal roles for several brain disorders, e.g. epilepsy, Alzheimer's disease, Parkinson's disease and schizophrenia.  Their involvement in neurol. diseases has stimulated widespread interest in their structure and function.  Since the first publication in 1998 of the structure of a recombinant sol. protein comprising the ligand-binding domain of GluA2 extensive studies have afforded numerous crystal structures of wildtype and mutant proteins including different ligands.  The structural information obtained combined with functional data have led to models for receptor activation and desensitization by agonists, inhibition by antagonists and block of desensitization by pos. allosteric modulators.  Furthermore, the structural and functional studies have formed a powerful platform for the design of new selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA5_dFKFmce7Vg90H21EOLACvtfcHk0lgtbtDuBXoViQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FK&md5=cade4bfad431cb7da3f8620d56c9926b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25B8hlsgaard%26aufirst%3DJ.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DLessons%2520from%2520More%2520than%252080%2520Structures%2520of%2520the%2520GluA2%2520Ligand-Binding%2520Domain%2520in%2520Complex%2520with%2520Agonists%252C%2520Antagonists%2520and%2520Allosteric%2520Modulators%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D135%26epage%3D150%26doi%3D10.1016%2Fj.neuropharm.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate Receptor: Crystal Structures of the GluR2 Ligand Binding Core</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)00094-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS0896-6273%2800%2900094-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=11086992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=165-181&author=N.+Armstrongauthor=E.+Gouaux&title=Mechanisms+for+Activation+and+Antagonism+of+an+AMPA-Sensitive+Glutamate+Receptor%3A+Crystal+Structures+of+the+GluR2+Ligand+Binding+Core&doi=10.1016%2FS0896-6273%2800%2900094-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core</span></div><div class="casAuthors">Armstrong, Neali; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-181</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Crystal structures of the GluR2 ligand binding core (S1S2) have been detd. in the apo state and in the presence of the antagonist DNQX, the partial agonist kainate, and the full agonists AMPA and glutamate.  The domains of the S1S2 ligand binding core are expanded in the apo state and contract upon ligand binding with the extent of domain sepn. decreasing in the order of apo > DNQX > kainate > glutamate ≃ AMPA.  These results suggest that agonist-induced domain closure gates the transmembrane channel and the extent of receptor activation depends upon the degree of domain closure.  AMPA and glutamate also promote a 180° flip of a trans peptide bond in the ligand binding site.  The crystal packing of the ligand binding cores suggests modes for subunit-subunit contact in the intact receptor and mechanisms by which allosteric effectors modulate receptor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNnbcNBzyXN7Vg90H21EOLACvtfcHk0lhGqXjNEzBs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGltLw%253D&md5=6be3ca25ce094c142ba3977a404afb3d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2900094-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252900094-5%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanisms%2520for%2520Activation%2520and%2520Antagonism%2520of%2520an%2520AMPA-Sensitive%2520Glutamate%2520Receptor%253A%2520Crystal%2520Structures%2520of%2520the%2520GluR2%2520Ligand%2520Binding%2520Core%26jtitle%3DNeuron%26date%3D2000%26volume%3D28%26spage%3D165%26epage%3D181%26doi%3D10.1016%2FS0896-6273%2800%2900094-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sobolevsky, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosconi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">X-Ray Structure, Symmetry and Mechanism of an AMPA-Subtype Glutamate Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span><span class="refDoi"> DOI: 10.1038/nature08624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1038%2Fnature08624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19946266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVylsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=745-756&author=A.+I.+Sobolevskyauthor=M.+P.+Rosconiauthor=E.+Gouaux&title=X-Ray+Structure%2C+Symmetry+and+Mechanism+of+an+AMPA-Subtype+Glutamate+Receptor&doi=10.1038%2Fnature08624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor</span></div><div class="casAuthors">Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">745-756</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate.  Despite their crucial role in neurobiol., the architecture and at. structure of an intact ionotropic glutamate receptor are unknown.  Here we report the crystal structure of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 Å resoln. in complex with a competitive antagonist.  The receptor harbors an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry.  A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D.  Therefore, the stereochem. manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits.  Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-d-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern.  We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcgGne1xeDrVg90H21EOLACvtfcHk0lhGqXjNEzBs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVylsb7N&md5=778cc7a01cbae8a5b33c0bf20adb6fed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnature08624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08624%26sid%3Dliteratum%253Aachs%26aulast%3DSobolevsky%26aufirst%3DA.%2BI.%26aulast%3DRosconi%26aufirst%3DM.%2BP.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DX-Ray%2520Structure%252C%2520Symmetry%2520and%2520Mechanism%2520of%2520an%2520AMPA-Subtype%2520Glutamate%2520Receptor%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D745%26epage%3D756%26doi%3D10.1038%2Fnature08624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span> </span><span class="NLM_article-title">Mixed Cyano-Gilman Cuprates - Advances in Conjugate Addition to Alpha,beta-Unsaturated Pyroglutaminol</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1055/s-2002-19303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1055%2Fs-2002-19303" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2002&publication_year=2002&pages=31-33&author=L.+Bunchauthor=P.+Krogsgaard-Larsenauthor=U.+Madsen&title=Mixed+Cyano-Gilman+Cuprates+-+Advances+in+Conjugate+Addition+to+Alpha%2Cbeta-Unsaturated+Pyroglutaminol&doi=10.1055%2Fs-2002-19303"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-19303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-19303%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26aulast%3DMadsen%26aufirst%3DU.%26atitle%3DMixed%2520Cyano-Gilman%2520Cuprates%2520-%2520Advances%2520in%2520Conjugate%2520Addition%2520to%2520Alpha%252Cbeta-Unsaturated%2520Pyroglutaminol%26jtitle%3DSynthesis%26date%3D2002%26volume%3D2002%26spage%3D31%26epage%3D33%26doi%3D10.1055%2Fs-2002-19303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crick, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase by Lipophilic Phosphonates: SAR, QSAR, and Crystallographic Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">54</span><span class="NLM_x">) </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4734</span><span class="refDoi"> DOI: 10.1021/jm200363d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200363d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4721-4734&issue=54&author=L.+Dengauthor=J.+Diaoauthor=P.+Chenauthor=V.+Pujariauthor=Y.+Yaoauthor=G.+Chengauthor=D.+C.+Crickauthor=B.+V.+V+Prasadauthor=Y.+Song&title=Inhibition+of+1-Deoxy-D-Xylulose-5-Phosphate+Reductoisomerase+by+Lipophilic+Phosphonates%3A+SAR%2C+QSAR%2C+and+Crystallographic+Studies&doi=10.1021%2Fjm200363d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm200363d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200363d%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DPujari%26aufirst%3DV.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DCrick%26aufirst%3DD.%2BC.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%25201-Deoxy-D-Xylulose-5-Phosphate%2520Reductoisomerase%2520by%2520Lipophilic%2520Phosphonates%253A%2520SAR%252C%2520QSAR%252C%2520and%2520Crystallographic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D54%26spage%3D4721%26epage%3D4734%26doi%3D10.1021%2Fjm200363d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Demmer, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Review on Modern Advances of Chemical Methods for the Introduction of a Phosphonic Acid Group</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">7981</span><span class="NLM_x">–</span> <span class="NLM_lpage">8006</span><span class="refDoi"> DOI: 10.1021/cr2002646</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2002646" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCiur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=7981-8006&author=C.+S.+Demmerauthor=N.+Krogsgaard-Larsenauthor=L.+Bunch&title=Review+on+Modern+Advances+of+Chemical+Methods+for+the+Introduction+of+a+Phosphonic+Acid+Group&doi=10.1021%2Fcr2002646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Review on Modern Advances of Chemical Methods for the Introduction of a Phosphonic Acid Group</span></div><div class="casAuthors">Demmer, Charles S.; Krogsgaard-Larsen, Niels; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7981-8006</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phys.-org. properties of the phosphonic acid group in connection to medicinal chem. aspects, together with an in depth review on advances and modern synthetic methods for its introduction compiled into sections with respect to substrate-carbon hybridization is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGn8S7af3R57Vg90H21EOLACvtfcHk0lhCU09C4Ufv0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCiur3O&md5=0813dd3e32704ecff31051eaed88d1cb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcr2002646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2002646%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DC.%2BS.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DN.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DReview%2520on%2520Modern%2520Advances%2520of%2520Chemical%2520Methods%2520for%2520the%2520Introduction%2520of%2520a%2520Phosphonic%2520Acid%2520Group%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D7981%26epage%3D8006%26doi%3D10.1021%2Fcr2002646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Carlsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A Greatly Improved Procedure for Ruthenium Tetroxide Catalyzed Oxidations of Organic Compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3936</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span><span class="refDoi"> DOI: 10.1021/jo00332a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00332a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=3936-3938&author=P.+H.+Carlsenauthor=T.+Katsukiauthor=V.+S.+Martinauthor=K.+B.+Sharpless&title=A+Greatly+Improved+Procedure+for+Ruthenium+Tetroxide+Catalyzed+Oxidations+of+Organic+Compounds&doi=10.1021%2Fjo00332a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span></div><div class="casAuthors">Carlsen, Per H. J.; Katsuki, Tsutomu; Martin, Victor S.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3936-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Addn. of MeCN to the traditional CCl4/H2O solvent system for RuO4-catalyzed oxidns. causes a great improvement apparently by preventing formation of insol. Ru species and thereby maintaining high catalyst activity.  Applications of the new catalytic system to the oxidn. of org. substrates (olefins, alcs., 1,2-diols, arom. rings, and ethers) are described.  Primary Me ethers are oxidized directly to the esters.  The Ru analog of the abnormal permanganate oxidn. of 1,5-dienes was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRHM2swdg5rVg90H21EOLACvtfcHk0lhCU09C4Ufv0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D&md5=ed05bc7a5eb549752691f363f6f2893c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00332a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00332a045%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsen%26aufirst%3DP.%2BH.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DV.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520Greatly%2520Improved%2520Procedure%2520for%2520Ruthenium%2520Tetroxide%2520Catalyzed%2520Oxidations%2520of%2520Organic%2520Compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D3936%26epage%3D3938%26doi%3D10.1021%2Fjo00332a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Venskutonyté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabassa, A. C. de</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Kainate Induces Various Domain Closures in AMPA and Kainate Receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1016/j.neuint.2012.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuint.2012.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22425692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFChtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=536-545&author=R.+Venskutonyt%C3%A9author=K.+Frydenvangauthor=H.+Haldauthor=A.+C.+de+Rabassaauthor=M.+Gajhedeauthor=P.+K.+Ahringauthor=J.+S.+Kastrup&title=Kainate+Induces+Various+Domain+Closures+in+AMPA+and+Kainate+Receptors&doi=10.1016%2Fj.neuint.2012.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kainate induces various domain closures in AMPA and kainate receptors</span></div><div class="casAuthors">Venskutonyte, Raminta; Frydenvang, Karla; Hald, Helle; Rabassa, Anna Ceravalls de; Gajhede, Michael; Ahring, Philip K.; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">536-545</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors are key players in fast excitatory synaptic transmission within the central nervous system.  These receptors have been divided into three subfamilies: the N-methyl-d-aspartic acid (NMDA), 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and kainate receptors.  Kainate has previously been crystd. with the ligand binding domain (LBD) of AMPA receptors (GluA2 and GluA4) and kainate receptors (GluK1 and GluK2).  Here, the authors report the structures of the kainate receptor GluK3 LBD in complex with kainate and GluK1 LBD in complex with kainate in the absence of glycerol.  Kainate introduces a conformational change in GluK3 LBD comparable to that of GluK2, but different from the conformational changes induced in GluA2 and GluK1.  Compared to their domain closures in a glutamate bound state, GluA2 and GluK1 become more open and kainate induces a domain closure of 60% and 62%, resp., relative to glutamate (100%).  In GluK2 and GluK3 with kainate, the domain closure is 88% and 83%, resp.  In previously detd. structures of GluK1 LBD in complex with kainate, glycerol is present in the binding site where it bridges interlobe residues and thus, might contribute to the large domain opening.  However, the structure of GluK1 LBD with kainate in the absence of glycerol confirms that the obsd. domain closure is not an artifact of crystn. conditions.  Comparison of the LBD structures with glutamate and kainate reveals that contacts are lost upon binding of kainate in the three kainate receptors, which is in contrast to the AMPA receptors where similar contacts are seen.  It was revealed by patch clamp electrophysiol. studies that kainate is a partial agonist at GluK1 with 36% efficacy compared to glutamate, which is in between the published efficacies of kainate at GluK2 and AMPA receptors.  The ranking of efficacies seems to correlate with LBD domain closures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqrkoC7BoerVg90H21EOLACvtfcHk0lhl-OrsqOlKsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFChtLw%253D&md5=3ddf3623824f36bcd1ca24a77a67a220</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DVenskutonyt%25C3%25A9%26aufirst%3DR.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DHald%26aufirst%3DH.%26aulast%3DRabassa%26aufirst%3DA.%2BC.%2Bde%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DKainate%2520Induces%2520Various%2520Domain%2520Closures%2520in%2520AMPA%2520and%2520Kainate%2520Receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D536%26epage%3D545%26doi%3D10.1016%2Fj.neuint.2012.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ayala-Mata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera-Mendoza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Vázquez, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas-Díaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zepeda, L. G.</span><span> </span><span class="NLM_article-title">Efficient Preparation of A-Ketoacetals</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13864</span><span class="NLM_x">–</span> <span class="NLM_lpage">13878</span><span class="refDoi"> DOI: 10.3390/molecules171213864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.3390%2Fmolecules171213864" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=13864-13878&author=F.+Ayala-Mataauthor=C.+Barrera-Mendozaauthor=H.+A.+Jim%C3%A9nez-V%C3%A1zquezauthor=E.+Vargas-D%C3%ADazauthor=L.+G.+Zepeda&title=Efficient+Preparation+of+A-Ketoacetals&doi=10.3390%2Fmolecules171213864"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules171213864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules171213864%26sid%3Dliteratum%253Aachs%26aulast%3DAyala-Mata%26aufirst%3DF.%26aulast%3DBarrera-Mendoza%26aufirst%3DC.%26aulast%3DJim%25C3%25A9nez-V%25C3%25A1zquez%26aufirst%3DH.%2BA.%26aulast%3DVargas-D%25C3%25ADaz%26aufirst%3DE.%26aulast%3DZepeda%26aufirst%3DL.%2BG.%26atitle%3DEfficient%2520Preparation%2520of%2520A-Ketoacetals%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D13864%26epage%3D13878%26doi%3D10.3390%2Fmolecules171213864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of New 2,4-<i>syn</i>-Functionalized (<i>S</i>)-Glutamate Analogues and Structure?Activity Relationship Studies at Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1021/jm301433m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301433m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1614-1628&author=Z.+Assafauthor=A.+P.+Larsenauthor=R.+Venskutonyt%C4%97author=L.+Hanauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=M.+Gajhedeauthor=J.+S.+Kastrupauthor=A.+A.+Jensenauthor=D.+S.+Pickeringauthor=K.+Frydenvangauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+New+2%2C4-syn-Functionalized+%28S%29-Glutamate+Analogues+and+Structure%3FActivity+Relationship+Studies+at+Ionotropic+Glutamate+Receptors+and+Excitatory+Amino+Acid+Transporters&doi=10.1021%2Fjm301433m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm301433m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301433m%26sid%3Dliteratum%253Aachs%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DLarsen%26aufirst%3DA.%2BP.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520New%25202%252C4-syn-Functionalized%2520%2528S%2529-Glutamate%2520Analogues%2520and%2520Structure%253FActivity%2520Relationship%2520Studies%2520at%2520Ionotropic%2520Glutamate%2520Receptors%2520and%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1614%26epage%3D1628%26doi%3D10.1021%2Fjm301433m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Krintel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceravalls de Rabassa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaern, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">L-Asp Is a Useful Tool in the Purification of the Ionotropic Glutamate Receptor A2 Ligand-Binding Domain</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">2422</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span><span class="refDoi"> DOI: 10.1111/febs.12795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Ffebs.12795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=24673938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=2422-2430&author=C.+Krintelauthor=K.+Frydenvangauthor=A.+Ceravalls+de+Rabassaauthor=A.+M.+Kaernauthor=M.+Gajhedeauthor=D.+S.+Pickeringauthor=J.+S.+Kastrup&title=L-Asp+Is+a+Useful+Tool+in+the+Purification+of+the+Ionotropic+Glutamate+Receptor+A2+Ligand-Binding+Domain&doi=10.1111%2Ffebs.12795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">L-Asp is a useful tool in the purification of the ionotropic glutamate receptor A2 ligand-binding domain</span></div><div class="casAuthors">Krintel, Christian; Frydenvang, Karla; Ceravalls de Rabassa, Anna; Kaern, Anne M.; Gajhede, Michael; Pickering, Darryl S.; Kastrup, Jette S.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2422-2430</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the purifn. of the ionotropic glutamate receptor A2 (GluA2) ligand-binding domain (LBD), L-glutamate-supplemented buffers have previously been used for protein stabilization during the procedure.  This sometimes hampers structural studies of low-affinity ligands, because L-glutamate is difficult to displace, despite extensive dialysis.  Here, the authors show that L-aspartate binds to full-length GluA2 with low affinity (Ki = 0.63 mM) and to the GluA2 LBD with even lower affinity (Ki = 2.6 mM), and they used differential scanning fluorometry to show that L-aspartate was able to stabilize the isolated GluA2 LBD.  The authors also show that L-aspartate can replace L-glutamate during purifn., providing both equal yields and purity of the resulting protein sample.  Furthermore, the authors solved 3 structures of the GluA2 LBD in the presence of 7.5, 50 and 250 mM L-aspartate.  Surprisingly, with 7.5 mM L-aspartate, the GluA2 LBD crystd. as a mixed dimer, with L-glutamate being present in one subunit, and neither L-aspartate nor L-glutamate being present in the other subunit.  Thus, residual L-glutamate was retained from the expression medium.  On the other hand, only L-aspartate was found at the binding site when 50 or 250 mM L-aspartate was used for crystn.  The binding mode obsd. for L-aspartate at the GluA2 LBD was very similar to that described for L-glutamate.  Taking these findings together, The authors showed that L-aspartate could be used instead of L-glutamate for ligand-dependent stabilization of the GluA2 LBD during purifn.  This will enable structural studies of low-affinity ligands for lead optimization in structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqggksXGyeYiLVg90H21EOLACvtfcHk0li3p2JXhT6b7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFemt78%253D&md5=e18cbd794383c1472059058aecf821bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12795%26sid%3Dliteratum%253Aachs%26aulast%3DKrintel%26aufirst%3DC.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DCeravalls%2Bde%2BRabassa%26aufirst%3DA.%26aulast%3DKaern%26aufirst%3DA.%2BM.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DL-Asp%2520Is%2520a%2520Useful%2520Tool%2520in%2520the%2520Purification%2520of%2520the%2520Ionotropic%2520Glutamate%2520Receptor%2520A2%2520Ligand-Binding%2520Domain%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D2422%26epage%3D2430%26doi%3D10.1111%2Ffebs.12795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Naur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Kainate Receptor GluR5 Ligand-Binding Core in Complex with (S)-Glutamate</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span><span class="refDoi"> DOI: 10.1016/j.febslet.2005.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.febslet.2005.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=15710405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlOnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=1154-1160&author=P.+Naurauthor=B.+Vestergaardauthor=L.+K.+Skovauthor=J.+Egebjergauthor=M.+Gajhedeauthor=J.+S.+Kastrup&title=Crystal+Structure+of+the+Kainate+Receptor+GluR5+Ligand-Binding+Core+in+Complex+with+%28S%29-Glutamate&doi=10.1016%2Fj.febslet.2005.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate</span></div><div class="casAuthors">Naur, Peter; Vestergaard, Bente; Skov, Lars K.; Egebjerg, Jan; Gajhede, Michael; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The x-ray structure of the ligand-binding core of the kainate receptor GluR5 (GluR5-S1S2) in complex with (S)-glutamate was detd. to 1.95 Å resoln.  The overall GluR5-S1S2 structure comprises two domains and is similar to the related AMPA receptor GluR2-S1S2J. (S)-glutamate binds as in GluR2-S1S2J.  Distinct features are obsd. for Ser741, which stabilizes a highly coordinated network of water mols. and forms an interdomain bridge.  The GluR5 complex exhibits a high degree of domain closure (26°) relative to apo GluR2-S1S2J.  In addn., GluR5-S1S2 forms a novel dimer interface with a different arrangement of the two protomers compared to GluR2-S1S2J.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtbs9jrVfsbVg90H21EOLACvtfcHk0li3p2JXhT6b7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlOnsLg%253D&md5=53693a84dad10af87aa0cff370788d8b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2005.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2005.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DNaur%26aufirst%3DP.%26aulast%3DVestergaard%26aufirst%3DB.%26aulast%3DSkov%26aufirst%3DL.%2BK.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Kainate%2520Receptor%2520GluR5%2520Ligand-Binding%2520Core%2520in%2520Complex%2520with%2520%2528S%2529-Glutamate%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D1154%26epage%3D1160%26doi%3D10.1016%2Fj.febslet.2005.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ursby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredslund, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, M. M. G. M.</span><span> </span><span class="NLM_article-title">The Macromolecular Crystallography Beamline I911–3 at the MAX IV Laboratory</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1107/S0909049513011734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0909049513011734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23765310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsVenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=648-653&author=T.+Ursbyauthor=J.+Ungeauthor=R.+Appioauthor=D.+T.+Loganauthor=F.+Fredslundauthor=C.+Svenssonauthor=K.+Larssonauthor=A.+Labradorauthor=M.+M.+G.+M.+Thunnissen&title=The+Macromolecular+Crystallography+Beamline+I911%E2%80%933+at+the+MAX+IV+Laboratory&doi=10.1107%2FS0909049513011734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The macromolecular crystallography beamline I911-3 at the MAX IV laboratory</span></div><div class="casAuthors">Ursby, Thomas; Unge, Johan; Appio, Roberto; Logan, Derek T.; Fredslund, Folmer; Svensson, Christer; Larsson, Krister; Labrador, Ana; Thunnissen, Marjolein M. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-653</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The macromol. crystallog. beamline I911-3, part of the Cassiopeia/I911 suite of beamlines, is based on a superconducting wiggler at the MAX II ring of the MAX IV Lab. in Lund, Sweden.  The beamline is energy-tunable within a range between 6 and 18 keV.  I911-3 opened for users in 2005.  In 2010-2011 the exptl. station was completely rebuilt and refurbished such that it has become a state-of-the-art exptl. station with better possibilities for rapid throughput, crystal screening and work with smaller samples.  This paper describes the complete I911-3 beamline and how it is embedded in the Cassiopeia suite of beamlines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHrhyNC6OdLLVg90H21EOLACvtfcHk0lhL0HQpFgdoxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsVenu7Y%253D&md5=4f204e3c3a4f2b8afe560f3e1b0f30c8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0909049513011734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049513011734%26sid%3Dliteratum%253Aachs%26aulast%3DUrsby%26aufirst%3DT.%26aulast%3DUnge%26aufirst%3DJ.%26aulast%3DAppio%26aufirst%3DR.%26aulast%3DLogan%26aufirst%3DD.%2BT.%26aulast%3DFredslund%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DLarsson%26aufirst%3DK.%26aulast%3DLabrador%26aufirst%3DA.%26aulast%3DThunnissen%26aufirst%3DM.%2BM.%2BG.%2BM.%26atitle%3DThe%2520Macromolecular%2520Crystallography%2520Beamline%2520I911%25E2%2580%25933%2520at%2520the%2520MAX%2520IV%2520Laboratory%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2013%26volume%3D20%26spage%3D648%26epage%3D653%26doi%3D10.1107%2FS0909049513011734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosflm</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powell&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosflm%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liFLIgwC1HcjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liFLIgwC1HcjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and Assessment of Data Quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+Assessment+of+Data+Quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0liFLIgwC1HcjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520Assessment%2520of%2520Data%2520Quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgmXntg4JvOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Szymańska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras-Sanz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafimoska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span> </span><span class="NLM_article-title">A New Phenylalanine Derivative Acts as an Antagonist at the AMPA Receptor GluA2 and Introduces Partial Domain Closure: Synthesis, Resolution, Pharmacology, and Crystal Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7289</span><span class="NLM_x">–</span> <span class="NLM_lpage">7298</span><span class="refDoi"> DOI: 10.1021/jm200862h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200862h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7289-7298&author=E.+Szyma%C5%84skaauthor=K.+Frydenvangauthor=A.+Contreras-Sanzauthor=D.+S.+Pickeringauthor=E.+Frolaauthor=Z.+Serafimoskaauthor=B.+Nielsenauthor=J.+S.+Kastrupauthor=T.+N.+Johansen&title=A+New+Phenylalanine+Derivative+Acts+as+an+Antagonist+at+the+AMPA+Receptor+GluA2+and+Introduces+Partial+Domain+Closure%3A+Synthesis%2C+Resolution%2C+Pharmacology%2C+and+Crystal+Structure&doi=10.1021%2Fjm200862h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm200862h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200862h%26sid%3Dliteratum%253Aachs%26aulast%3DSzyma%25C5%2584ska%26aufirst%3DE.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DContreras-Sanz%26aufirst%3DA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrola%26aufirst%3DE.%26aulast%3DSerafimoska%26aufirst%3DZ.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26atitle%3DA%2520New%2520Phenylalanine%2520Derivative%2520Acts%2520as%2520an%2520Antagonist%2520at%2520the%2520AMPA%2520Receptor%2520GluA2%2520and%2520Introduces%2520Partial%2520Domain%2520Closure%253A%2520Synthesis%252C%2520Resolution%252C%2520Pharmacology%252C%2520and%2520Crystal%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7289%26epage%3D7298%26doi%3D10.1021%2Fjm200862h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljmq9fo3QbQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Electronic Ligand Builder and Optimization Workbench (eLBOW): A Tool for Ligand Coordinate and Restraint Generation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=Electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+A+Tool+for+Ligand+Coordinate+and+Restraint+Generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0ljmq9fo3QbQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DElectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520A%2520Tool%2520for%2520Ligand%2520Coordinate%2520and%2520Restraint%2520Generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: A Comprehensive Python-Based System for Macromolecular Structure Solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+Comprehensive+Python-Based+System+for+Macromolecular+Structure+Solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljmq9fo3QbQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520Comprehensive%2520Python-Based%2520System%2520for%2520Macromolecular%2520Structure%2520Solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valadés, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymańska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span> </span><span class="NLM_article-title">Structural and Pharmacological Characterization of Phenylalanine-Based AMPA Receptor Antagonists at Kainate Receptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span><span class="refDoi"> DOI: 10.1002/cmdc.201100599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fcmdc.201100599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1793-1798&author=R.+Venskutonyt%C4%97author=K.+Frydenvangauthor=E.+A.+Valad%C3%A9sauthor=E.+Szyma%C5%84skaauthor=T.+N.+Johansenauthor=J.+S.+Kastrupauthor=D.+S.+Pickering&title=Structural+and+Pharmacological+Characterization+of+Phenylalanine-Based+AMPA+Receptor+Antagonists+at+Kainate+Receptors&doi=10.1002%2Fcmdc.201100599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100599%26sid%3Dliteratum%253Aachs%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DValad%25C3%25A9s%26aufirst%3DE.%2BA.%26aulast%3DSzyma%25C5%2584ska%26aufirst%3DE.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26atitle%3DStructural%2520and%2520Pharmacological%2520Characterization%2520of%2520Phenylalanine-Based%2520AMPA%2520Receptor%2520Antagonists%2520at%2520Kainate%2520Receptors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1793%26epage%3D1798%26doi%3D10.1002%2Fcmdc.201100599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hayward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. A.</span><span> </span><span class="NLM_article-title">Improvements in the Analysis of Domain Motions in Proteins from Conformational Change: DynDom Version 1.50</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/S1093-3263(02)00140-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS1093-3263%2802%2900140-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=12463636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Shsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=181-183&author=S.+Haywardauthor=R.+A.+Lee&title=Improvements+in+the+Analysis+of+Domain+Motions+in+Proteins+from+Conformational+Change%3A+DynDom+Version+1.50&doi=10.1016%2FS1093-3263%2802%2900140-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50</span></div><div class="casAuthors">Hayward, Steven; Lee, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-183</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">DynDom is a program that analyses conformational change in proteins for dynamic domains, hinge axes, and hinge-bending regions.  Here, a no. of improvements and addns. are reported which have been implemented in the new version 1.50.  The most significant improvement is in the detn. of the hinge-bending residues.  A new routine also compares quantities relating to the main-chain dihedrals of bending residues with the hinge-bending motion.  This version of the program can now be run from the DynDom website at: http://www.sys.uea.ac.uk/dyndom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Q8EuiL6bC7Vg90H21EOLACvtfcHk0lhKrfG3q0D3zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Shsb4%253D&md5=0cf86455d3af0b0e7f253d9ed1d1566d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900140-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900140-7%26sid%3Dliteratum%253Aachs%26aulast%3DHayward%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BA.%26atitle%3DImprovements%2520in%2520the%2520Analysis%2520of%2520Domain%2520Motions%2520in%2520Proteins%2520from%2520Conformational%2520Change%253A%2520DynDom%2520Version%25201.50%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2002%26volume%3D21%26spage%3D181%26epage%3D183%26doi%3D10.1016%2FS1093-3263%2802%2900140-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Mayer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2852</span><span class="NLM_x">–</span> <span class="NLM_lpage">2861</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0123-06.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1523%2FJNEUROSCI.0123-06.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16540562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFKmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2852-2861&author=M.+L.+Mayerauthor=A.+Ghosalauthor=N.+P.+Dolmanauthor=D.+E.+Jane&title=Crystal+Structures+of+the+Kainate+Receptor+GluR5+Ligand+Binding+Core+Dimer+with+Novel+GluR5-Selective+Antagonists&doi=10.1523%2FJNEUROSCI.0123-06.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists</span></div><div class="casAuthors">Mayer, Mark L.; Ghosal, Alokesh; Dolman, Nigel P.; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2852-2861</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Glutamate receptor (GluR) ion channels mediate fast synaptic transmission in the mammalian CNS.  Numerous crystallog. studies, the majority on the GluR2-subtype AMPA receptor, have revealed the structural basis for binding of subtype-specific agonists.  In contrast, because there are far fewer antagonist-bound structures, the mechanisms for antagonist binding are much less well understood, particularly for kainate receptors that exist as multiple subtypes with a distinct biol. encoded by the GluR5-7, KA1, and KA2 genes.  We describe here high-resoln. crystal structures for the GluR5 ligand-binding core complex with UBP302 and UBP310, novel GluR5-selective antagonists.  The crystal structures reveal the structural basis for the high selectivity for GluR5 obsd. in radiolabel displacement assays for the isolated ligand binding cores of the GluR2, GluR5, and GluR6 subunits and during inhibition of glutamate-activated currents in studies on full-length ion channels.  The antagonists bind via a novel mechanism and do not form direct contacts with the E723 side chain, as occurs in all previously solved AMPA and kainate receptor agonist and antagonist complexes.  This results from a hyperextension of the ligand binding core compared with previously solved structures.  As a result, in dimer assemblies, there is a 22 Å extension of the ion channel linkers in the transition from antagonist- to glutamate-bound forms.  This large conformational change is substantially different from that described for AMPA receptors, was not possible to predict from previous work, and suggests that glutamate receptors are capable of much larger movements than previously thought.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkS4TUumki7Vg90H21EOLACvtfcHk0lhKrfG3q0D3zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFKmtLs%253D&md5=5a880d1af759237096a2919d856d5e2a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0123-06.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0123-06.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DDolman%26aufirst%3DN.%2BP.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Kainate%2520Receptor%2520GluR5%2520Ligand%2520Binding%2520Core%2520Dimer%2520with%2520Novel%2520GluR5-Selective%2520Antagonists%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D2852%26epage%3D2861%26doi%3D10.1523%2FJNEUROSCI.0123-06.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chaoying Zheng, Tao Xie, Haibing He, <span class="NLM_string-name hlFld-ContribAuthor">Shuanhu Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Total Synthesis of PD-116740. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 469-473. <a href="https://doi.org/10.1021/acs.orglett.0c03990" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03990%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BTotal%252BSynthesis%252Bof%252BPD-116740%26aulast%3DZheng%26aufirst%3DChaoying%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01122020%26date%3D05012021%26volume%3D23%26issue%3D2%26spage%3D469%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Silke Kayser, Jacob C. Hansen, Markus Staudt, Aleksandra Moroz, Younes Larsen, Piero Temperini, Feng Yi, Jed T. Syrenne, Niels Krogsgaard-Larsen, Stylianos Iliadis, Birgitte Nielsen, Kasper B. Hansen, Darryl S. Pickering, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of New (2S,3R)-3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid Analogues Utilizing a C(sp3)–H Activation Strategy and Structure–Activity Relationship Studies at the Ionotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 674-701. <a href="https://doi.org/10.1021/acschemneuro.0c00003" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00003%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DStereoselective%252BSynthesis%252Bof%252BNew%252B%2525282S%25252C3R%252529-3-Carboxyphenyl%252529pyrrolidine-2-carboxylic%252BAcid%252BAnalogues%252BUtilizing%252Ba%252BC%252528sp3%252529%2525E2%252580%252593H%252BActivation%252BStrategy%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bat%252Bthe%252BIonotropic%252BGlutamate%252BReceptors%26aulast%3DKayser%26aufirst%3DSilke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02012020%26date%3D27012020%26date%3D17022020%26volume%3D11%26issue%3D5%26spage%3D674%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Silke Kayser, Piero Temperini, Christian B. M. Poulie, Markus Staudt, Birgitte Nielsen, Darryl S. Pickering, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">A Diversity Oriented Synthesis Approach to New 2,3-trans-Substituted l-Proline Analogs as Potential Ligands for the Ionotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 702-714. <a href="https://doi.org/10.1021/acschemneuro.0c00005" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00005%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BDiversity%252BOriented%252BSynthesis%252BApproach%252Bto%252BNew%252B2%25252C3-trans-Substituted%252Bl-Proline%252BAnalogs%252Bas%252BPotential%252BLigands%252Bfor%252Bthe%252BIonotropic%252BGlutamate%252BReceptors%26aulast%3DKayser%26aufirst%3DSilke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03012020%26date%3D03022020%26date%3D18022020%26volume%3D11%26issue%3D5%26spage%3D702%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ruowei Jiang, Juan Zhang, Si Zou, Shanshan Jia, Xiebin Leng, Yinghua Qi, Xuekun Zou, Baojie Shen, Weidan Li, Wenting Lu, <span class="NLM_string-name hlFld-ContribAuthor">Hongying Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Electron Acceptive Mass Tag for Mass Spectrometric Imaging-Guided Synergistic Targeting to Mice Brain Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 757-767. <a href="https://doi.org/10.1021/acschemneuro.8b00580" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00580%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DElectron%252BAcceptive%252BMass%252BTag%252Bfor%252BMass%252BSpectrometric%252BImaging-Guided%252BSynergistic%252BTargeting%252Bto%252BMice%252BBrain%252BGlutamate%252BReceptors%26aulast%3DJiang%26aufirst%3DRuowei%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29102018%26date%3D21122018%26date%3D31122018%26date%3D21122018%26volume%3D10%26issue%3D1%26spage%3D757%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephen W. Wright, Bryan Li, Zhihui Peng, Lulin Wei, Emma McInturff, David Place, David B. Damon, <span class="NLM_string-name hlFld-ContribAuthor">Robert A. Singer</span>. </span><span class="cited-content_cbyCitation_article-title">Improvements to Enable the Large Scale Synthesis of 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833). </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (12)
                                     , 1835-1845. <a href="https://doi.org/10.1021/acs.oprd.8b00386" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00386%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DImprovements%252Bto%252BEnable%252Bthe%252BLarge%252BScale%252BSynthesis%252Bof%252B1-%25257B%25255B%2525282S%25252C3S%25252C4S%252529-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl%25255Dmethoxy%25257D-7-methoxyisoquinoline-6-carboxamide%252B%252528PF-06650833%252529%26aulast%3DWright%26aufirst%3DStephen%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19112018%26date%3D10122018%26date%3D27112018%26volume%3D22%26issue%3D12%26spage%3D1835%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikko  Gynther</span>, <span class="hlFld-ContribAuthor ">Ilaria  Proietti Silvestri</span>, <span class="hlFld-ContribAuthor ">Jacob C.  Hansen</span>, <span class="hlFld-ContribAuthor ">Kasper B.  Hansen</span>, <span class="hlFld-ContribAuthor ">Tarja  Malm</span>, <span class="hlFld-ContribAuthor ">Yevheniia  Ishchenko</span>, <span class="hlFld-ContribAuthor ">Younes  Larsen</span>, <span class="hlFld-ContribAuthor ">Liwei  Han</span>, <span class="hlFld-ContribAuthor ">Silke  Kayser</span>, <span class="hlFld-ContribAuthor ">Seppo  Auriola</span>, <span class="hlFld-ContribAuthor ">Aleksanteri  Petsalo</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, and <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>  . </span><span class="cited-content_cbyCitation_article-title">Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9885-9904. <a href="https://doi.org/10.1021/acs.jmedchem.7b01624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAugmentation%252Bof%252BAnticancer%252BDrug%252BEfficacy%252Bin%252BMurine%252BHepatocellular%252BCarcinoma%252BCells%252Bby%252Ba%252BPeripherally%252BActing%252BCompetitive%252BN-Methyl-d-aspartate%252B%252528NMDA%252529%252BReceptor%252BAntagonist%26aulast%3DGynther%26aufirst%3DMikko%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03112017%26date%3D05122017%26date%3D14122017%26volume%3D60%26issue%3D23%26spage%3D9885%26epage%3D9904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles S.  Demmer</span>, <span class="hlFld-ContribAuthor ">David  Rombach</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, and <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>  . </span><span class="cited-content_cbyCitation_article-title">Revisiting the Quinoxalinedione Scaffold in the Construction of New Ligands for the Ionotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2477-2495. <a href="https://doi.org/10.1021/acschemneuro.7b00243" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00243%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRevisiting%252Bthe%252BQuinoxalinedione%252BScaffold%252Bin%252Bthe%252BConstruction%252Bof%252BNew%252BLigands%252Bfor%252Bthe%252BIonotropic%252BGlutamate%252BReceptors%26aulast%3DDemmer%26aufirst%3DCharles%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03072017%26date%3D24082017%26date%3D05092017%26date%3D15112017%26volume%3D8%26issue%3D11%26spage%3D2477%26epage%3D2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niels  Krogsgaard-Larsen</span>, <span class="hlFld-ContribAuthor ">Claudia G.  Delgar</span>, <span class="hlFld-ContribAuthor ">Karina  Koch</span>, <span class="hlFld-ContribAuthor ">Patricia M. G. E.  Brown</span>, <span class="hlFld-ContribAuthor ">Charlotte  Møller</span>, <span class="hlFld-ContribAuthor ">Liwei  Han</span>, <span class="hlFld-ContribAuthor ">Tri H. V.  Huynh</span>, <span class="hlFld-ContribAuthor ">Stinne W.  Hansen</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Derek  Bowie</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, <span class="hlFld-ContribAuthor ">Jette Sandholm  Kastrup</span>, <span class="hlFld-ContribAuthor ">Karla  Frydenvang</span>, and <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidine-2-carboxylic Acid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 441-457. <a href="https://doi.org/10.1021/acs.jmedchem.6b01516" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BSeries%252Bof%252Bl-trans-4-Substituted%252BProlines%252Bas%252BSelective%252BAntagonists%252Bfor%252Bthe%252BIonotropic%252BGlutamate%252BReceptors%252BIncluding%252BFunctional%252Band%252BX-ray%252BCrystallographic%252BStudies%252Bof%252BNew%252BSubtype%252BSelective%252BKainic%252BAcid%252BReceptor%252BSubtype%252B1%252B%252528GluK1%252529%252BAntagonist%252B%2525282S%25252C4R%252529-4-%2525282-Carboxyphenoxy%252529pyrrolidine-2-carboxylic%252BAcid%26aulast%3DKrogsgaard-Larsen%26aufirst%3DNiels%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D15102016%26date%3D22122016%26date%3D12012017%26volume%3D60%26issue%3D1%26spage%3D441%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jue Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Mark W.  Irvine</span>, <span class="hlFld-ContribAuthor ">Erica S.  Burnell</span>, <span class="hlFld-ContribAuthor ">Kiran  Sapkota</span>, <span class="hlFld-ContribAuthor ">Robert J.  Thatcher</span>, <span class="hlFld-ContribAuthor ">Minjun  Li</span>, <span class="hlFld-ContribAuthor ">Noriko  Simorowski</span>, <span class="hlFld-ContribAuthor ">Arturas  Volianskis</span>, <span class="hlFld-ContribAuthor ">Graham L.  Collingridge</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Monaghan</span>, <span class="hlFld-ContribAuthor ">David E.  Jane</span>, <span class="hlFld-ContribAuthor ">Hiro  Furukawa</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-14321-0" title="DOI URL">https://doi.org/10.1038/s41467-020-14321-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-14321-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-14321-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Bbasis%252Bof%252Bsubtype-selective%252Bcompetitive%252Bantagonism%252Bfor%252BGluN2C%25252F2D-containing%252BNMDA%252Breceptors%26aulast%3DWang%26aufirst%3DJue%2BXiang%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Zheng</span>, <span class="hlFld-ContribAuthor ">Yajie  Liu</span>, <span class="hlFld-ContribAuthor ">Jiajie  Qiao</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Selective synthesis of β-nitrated N-heterocycles and
              N
              -nitroso-2-alkoxyamine aldehydes from inactivated cyclic amines promoted by
              t
              BuONO and oxoammonium salt. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (82)
                                     , 12372-12375. <a href="https://doi.org/10.1039/C9CC05963F" title="DOI URL">https://doi.org/10.1039/C9CC05963F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC05963F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC05963F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSelective%252Bsynthesis%252Bof%252B%2525CE%2525B2-nitrated%252BN-heterocycles%252Band%252BN%252B-nitroso-2-alkoxyamine%252Baldehydes%252Bfrom%252Binactivated%252Bcyclic%252Bamines%252Bpromoted%252Bby%252Bt%252BBuONO%252Band%252Boxoammonium%252Bsalt%26aulast%3DHe%26aufirst%3DYan%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D82%26spage%3D12372%26epage%3D12375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgan A.  Alford</span>, <span class="hlFld-ContribAuthor ">Zhenlin  Tian</span>, <span class="hlFld-ContribAuthor ">Frederic  Menard</span>, <span class="hlFld-ContribAuthor ">Andis  Klegeris</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of novel kainic acid analogs as inhibitors of select microglial functions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>851 </em>, 25-35. <a href="https://doi.org/10.1016/j.ejphar.2019.02.025" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.02.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.02.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DCharacterization%252Bof%252Bnovel%252Bkainic%252Bacid%252Banalogs%252Bas%252Binhibitors%252Bof%252Bselect%252Bmicroglial%252Bfunctions%26aulast%3DAlford%26aufirst%3DMorgan%2BA.%26date%3D2019%26volume%3D851%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin T.  Pelkey</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Pelkey</span>, <span class="hlFld-ContribAuthor ">Jessica G.  Greger</span>. </span><span class="cited-content_cbyCitation_article-title">Reactions of 3-pyrrolin-2-ones. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 433-565. <a href="https://doi.org/10.1016/bs.aihch.2018.10.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.10.004%26sid%3Dliteratum%253Aachs%26atitle%3DReactions%252Bof%252B3-pyrrolin-2-ones%26aulast%3DPelkey%26aufirst%3DErin%2BT.%26date%3D2019%26spage%3D433%26epage%3D565%26pub%3DElsevier%26date%3D2019%26volume%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stine  Møllerud</span>, <span class="hlFld-ContribAuthor ">Karla  Frydenvang</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, <span class="hlFld-ContribAuthor ">Jette Sandholm  Kastrup</span>. </span><span class="cited-content_cbyCitation_article-title">Lessons from crystal structures of kainate receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>112 </em>, 16-28. <a href="https://doi.org/10.1016/j.neuropharm.2016.05.014" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2016.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2016.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2016.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DLessons%252Bfrom%252Bcrystal%252Bstructures%252Bof%252Bkainate%252Breceptors%26aulast%3DM%25C3%25B8llerud%26aufirst%3DStine%26date%3D2017%26volume%3D112%26spage%3D16%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. C. V.  Martins</span>, <span class="hlFld-ContribAuthor ">P.  de-Lima-Neto</span>, <span class="hlFld-ContribAuthor ">E. W. S.  Caetano</span>, <span class="hlFld-ContribAuthor ">V. N.  Freire</span>. </span><span class="cited-content_cbyCitation_article-title">An improved quantum biochemistry description of the glutamate–GluA2 receptor binding within an inhomogeneous dielectric function framework. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (14)
                                     , 6167-6179. <a href="https://doi.org/10.1039/C6NJ03939A" title="DOI URL">https://doi.org/10.1039/C6NJ03939A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ03939A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ03939A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DAn%252Bimproved%252Bquantum%252Bbiochemistry%252Bdescription%252Bof%252Bthe%252Bglutamate%2525E2%252580%252593GluA2%252Breceptor%252Bbinding%252Bwithin%252Ban%252Binhomogeneous%252Bdielectric%252Bfunction%252Bframework%26aulast%3DMartins%26aufirst%3DA.%2BC.%2BV.%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D14%26spage%3D6167%26epage%3D6179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">Joost  Verbeek</span>, <span class="hlFld-ContribAuthor ">Uta  Funke</span>, <span class="hlFld-ContribAuthor ">Joan  Lecina</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO
              2
              : Opportunities for
              11
              C Radiochemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2016,</strong> <em>8 </em>
                                    (24)
                                     , 3692-3700. <a href="https://doi.org/10.1002/cctc.201600943" title="DOI URL">https://doi.org/10.1002/cctc.201600943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201600943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201600943%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DRecent%252BProgress%252Bin%252BMetal%252BCatalyzed%252BDirect%252BCarboxylation%252Bof%252BAryl%252BHalides%252Band%252BPseudo%252BHalides%252BEmploying%252BCO%252B2%252B%25253A%252BOpportunities%252Bfor%252B11%252BC%2525E2%252580%252585Radiochemistry%26aulast%3DAhamed%26aufirst%3DMuneer%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D24%26spage%3D3692%26epage%3D3700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Tamborini</span>, <span class="hlFld-ContribAuthor ">Gregorio  Cullia</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Carlo  De Micheli</span>, <span class="hlFld-ContribAuthor ">Paola  Conti</span>, <span class="hlFld-ContribAuthor ">Andrea  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (22)
                                     , 5741-5747. <a href="https://doi.org/10.1016/j.bmc.2016.09.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bconformationally%252Bconstrained%252Bglutamic%252Bacid%252Bhigher%252Bhomologues%26aulast%3DTamborini%26aufirst%3DLucia%26date%3D2016%26volume%3D24%26issue%3D22%26spage%3D5741%26epage%3D5747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongxiang  Xie</span>, <span class="hlFld-ContribAuthor ">Bowen  Gong</span>, <span class="hlFld-ContribAuthor ">Xinran  Zhong</span>, <span class="hlFld-ContribAuthor ">Hongming  Cui</span>, <span class="hlFld-ContribAuthor ">Jinbao  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Cycloaddition of Azomethine Ylides Activated by Aromatic Rings: Scope and Limitations. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (7)
                                     , 484-492. <a href="https://doi.org/10.1007/s10593-016-1912-9" title="DOI URL">https://doi.org/10.1007/s10593-016-1912-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1912-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1912-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DIntramolecular%252BCycloaddition%252Bof%252BAzomethine%252BYlides%252BActivated%252Bby%252BAromatic%252BRings%25253A%252BScope%252Band%252BLimitations%26aulast%3DXie%26aufirst%3DHongxiang%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D7%26spage%3D484%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Alcaide</span>, <span class="hlFld-ContribAuthor ">Laura  Marconi</span>, <span class="hlFld-ContribAuthor ">Ales  Marek</span>, <span class="hlFld-ContribAuthor ">Isabell  Haym</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Stine  Møllerud</span>, <span class="hlFld-ContribAuthor ">Mikael  Jensen</span>, <span class="hlFld-ContribAuthor ">Paola  Conti</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological characterization of the selective GluK1 radioligand (S)-2-amino-3-(6-[
              3
              H]-2,4-dioxo-3,4-dihydrothieno[3,2-d]pyrimidin-1(2H)-yl)propanoic acid ([
              3
              H]-NF608). </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 2136-2144. <a href="https://doi.org/10.1039/C6MD00339G" title="DOI URL">https://doi.org/10.1039/C6MD00339G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00339G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00339G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bcharacterization%252Bof%252Bthe%252Bselective%252BGluK1%252Bradioligand%252B%252528S%252529-2-amino-3-%2525286-%25255B%252B3%252BH%25255D-2%25252C4-dioxo-3%25252C4-dihydrothieno%25255B3%25252C2-d%25255Dpyrimidin-1%2525282H%252529-yl%252529propanoic%252Bacid%252B%252528%25255B%252B3%252BH%25255D-NF608%252529%26aulast%3DAlcaide%26aufirst%3DAnna%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D11%26spage%3D2136%26epage%3D2144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of rationally designed analogues <b>2a</b>–<b>h</b> of lead structure <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>2a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBSCl, imidazole, DCM, rt, 24 h, aq workup, then BOC<sub>2</sub>O, DMAP, CH<sub>3</sub>CN, rt, 16 h (two steps, 91%); (b) LHMDS, PhSeCl, THF, −78 °C, then 30% H<sub>2</sub>O<sub>2</sub>, EtOAc, 0 °C to rt (two steps, 64%); (c) <b>6a</b>, <i>tert</i>-BuLi, CuCN, Et<sub>2</sub>O, −78 to −42 °C (70%); (d) BH<sub>3</sub>·THF, THF, reflux, 3.5 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 3.5 h (46%); (e) TBAF, THF, rt, 2 h (87%); (f) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 1.5 h (<b>10a</b>, 22%; <b>11</b>, 40%); (g) <b>10a</b> only, TFA:H<sub>2</sub>O (1:1), rt, 16 h (59%).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0015.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Bromide <b>6a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2-dimethoxypropane, ZnCl<sub>2</sub>, acetone, 40 °C, 1.5 h (88%).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0016.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Attempted Oxidation of Phenolic Diol <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p</i>-TsOH, MeOH, rt, 5 h (71%).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>2b</b>–<b>e</b> and Chemical Structure of Side Product <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6b</b>–<b>d</b>, <i>tert</i>-BuLi, CuCN, lithium thiophene, Et<sub>2</sub>O, −78 to −42 °C (42–62%); (b) BH<sub>3</sub>·THF, THF, reflux, 20 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 1 h (51–60%); (c) TBAF, THF, rt, (92–94%); (d) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 2 h (66–83%); (e) 2 M HCl in Et<sub>2</sub>O, AcOH, rt, 18 h (87–99%); (f) <b>2c</b> only, H<sub>2</sub>(g), Pd/C (10%), AcOH, rt, 6 days (44%).</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted Phenylbromides <b>6b</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>·THF, THF, 0 °C to rt, aq workup, then TBSCl, imidazole, DMF, 0 °C to rt (71%); (b) for <b>6b</b>, <i>n</i>-PrBr, K<sub>2</sub>CO<sub>3</sub>, rt in DMF (90%); for <b>6c</b>,<b>d</b>, RBr, K<sub>2</sub>CO<sub>3</sub>, reflux in acetone (92–95%).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>cis</i>-2,4-Substituted Target Compounds <b>2f</b> and <b>2g</b> from Intermediate <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, RBr, THF −42/–52 °C (49% and 72%); (b) for <b>19a</b>, first H<sub>2</sub>, Pd/C, rt, then for both <b>19a</b>,<b>b</b>, BH<sub>3</sub>·THF, THF, reflux, 20 h, then H<sub>2</sub>O, NaOH, H<sub>2</sub>O<sub>2</sub>, rt, 1 h (59% and 30%); (c) TBAF, THF, rt, (89% and 79%); (d) NaIO<sub>4</sub>, RuCl<sub>3</sub>, 0 °C, 2 h (93% and 45%); (e) HCl in AcOH, rt, 18 h (82% and 69%).</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Strategy for the Synthesis of <b>2h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-dibromobenzene, <i>n</i>-BuLi, CuCN, TMSCl, THF, −50 °C (63%); (b) BH<sub>3</sub>·THF then NaOH, H<sub>2</sub>O<sub>2</sub> (73%); (c) <i>n</i>-BuLi, ClPO<sub>3</sub>Et<sub>2</sub>, THF, −78 °C (66%); (d) TBAF, THF rt, (65%); (e) RuCl<sub>3</sub>, NaIO<sub>4</sub>, H<sub>2</sub>O, CH<sub>3</sub>CN, EtOAc, rt (82%); (f) 2 N HCl, H<sub>2</sub>O, 80 °C (40%).</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand binding domain of GluA2 in complex with <b>2e</b>. (A) Cartoon representation of the GluA2-LBD dimer (molA cyan and molB light cyan) with <b>2e</b> (gray space fill representation) bound at the binding site. (B) Zoom on the binding site (molA). Possible hydrogen bonds (up to 3.2 Å) between <b>2e</b> and GluA2, as well as to water molecules and a putative sulfate ion, are displayed as black dashes. Indirect interactions through water and sulfate are shown as red dashes. The electron density map (omit 2m<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) is shown at 1.0 σ and carved around the ligand at 1.6 Å radius. (C) Comparison of the structures of GluA2-LBD with <b>2e</b> (gray) and kainate (light pink; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FW0">1FW0</a>). The structures were superimposed on domain D1 residues. GluA2 residues for complex with kainate are shown in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/medium/jm-2015-00750j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ligand binding domain of GluK1 in complex with <b>2f</b>. (A) Cartoon representation of the GluK1-LBD dimer (mol A forest green; mol B green) with <b>2f</b> (yellow space fill representation) bound at the binding site. (B) Zoom on the binding site (molA). Possible hydrogen bonds (up to 3.2 Å) between <b>2f</b> and GluK1 as well as to water molecules are displayed as black dashes. The electron density map (omit 2m<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) is shown at 1.0 σ and carved around the ligand at 1.6 Å radius. (C) Comparison of the structures of GluK1-LBD with <b>2f</b> and kainate (light pink; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E0X">4E0X</a>). The structures were superimposed on domain D1 residues. GluK1 residues are shown in white for complex with kainate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00750/20150807/images/large/jm-2015-00750j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00750&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Meldrum, B. S.</span><span> </span><span class="NLM_article-title">Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology</span> <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007S</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015S</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1093%2Fjn%2F130.4.1007S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10736372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1eiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1007S-1015S&author=B.+S.+Meldrum&title=Glutamate+as+a+Neurotransmitter+in+the+Brain%3A+Review+of+Physiology+and+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate as a neurotransmitter in the brain: review of physiology and pathology</span></div><div class="casAuthors">Meldrum, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4S</span>),
    <span class="NLM_cas:pages">1007S-1015S</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">A review with 107 refs.  Glutamate is the principal excitatory neurotransmitter in brain.  The knowledge of the glutamatergic synapse has advanced enormously in the last 10 yr, primarily through application of mol. biol. techniques to the study of glutamate receptors and transporters.  There are three families of ionotropic receptors with intrinsic cation permeable channels [N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate].  There are three groups of metabotropic, G protein-coupled glutamate receptors (mGluR) that modify neuronal and glial excitability through G protein subunits acting on membrane ion channels and second messengers such as diacylglycerol and cAMP.  There are also two glial glutamate transporters and three neuronal transporters in the brain.  Glutamate is the most abundant amino acid in the diet.  There is no evidence for brain damage in humans resulting from dietary glutamate.  A kainate analog, domoate, is sometimes ingested accidentally in blue mussels; this potent toxin causes limbic seizures, which can lead to hippocampal and related pathol. and amnesia.  Endogenous glutamate, by activating NMDA, AMPA or mGluR1 receptors, may contribute to the brain damage occurring acutely after status epilepticus, cerebral ischemia or traumatic brain injury.  It may also contribute to chronic neurodegeneration in such disorders as amyotrophic lateral sclerosis and Huntington's chorea.  In animal models of cerebral ischemia and traumatic brain injury, NMDA and AMPA receptor antagonists protect against acute brain damage and delayed behavioral deficits.  Such compds. are undergoing testing in humans, but therapeutic efficacy has yet to be established.  Other clin. conditions that may respond to drugs acting on glutamatergic transmission include epilepsy, amnesia, anxiety, hyperalgesia and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKb4ZXcCmp-7Vg90H21EOLACvtfcHk0lihsKOm1tOFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1eiu7c%253D&md5=01ad34f6a1483ea6dd2766e15d73bd01</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F130.4.1007S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F130.4.1007S%26sid%3Dliteratum%253Aachs%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DGlutamate%2520as%2520a%2520Neurotransmitter%2520in%2520the%2520Brain%253A%2520Review%2520of%2520Physiology%2520and%2520Pathology%26jtitle%3DJ.%2520Nutr.%26date%3D2000%26volume%3D130%26spage%3D1007S%26epage%3D1015S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Anggono, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huganir, R. L.</span><span> </span><span class="NLM_article-title">Regulation of AMPA Receptor Trafficking and Synaptic Plasticity</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1016/j.conb.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.conb.2011.12.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=461-469&author=V.+Anggonoauthor=R.+L.+Huganir&title=Regulation+of+AMPA+Receptor+Trafficking+and+Synaptic+Plasticity&doi=10.1016%2Fj.conb.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DAnggono%26aufirst%3DV.%26aulast%3DHuganir%26aufirst%3DR.%2BL.%26atitle%3DRegulation%2520of%2520AMPA%2520Receptor%2520Trafficking%2520and%2520Synaptic%2520Plasticity%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2012%26volume%3D22%26spage%3D461%26epage%3D469%26doi%3D10.1016%2Fj.conb.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lovinger, D. M.</span><span> </span><span class="NLM_article-title">Neurotransmitter Roles in Synaptic Modulation, Plasticity and Learning in the Dorsal Striatum</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2010.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20096294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVektrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=951-961&author=D.+M.+Lovinger&title=Neurotransmitter+Roles+in+Synaptic+Modulation%2C+Plasticity+and+Learning+in+the+Dorsal+Striatum&doi=10.1016%2Fj.neuropharm.2010.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum</span></div><div class="casAuthors">Lovinger, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-961</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dorsal striatum is a large forebrain region involved in action initiation, timing, control, learning and memory.  Learning and remembering skilled movement sequences requires the dorsal striatum, and striatal subregions participate in both goal-directed (action-outcome) and habitual (stimulus-response) learning.  Modulation of synaptic transmission plays a large part in controlling input to as well as the output from striatal medium spiny projection neurons (MSNs).  Synapses in this brain region are subject to short-term modulation, including allosteric alterations in ion channel function and prominent presynaptic inhibition.  Two forms of long-term synaptic plasticity have also been obsd. in striatum, long-term potentiation (LTP) and long-term depression (LTD).  LTP at glutamatergic synapses onto MSNs involves activation of NMDA-type glutamate receptors and D1 dopamine or A2A adenosine receptors.  Expression of LTP appears to involve postsynaptic mechanisms.  LTD at glutamatergic synapses involves retrograde endocannabinoid signaling stimulated by activation of metabotropic glutamate receptors (mGluRs) and D2 dopamine receptors.  While postsynaptic mechanisms participate in LTD induction, maintained expression involves presynaptic mechanisms.  A similar form of LTD has also been obsd. at GABAergic synapses onto MSNs.  Studies have just begun to examine the roles of synaptic plasticity in striatal-based learning.  Findings to date indicate that mols. implicated in induction of plasticity participate in these forms of learning.  Neurotransmitter receptors involved in LTP induction are necessary for proper skill and goal-directed instrumental learning.  Interestingly, receptors involved in LTP and LTD at glutamatergic synapses onto MSNs of the "indirect pathway" appear to have important roles in habit learning.  More work is needed to reveal if and when synaptic plasticity occurs during learning and if so what mols. and cellular processes, both short- and long-term, contribute to this plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGote-5gnOPC57Vg90H21EOLACvtfcHk0lgnu8JeCF-rmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVektrg%253D&md5=7ce322f4b31795632446b3417c014ab3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DLovinger%26aufirst%3DD.%2BM.%26atitle%3DNeurotransmitter%2520Roles%2520in%2520Synaptic%2520Modulation%252C%2520Plasticity%2520and%2520Learning%2520in%2520the%2520Dorsal%2520Striatum%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D951%26epage%3D961%26doi%3D10.1016%2Fj.neuropharm.2010.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Cocaine and Amphetamine-like Psychostimulants: Neurocircuitry and Glutamate Neuroplasticity</span> <span class="citation_source-journal">Dialogues Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18286799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ivVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=389-397&author=P.+W.+Kalivas&title=Cocaine+and+Amphetamine-like+Psychostimulants%3A+Neurocircuitry+and+Glutamate+Neuroplasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity</span></div><div class="casAuthors">Kalivas Peter W</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-97</span>
        ISSN:<span class="NLM_cas:issn">1294-8322</span>.
    </div><div class="casAbstract">Although the pharmacology of amphetamine-like psychostimulants at dopamine transporters is well understood, addiction to this class of drugs has proven difficult to deal with.  The reason for this disconnection is that while the molecular mechanism of amphetamine action is critical to reinforce drug use, it is only the first step in a sequence of widespread neuroplastic events in brain circuitry.  This review outlines the affect of psychostimulants on mesocorticolimbic dopamine projections that mediate their reinforcing effect, and how this action ultimately leads to enduring pathological neuroplasticity in glutamatergic projections from the prefrontal cortex to the nucleus accumbens.  Molecular neuroadaptations induced by psychostimulant abuse are described in glutamate neurotransmission, and from this information potential pharmacotherapeutic targets are identified, based upon reversing or countermanding psychostimulant-induced neuroplasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQD9KXpjMZxgHp3bfzSLaX5fW6udTcc2eYo2p36zR873bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ivVegtw%253D%253D&md5=612056ab28b3c50a5e1033dd2e3f9963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DCocaine%2520and%2520Amphetamine-like%2520Psychostimulants%253A%2520Neurocircuitry%2520and%2520Glutamate%2520Neuroplasticity%26jtitle%3DDialogues%2520Clin.%2520Neurosci.%26date%3D2007%26volume%3D9%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ruiz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullmann, D. M.</span><span> </span><span class="NLM_article-title">Ionotropic Receptors at Hippocampal Mossy Fibers: Roles in Axonal Excitability, Synaptic Transmission, and Plasticity</span> <span class="citation_source-journal">Front. Neural Circuits</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="refDoi"> DOI: 10.3389/fncir.2012.00112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.3389%2Ffncir.2012.00112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23316138" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=112&author=A.+J.+Ruizauthor=D.+M.+Kullmann&title=Ionotropic+Receptors+at+Hippocampal+Mossy+Fibers%3A+Roles+in+Axonal+Excitability%2C+Synaptic+Transmission%2C+and+Plasticity&doi=10.3389%2Ffncir.2012.00112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffncir.2012.00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncir.2012.00112%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DA.%2BJ.%26aulast%3DKullmann%26aufirst%3DD.%2BM.%26atitle%3DIonotropic%2520Receptors%2520at%2520Hippocampal%2520Mossy%2520Fibers%253A%2520Roles%2520in%2520Axonal%2520Excitability%252C%2520Synaptic%2520Transmission%252C%2520and%2520Plasticity%26jtitle%3DFront.%2520Neural%2520Circuits%26date%3D2013%26volume%3D6%26spage%3D112%26doi%3D10.3389%2Ffncir.2012.00112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mellor, J. R.</span><span> </span><span class="NLM_article-title">Synaptic Plasticity of Kainate Receptors</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.1042/BST0340949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1042%2FBST0340949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17052234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=949-951&author=J.+R.+Mellor&title=Synaptic+Plasticity+of+Kainate+Receptors&doi=10.1042%2FBST0340949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic plasticity of kainate receptors</span></div><div class="casAuthors">Mellor, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">949-951</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Synaptic plasticity of ionotropic glutamate receptors has been extensively studied with a particular focus on the role played by NMDA (N-methyl-D-aspartate) receptors in the induction of synaptic plasticity and the subsequent movement of AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors.  The third subtype of ionotropic glutamate receptor, kainate receptors, has not been studied to the same extent, but recent evidence shows that these receptors also exhibit synaptic plasticity in response to activity.  There is also a growing body of data on the mechanisms underlying kainate receptor trafficking and the proteins they interact with.  This review summarizes the current state of knowledge on this topic, focusing on the evidence for the removal or insertion of functional kainate receptors in response to synaptic activity and the cellular mechanisms that underlie this regulation of neuronal kainate receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEQGzAejuFB7Vg90H21EOLACvtfcHk0ljtDDnuovIm1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb3O&md5=e8301e7e3fc20c1af6d49a8dae2c7b72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBST0340949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340949%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DJ.%2BR.%26atitle%3DSynaptic%2520Plasticity%2520of%2520Kainate%2520Receptors%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D949%26epage%3D951%26doi%3D10.1042%2FBST0340949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span> </span><span class="NLM_article-title">Kainate Receptors: Pharmacology, Function and Therapeutic Potential</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2008.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18793656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FkvVantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=90-113&author=D.+E.+Janeauthor=D.+Lodgeauthor=G.+L.+Collingridge&title=Kainate+Receptors%3A+Pharmacology%2C+Function+and+Therapeutic+Potential&doi=10.1016%2Fj.neuropharm.2008.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Kainate receptors: pharmacology, function and therapeutic potential</span></div><div class="casAuthors">Jane David E; Lodge David; Collingridge Graham L</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-113</span>
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    </div><div class="casAbstract">Compared to the other glutamate receptors, progress in the understanding of the functions of kainate receptors (KARs) has lagged behind, due mainly to the relative lack of specific pharmacological tools.  Over the last decade subunit selective agonists (e.g.  ATPA and 5-iodowillardiine) and orthosteric (e.g.  LY382884 and ACET) and allosteric antagonists for KARs that contain GluK1 (GluR5) subunits have been developed.  However, no selective ligands for the other KAR subunits have been identified.  The use of GluK1 antagonists has enabled several functions of KARs, that contain this subunit, to be identified.  Thus, KARs have been shown to regulate excitatory and inhibitory synaptic transmission.  In the case of the regulation of L-glutamate release, they can function as facilitatory autoreceptors or inhibitory autoreceptors during repetitive synaptic activation and can respond to ambient levels of L-glutamate to provide a tonic regulation of L-glutamate release.  KARs also contribute a component of excitatory synaptic transmission at certain synapses.  They can also act as triggers for both long-term potentiation (LTP) and long-term depression (LTD) and rapid alterations in their trafficking can result in altered synaptic transmission during both synaptic plasticity and neuronal development.  KARs also contribute to synchronised rhythmic activity in the brain and are involved in forms of learning and memory.  With respect to therapeutic indications, antagonists for GluK1 have shown positive activity in animal models of pain, migraine, epilepsy, stroke and anxiety.  This potential has now been confirmed in dental pain and migraine in initial studies in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR1K3JQEA6lWyYR5VtavbzfW6udTcc2eYCGoh84OKpGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FkvVantA%253D%253D&md5=bd4bbdccdf7b3178730e63167476188a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DKainate%2520Receptors%253A%2520Pharmacology%252C%2520Function%2520and%2520Therapeutic%2520Potential%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26spage%3D90%26epage%3D113%26doi%3D10.1016%2Fj.neuropharm.2008.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Sanacora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treccani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, M.</span><span> </span><span class="NLM_article-title">Towards a Glutamate Hypothesis of Depression: An Emerging Frontier of Neuropsychopharmacology for Mood Disorders</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2011.07.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=63-77&author=G.+Sanacoraauthor=G.+Treccaniauthor=M.+Popoli&title=Towards+a+Glutamate+Hypothesis+of+Depression%3A+An+Emerging+Frontier+of+Neuropsychopharmacology+for+Mood+Disorders&doi=10.1016%2Fj.neuropharm.2011.07.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DSanacora%26aufirst%3DG.%26aulast%3DTreccani%26aufirst%3DG.%26aulast%3DPopoli%26aufirst%3DM.%26atitle%3DTowards%2520a%2520Glutamate%2520Hypothesis%2520of%2520Depression%253A%2520An%2520Emerging%2520Frontier%2520of%2520Neuropsychopharmacology%2520for%2520Mood%2520Disorders%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D63%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2011.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanacora, G.</span><span> </span><span class="NLM_article-title">Glutamate-Based Depression GBD</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span><span class="refDoi"> DOI: 10.1016/j.mehy.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.mehy.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22391030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XltlantLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=675-681&author=D.+J.+McCarthyauthor=R.+Alexanderauthor=M.+A.+Smithauthor=S.+Pathakauthor=S.+Kanesauthor=C.-M.+Leeauthor=G.+Sanacora&title=Glutamate-Based+Depression+GBD&doi=10.1016%2Fj.mehy.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate-based depression GBD</span></div><div class="casAuthors">McCarthy, Dennis J.; Alexander, Robert; Smith, Mark A.; Pathak, Sanjeev; Kanes, Stephen; Lee, Chi-Ming; Sanacora, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">675-681</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  We describe a new term: glutamate-based depression (GBD).  GBD is defined as a chronic depressive illness assocd. with environmental stress and diseases assocd. with altered glutamate neurotransmission.  We hypothesize that glutamate-induced over-activation of extrasynaptic NMDA receptors in the subgenual cingulate area called Brodmann's 25 plays an important role in the etiol. of depression and may be responsible for the high incidence of co-morbid depression assocd. in diseases with glutamate etiol.  While depression is a syndrome with multiple possible etiologies, we propose that a disruption in glutamatergic neurotransmission may underline a substantial proportion of clin. obsd. depression.  The high rates of depressive symptoms assocd. with various disorders in which altered glutamatergic functions have been identified, may suggest a common pathophysiol. mechanism is underlying the diverse clin. presentations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprR_HdGR4iL7Vg90H21EOLACvtfcHk0lhxr9EFZryO6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltlantLg%253D&md5=15ac8bdcb7de0cbe4157e21e4d4c7376</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DKanes%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.-M.%26aulast%3DSanacora%26aufirst%3DG.%26atitle%3DGlutamate-Based%2520Depression%2520GBD%26jtitle%3DMed.%2520Hypotheses%26date%3D2012%26volume%3D78%26spage%3D675%26epage%3D681%26doi%3D10.1016%2Fj.mehy.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Riaza Bermudo-Soriano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Rodriguez, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero-Lorenzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca-Garcia, E.</span><span> </span><span class="NLM_article-title">New Perspectives in Glutamate and Anxiety</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.pbb.2011.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.pbb.2011.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2012&pages=752-774&author=C.+Riaza+Bermudo-Sorianoauthor=M.+M.+Perez-Rodriguezauthor=C.+Vaquero-Lorenzoauthor=E.+Baca-Garcia&title=New+Perspectives+in+Glutamate+and+Anxiety&doi=10.1016%2Fj.pbb.2011.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2011.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2011.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DRiaza%2BBermudo-Soriano%26aufirst%3DC.%26aulast%3DPerez-Rodriguez%26aufirst%3DM.%2BM.%26aulast%3DVaquero-Lorenzo%26aufirst%3DC.%26aulast%3DBaca-Garcia%26aufirst%3DE.%26atitle%3DNew%2520Perspectives%2520in%2520Glutamate%2520and%2520Anxiety%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2012%26volume%3D100%26spage%3D752%26epage%3D774%26doi%3D10.1016%2Fj.pbb.2011.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lea, P. M. th</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptor Subtype 5 Antagonists MPEP and MTEP</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2006.00149.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Fj.1527-3458.2006.00149.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=149-166&author=P.+M.+th+Leaauthor=A.+I.+Faden&title=Metabotropic+Glutamate+Receptor+Subtype+5+Antagonists+MPEP+and+MTEP&doi=10.1111%2Fj.1527-3458.2006.00149.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2006.00149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2006.00149.x%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DP.%2BM.%2Bth%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DMetabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Antagonists%2520MPEP%2520and%2520MTEP%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D149%26epage%3D166%26doi%3D10.1111%2Fj.1527-3458.2006.00149.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vikelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsikostas, D. D.</span><span> </span><span class="NLM_article-title">The Role of Glutamate and Its Receptors in Migraine</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.2174/187152707781387279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.2174%2F187152707781387279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17691981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=251-257&author=M.+Vikelisauthor=D.+D.+Mitsikostas&title=The+Role+of+Glutamate+and+Its+Receptors+in+Migraine&doi=10.2174%2F187152707781387279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glutamate and its receptors in migraine</span></div><div class="casAuthors">Vikelis, Michail; Mitsikostas, Dimos D.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-257</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate (Glu) is the principal excitatory neurotransmitter in the central nervous system.  Its receptors are classified into ionotropic receptors, which are ion channels and include NMDA, AMPA and kainate receptors, named after the agonists that selectively bind to them, and metabotropic receptors, which are G-protein coupled receptors.  The trigeminal system is considered to play a key role in migraine pathophysiol., trafficking pain signals from the head and face to the trigeminal nucleus caudalis.  The role of glutamate in the pathophysiol. of migraine is implicated by data from animal and human studies.  Animal studies include expts. of cortical spreading depression, studies of c-fos protein expression in trigeminal nucleus caudalis, studies of plasma protein extravasation and electrophysiol. studies.  Human studies investigating the role of Glu in migraine pathogenesis measured the levels of Glu in plasma, platelets and cerebrospinal fluid, studied its effect on migraine symptoms and examd. the effect of Glu in modulating sensitization.  Findings from both the animal and the human studies suggest a link between glutamate and migraine and further suggest that glutamate plays a key role in migraine mechanisms.  In the future, efforts should be made to further investigate the role of glutamate in migraine pathogenesis and, subsequently, in migraine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VOPUyFebWrVg90H21EOLACvtfcHk0lhxr9EFZryO6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehsLfO&md5=5a05c3ccc1aa945cb2ab018b470f4c36</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F187152707781387279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707781387279%26sid%3Dliteratum%253Aachs%26aulast%3DVikelis%26aufirst%3DM.%26aulast%3DMitsikostas%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Role%2520of%2520Glutamate%2520and%2520Its%2520Receptors%2520in%2520Migraine%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D251%26epage%3D257%26doi%3D10.2174%2F187152707781387279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Weiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieckman, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens-Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkalla, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">772</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span><span class="refDoi"> DOI: 10.1124/jpet.106.101428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1124%2Fjpet.106.101428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16690725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=772-781&author=B.+Weissauthor=A.+Altauthor=A.+M.+Ogdenauthor=M.+Gatesauthor=D.+K.+Dieckmanauthor=A.+Clemens-Smithauthor=K.+H.+Hoauthor=K.+Jarvieauthor=G.+Rizkallaauthor=R.+A.+Wright&title=Pharmacological+Characterization+of+the+Competitive+GLUK5+Receptor+Antagonist+Decahydroisoquinoline+LY466195+in+Vitro+and+in+Vivo&doi=10.1124%2Fjpet.106.101428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo</span></div><div class="casAuthors">Weiss, Brianne; Alt, Andrew; Ogden, Ann Marie; Gates, Mary; Dieckman, Donna K.; Clemens-Smith, Amy; Ho, Ken H.; Jarvie, Keith; Rizkalla, Geihan; Wright, Rebecca A.; Calligaro, David O.; Schoepp, Darryle; Mattiuz, Edward L.; Stratford, Robert E.; Johnson, Bryan; Salhoff, Craig; Katofiasc, Mary; Phebus, Lee A.; Schenck, Kathryn; Cohen, Marlene; Filla, Sandra A.; Ornstein, Paul L.; Johnson, Kirk W.; Bleakman, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">772-781</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The excitatory neurotransmitter glutamate has been implicated in both migraine and persistent pain.  The identification of the kainate receptor GLUK5 in dorsal root ganglia, the dorsal horn, and trigeminal ganglia makes it a target of interest for these indications.  We examd. the in vitro and in vivo pharmacol. of the competitive GLUK5-selective kainate receptor antagonist LY466195, the most potent GLUK5 antagonist described to date.  Comparisons were made to the competitive GLUK5/α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonist LY293558 [(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid], other decahydroisoquinoline GLUK5 receptor antagonists, and the noncompetitive AMPA receptor antagonist LY300168 [1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodi-azepine].  When characterized electrophysiol. in rat dorsal root ganglion neurons, LY466195 antagonized kainate (30 μM)-induced currents with an IC50 value of 0.045 ± 0.011 μM.  In HEK293 cells transfected with GLUK5, GLUK2/GLUK5, or GLUK5/GLUK6 receptors, LY466195 produced IC50 values of 0.08 ± 0.02, 0.34 ± 0.17, and 0.07 ± 0.02 μM, resp.  LY466195 was efficacious in a dural plasma protein extravasation (PPE) model of migraine with an ID100 value of 100 μg/kg i.v.  LY466195 was also efficacious in the c-fos migraine model, with a dose of 1 μg/kg i.v. significantly reducing the no. of Fos-pos. cells in the rat nucleus caudalis after elec. stimulation of the trigeminal ganglion.  Furthermore, LY466195 showed no contractile activity in the rabbit saphenous vein in vitro.  The di-Et ester prodrug of LY466195 was also efficacious in the same PPE and c-fos models after oral administration at doses of 10 and 100 μg/kg, resp. while having no N-methyl-D-aspartate antagonist-like behavioral effects at oral doses up to 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwe6dtAoo61bVg90H21EOLACvtfcHk0lhxr9EFZryO6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOltro%253D&md5=decb91d0148d7a4049f15e1c4622925a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101428%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DB.%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DOgden%26aufirst%3DA.%2BM.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DDieckman%26aufirst%3DD.%2BK.%26aulast%3DClemens-Smith%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DK.%2BH.%26aulast%3DJarvie%26aufirst%3DK.%26aulast%3DRizkalla%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DR.%2BA.%26atitle%3DPharmacological%2520Characterization%2520of%2520the%2520Competitive%2520GLUK5%2520Receptor%2520Antagonist%2520Decahydroisoquinoline%2520LY466195%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D772%26epage%3D781%26doi%3D10.1124%2Fjpet.106.101428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">De Bartolomeis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarappa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iasevoli, F.</span><span> </span><span class="NLM_article-title">Targeting Glutamate System for Novel Antipsychotic Approaches: Relevance for Residual Psychotic Symptoms and Treatment Resistant Schizophrenia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">682</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.ejphar.2012.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22387855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=682&publication_year=2012&pages=1-11&author=A.+De+Bartolomeisauthor=C.+Sarappaauthor=S.+Magaraauthor=F.+Iasevoli&title=Targeting+Glutamate+System+for+Novel+Antipsychotic+Approaches%3A+Relevance+for+Residual+Psychotic+Symptoms+and+Treatment+Resistant+Schizophrenia&doi=10.1016%2Fj.ejphar.2012.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia</span></div><div class="casAuthors">de Bartolomeis, Andrea; Sarappa, Chiara; Magara, Salvatore; Iasevoli, Felice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">682</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antipsychotics are the mainstay of schizophrenia treatment.  However, approx. one third of schizophrenic patients do not respond or respond poorly to antipsychotics.  Therefore, there is a need for new approaches that can improve schizophrenia treatment significantly.  Promising strategies arise from the modulation of glutamatergic system, according to its proposed involvement in schizophrenia pathogenesis.  In this review, we critically updated preclin. and clin. data on the modulation of glutamate N-methyl-D-aspartate (NMDA) receptor activity by NMDA-Rs co-agonists, glycine transporters inhibitors, AMPAkines, mGluR5 agonists, NMDA-Rs partial agonists.  We focused on: 1) preclin. results in animal models mimicking the pathophysiol. of psychosis, mainly believed to be responsible of neg. and cognitive symptoms, and predicting antipsychotic-like activity of these compds.; and 2) clin. efficacy in open-label and double-blind trials.  Albeit promising preclin. findings for virtually all compds., clin. efficacy has not been confirmed for D-cycloserine.  Contrasting evidence has been reported for glycine and D-serine, that may however have a role as add-on agents.  More promising results in humans have been found for glycine transporter inhibitors.  AMPAkines appear to be beneficial as pro-cognitive agents, while pos. allosteric modulators of mGluR5 have not been tested in humans.  Memantine has been proposed in early stages of schizophrenia, as it may counteract the effects of glutamate excitotoxicity correlated to high glutamate levels, slowing the progression of neg. symptoms assocd. to more advanced stages of the illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGEDAptXZnLVg90H21EOLACvtfcHk0lgdTykYKUztNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggtb8%253D&md5=1f192ddf1f7dc0eb73a7f994c0f41bdf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBartolomeis%26aufirst%3DA.%26aulast%3DSarappa%26aufirst%3DC.%26aulast%3DMagara%26aufirst%3DS.%26aulast%3DIasevoli%26aufirst%3DF.%26atitle%3DTargeting%2520Glutamate%2520System%2520for%2520Novel%2520Antipsychotic%2520Approaches%253A%2520Relevance%2520for%2520Residual%2520Psychotic%2520Symptoms%2520and%2520Treatment%2520Resistant%2520Schizophrenia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D682%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.ejphar.2012.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benneyworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopaske, G.</span><span> </span><span class="NLM_article-title">Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1007/978-3-642-25758-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1007%2F978-3-642-25758-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23027419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=267-295&author=J.+T.+Coyleauthor=A.+Basuauthor=M.+Benneyworthauthor=D.+Baluauthor=G.+Konopaske&title=Glutamatergic+Synaptic+Dysregulation+in+Schizophrenia%3A+Therapeutic+Implications&doi=10.1007%2F978-3-642-25758-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications</span></div><div class="casAuthors">Coyle, Joseph T.; Basu, Alo; Benneyworth, Michael; Balu, Darrick; Konopaske, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">267-295</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Schizophrenia affects approx. 1% of the population and continues to be assocd. with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications.  An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clin. observations that NMDA receptor antagonists, the dissociative anesthetics like ketamine, can replicate in normal individuals the full range of symptoms of schizophrenia including psychosis, neg. symptoms, and cognitive impairments.  Low dose ketamine can also re-create a no. of physiol. abnormalities characteristic of schizophrenia.  Postmortem studies have revealed abnormalities in endogenous modulators of NMDA receptors in schizophrenia as well as components of a postsynaptic d. where NMDA receptors are localized.  Gene assocn. studies have revealed several genes that affect NMDA receptor function whose allelic variants are assocd. with increased risk for schizophrenia including genes encoding D-amino acid oxidase, its modulator G72, dysbindin, and neuregulin.  The parvalbumin-pos., fast-firing GABAergic interneurons that provide recurrent inhibition to cortical-limbic pyramidal neurons seem to be most sensitive to NMDA receptor hypofunction.  As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and neg. symptoms, and drives subcortical dopamine release, resulting in psychosis.  Drugs designed to correct the cortical-limbic dysregulated glutamatergic neurotransmission show promise for reducing neg. and cognitive symptoms of schizophrenia as well as its pos. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUOYchIYYK7Vg90H21EOLACvtfcHk0lgdTykYKUztNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D&md5=1cda996ff05ed79c6ff89bc9cac0d050</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBenneyworth%26aufirst%3DM.%26aulast%3DBalu%26aufirst%3DD.%26aulast%3DKonopaske%26aufirst%3DG.%26atitle%3DGlutamatergic%2520Synaptic%2520Dysregulation%2520in%2520Schizophrenia%253A%2520Therapeutic%2520Implications%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26spage%3D267%26epage%3D295%26doi%3D10.1007%2F978-3-642-25758-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Glutamatergic Theories of Schizophrenia</span> <span class="citation_source-journal">Isr. J. Psychiatry Relat. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20686195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A280%3ADC%252BC3cjis1Glug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=4-16&author=D.+C.+Javitt&title=Glutamatergic+Theories+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic theories of schizophrenia</span></div><div class="casAuthors">Javitt Daniel C</div><div class="citationInfo"><span class="NLM_cas:title">The Israel journal of psychiatry and related sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia is a serious mental disorder that affects up to 1% of the population worldwide.  Traditional models of schizophrenia have emphasized dopaminergic dysfunction.  Over the last 20 years, however, limitations of the dopamine model have become increasingly apparent, necessitating development of alternative models.  Glutamatergic models are based upon the observation that the psychotomimetic agents such as phencyclidine (PCP) and ketamine induce psychotic symptoms and neurocognitive disturbances similar to those of schizophrenia by blocking neurotransmission at N-methyl-D-aspartate (NMDA)-type glutamate receptors.  Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of NMDA receptors throughout the brain.  Further, NMDA receptors are located on brain circuits that regulate dopamine release, suggesting that dopaminergic deficits in schizophrenia may also be secondary to underlying glutamatergic dysfunction.  Agents that stimulate NMDA receptor-mediated neurotransmission, including glycine-site agonists and glycine transport inhibitors, have shown encouraging results in preclinical studies and are currently undergoing clinical development.  Encouraging results have been observed as well with agents such as metabotropic 2/3 agonists that decrease resting glutamate levels, reversing potential disruption in firing patterns within prefrontal cortex and possibly other brain regions.  Overall, these findings suggest that glutamatergic theories may lead to new conceptualizations and treatment approaches that would not be possible based upon dopaminergic models alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN9-HE38_eScAKB7Fa-xrUfW6udTcc2eaHyBKKTrULsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjis1Glug%253D%253D&md5=d55be824c89af674880f2269514c7a3c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlutamatergic%2520Theories%2520of%2520Schizophrenia%26jtitle%3DIsr.%2520J.%2520Psychiatry%2520Relat.%2520Sci.%26date%3D2010%26volume%3D47%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Almeida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. M.</span><span> </span><span class="NLM_article-title">Glutamate Neurotoxicity Is Associated with Nitric Oxide-Mediated Mitochondrial Dysfunction and Glutathione Depletion</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">790</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S0006-8993(98)00064-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS0006-8993%2898%2900064-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=9593899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=790&publication_year=1998&pages=209-216&author=A.+Almeidaauthor=S.+J.+Healesauthor=J.+P.+Bolanosauthor=J.+M.+Medina&title=Glutamate+Neurotoxicity+Is+Associated+with+Nitric+Oxide-Mediated+Mitochondrial+Dysfunction+and+Glutathione+Depletion&doi=10.1016%2FS0006-8993%2898%2900064-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion</span></div><div class="casAuthors">Almeida, Angeles; Heales, Simon J. R.; Bolanos, Juan P.; Medina, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">790</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The role of mitochondrial energy metab. in glutamate mediated neurotoxicity was studied in rat neurons in primary culture.  A brief (15 min) exposure of the neurons to glutamate caused a dose-dependent (0.01-1 mM) increase in cGMP levels together with delayed (24 h) neurotoxicity and ATP depletion.  These effects were prevented by either the nitric oxide (·NO) synthase (NOS) inhibitor Nω-nitro-L-arginine Me ester (NAME; 1 mM) or by the N-methyl-D-aspartate (NMDA) glutamate-subtype receptor antagonist d-(-)-2-amino-5-phosphonopentanoate (APV; 0.1 mM).  Glutamate exposure (0.1 mM and 1 mM) followed by 24 h of incubation caused the inhibition of succinate-cytochrome c reductase (20-25%) and cytochrome c oxidase (31%) activities in the surviving neurons, without affecting NADH-coenzyme-Q1 reductase activity.  The rate of oxygen consumption was impaired in neurons exposed to 1 mM glutamate, either with glucose (by 26%) or succinate (by 39%) as substrates.  These effects on the mitochondrial respiratory chain and neuronal respiration, together with the obsd. glutathione depletion (20%) by glutamate exposure were completely prevented by NAME or APV.  The results suggest that mitochondrial dysfunction and impairment of antioxidant status may account for glutamate-mediated neurotoxicity via a mechanism involving ·NO biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbRvzupIizbVg90H21EOLACvtfcHk0lgOZTQZgDbjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVGrt7g%253D&md5=c3c7699550f0fc2845a1a5261c7c5628</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900064-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900064-X%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DA.%26aulast%3DHeales%26aufirst%3DS.%2BJ.%26aulast%3DBolanos%26aufirst%3DJ.%2BP.%26aulast%3DMedina%26aufirst%3DJ.%2BM.%26atitle%3DGlutamate%2520Neurotoxicity%2520Is%2520Associated%2520with%2520Nitric%2520Oxide-Mediated%2520Mitochondrial%2520Dysfunction%2520and%2520Glutathione%2520Depletion%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D790%26spage%3D209%26epage%3D216%26doi%3D10.1016%2FS0006-8993%2898%2900064-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takarada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, Y.</span><span> </span><span class="NLM_article-title">Possible Protection by Notoginsenoside R1 against Glutamate Neurotoxicity Mediated by N-Methyl-D-Aspartate Receptors Composed of an NR1/NR2B Subunit Assembly</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span><span class="refDoi"> DOI: 10.1002/jnr.22021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fjnr.22021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19224577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2rsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=2145-2156&author=B.+Guauthor=N.+Nakamichiauthor=W.-S.+Zhangauthor=Y.+Nakamuraauthor=Y.+Kambeauthor=R.+Fukumoriauthor=K.+Takumaauthor=K.+Yamadaauthor=T.+Takaradaauthor=H.+Taniuraauthor=Y.+Yoneda&title=Possible+Protection+by+Notoginsenoside+R1+against+Glutamate+Neurotoxicity+Mediated+by+N-Methyl-D-Aspartate+Receptors+Composed+of+an+NR1%2FNR2B+Subunit+Assembly&doi=10.1002%2Fjnr.22021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly</span></div><div class="casAuthors">Gu, Bin; Nakamichi, Noritaka; Zhang, Wen-Sheng; Nakamura, Yukary; Kambe, Yuki; Fukumori, Ryo; Takuma, Kazuhiro; Yamada, Kiyofumi; Takarada, Takeshi; Taniura, Hideo; Yoneda, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2145-2156</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Notoginsenoside R1 (NTR1) is the main active ingredient in Panax notoginseng, a herbal medicine widely used in Asia for years.  The purpose of this study was to investigate pharmacol. properties of NTR1 on neurotoxicity of glutamate (Glu) in primary cultured mouse cortical neurons along with its possible mechanism of action.  It was found that NTR1 significantly protected neurons from the loss of cellular viability caused by brief exposure to 10 μM Glu for 1 h in a dose-dependent manner at concns. from 0.1 to 10 μM, without affecting the viability alone.  NTR1 significantly inhibited the increased no. of cells pos. to propidium iodide (PI) staining, increase of intracellular free Ca2+ ions, overprodn. of intracellular reactive oxygen species, and depolarization of mitochondrial membrane potential in cultured neurons exposed to Glu, in addn. to blocking decreased Bcl-2 and increased Bax expression levels.  The target site at which NTR1 protects neurons from Glu toxicity was further evaluated by using the acquired expression strategy of N-methyl-D-aspartate (NMDA) receptor subunits in human embryonic kidney 293 cells.  It was found that 10 μM NTR1 protected NR1/NR2B subunit expressing cells from cell death by 100 μM NMDA, but not cells expressing NR1/NR2A subunits, when detd. by PI staining.  These results suggest that NTR1 may preferentially protect neurons from Glu excitotoxicity mediated by NMDA receptor composed of an NR1/NR2B subunit assembly in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbk7iwgM7TKLVg90H21EOLACvtfcHk0lgOZTQZgDbjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2rsbo%253D&md5=aedd5ccd363d8fd1e6621da8f2b2da0b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22021%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DB.%26aulast%3DNakamichi%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.-S.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKambe%26aufirst%3DY.%26aulast%3DFukumori%26aufirst%3DR.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakarada%26aufirst%3DT.%26aulast%3DTaniura%26aufirst%3DH.%26aulast%3DYoneda%26aufirst%3DY.%26atitle%3DPossible%2520Protection%2520by%2520Notoginsenoside%2520R1%2520against%2520Glutamate%2520Neurotoxicity%2520Mediated%2520by%2520N-Methyl-D-Aspartate%2520Receptors%2520Composed%2520of%2520an%2520NR1%252FNR2B%2520Subunit%2520Assembly%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D2145%26epage%3D2156%26doi%3D10.1002%2Fjnr.22021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, G. N.</span><span> </span><span class="NLM_article-title">Cell Death Mechanisms in the Early Stages of Acute Glutamate Neurotoxicity</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.1016/j.neures.2009.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neures.2009.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19944120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=271-278&author=A.+Kumarauthor=R.+L.+Singhauthor=G.+N.+Babu&title=Cell+Death+Mechanisms+in+the+Early+Stages+of+Acute+Glutamate+Neurotoxicity&doi=10.1016%2Fj.neures.2009.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death mechanisms in the early stages of acute glutamate neurotoxicity</span></div><div class="casAuthors">Kumar, Alok; Singh, Ram Lakhan; Babu, G. Nagesh</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-278</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study focused on the early stages of acute glutamate (L-Glu)-induced neurotoxic mechanisms, both biochem., e.g. intracellular reactive oxygen species (ROS) and assocd. parameters as well as gene expression of cell survival/death pathways, i.e. Bcl-2 and caspases.  Stereotactic intracortical injections of L-Glu (1 μmol/1 μl) resulted in decreased size of pyramidal neurons in rat after 1 h.  We also obsd. that intracellular ROS, calcium (Ca2+) and peroxynitrite (ONOO-) prodn. were significantly elevated, whereas, mitochondrial transmembrane potential (ΔΨm) and total glutathione were significantly decreased by L-Glu bolus.  The Bcl-2/Bax ratio in the L-Glu-injected rats was found to be significantly lower than the controls.  Moreover, acute L-Glu significantly induced mRNA expression of nNOS, iNOS, caspase-3 and caspase-9.  It may be concluded from the present study that acute L-Glu administration, at an early stage, increases intracellular ROS accumulation, Ca2+ levels and peroxynitrite prodn. and decreases glutathione pool.  Furthermore, it appears that decreased mitochondrial Bcl-2/Bax ratio might have upregulated the mRNA expression of caspase-3 and caspase-9 which launch cell death cascade.  Regarding the chronol. of the events, we presume that acute L-Glu increases ROS and decreases ΔΨm and glutathione rapidly and it is more likely that these events precede gene expression changes, ultimately resulting in neuronal damage/death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQriJiaH5O1bVg90H21EOLACvtfcHk0lgOZTQZgDbjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVaqu7s%253D&md5=7850c711ce9c9c4222e282a8cdff482f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2009.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2009.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%2BL.%26aulast%3DBabu%26aufirst%3DG.%2BN.%26atitle%3DCell%2520Death%2520Mechanisms%2520in%2520the%2520Early%2520Stages%2520of%2520Acute%2520Glutamate%2520Neurotoxicity%26jtitle%3DNeurosci.%2520Res.%26date%3D2010%26volume%3D66%26spage%3D271%26epage%3D278%26doi%3D10.1016%2Fj.neures.2009.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, C. G.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease, β-Amyloid, Glutamate, NMDA Receptors and Memantine--Searching for the Connections</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02057.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Fj.1476-5381.2012.02057.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22646481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=324-352&author=W.+Danyszauthor=C.+G.+Parsons&title=Alzheimer%E2%80%99s+Disease%2C+%CE%B2-Amyloid%2C+Glutamate%2C+NMDA+Receptors+and+Memantine%2D%2DSearching+for+the+Connections&doi=10.1111%2Fj.1476-5381.2012.02057.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections</span></div><div class="casAuthors">Danysz, Wojciech; Parsons, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-352</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Amyloid (Aβ) is widely accepted to be one of the major pathomechanisms underlying Alzheimer's disease (AD), although there is presently lively debate regarding the relative roles of particular species/forms of this peptide.  Most recent evidence indicates that sol. oligomers rather than plaques are the major cause of synaptic dysfunction and ultimately neurodegeneration.  Sol. oligomeric Aβ has been shown to interact with several proteins, for example glutamatergic receptors of the NMDA type and proteins responsible for maintaining glutamate homeostasis such as uptake and release.  As NMDA receptors are critically involved in neuronal plasticity including learning and memory, we felt that it would be valuable to provide an up to date review of the evidence connecting Aβ to these receptors and related neuronal plasticity.  Strong support for the clin. relevance of such interactions is provided by the NMDA receptor antagonist memantine.  This substance is the only NMDA receptor antagonist used clin. in the treatment of AD and therefore offers an excellent tool to facilitate translational extrapolations from in vitro studies through in vivo animal expts. to its ultimate clin. utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQTCiAIwYyrVg90H21EOLACvtfcHk0lifgEU12JtGlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShurfN&md5=fbf694fc7ef433aa83c13b48244d3e8e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02057.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02057.x%26sid%3Dliteratum%253Aachs%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DParsons%26aufirst%3DC.%2BG.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%252C%2520%25CE%25B2-Amyloid%252C%2520Glutamate%252C%2520NMDA%2520Receptors%2520and%2520Memantine--Searching%2520for%2520the%2520Connections%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D324%26epage%3D352%26doi%3D10.1111%2Fj.1476-5381.2012.02057.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">McKeage, K.</span><span> </span><span class="NLM_article-title">Memantine: A Review of Its Use in Moderate to Severe Alzheimer’s Disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.2165/11201020-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.2165%2F11201020-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=881-897&author=K.+McKeage&title=Memantine%3A+A+Review+of+Its+Use+in+Moderate+to+Severe+Alzheimer%E2%80%99s+Disease&doi=10.2165%2F11201020-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2165%2F11201020-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11201020-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeage%26aufirst%3DK.%26atitle%3DMemantine%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520Moderate%2520to%2520Severe%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2009%26volume%3D23%26spage%3D881%26epage%3D897%26doi%3D10.2165%2F11201020-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Francis, P. T.</span><span> </span><span class="NLM_article-title">Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1159/000113713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1159%2F000113713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18322401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Whtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=241-243&author=P.+T.+Francis&title=Glutamatergic+Approaches+to+the+Treatment+of+Cognitive+and+Behavioural+Symptoms+of+Alzheimer%E2%80%99s+Disease&doi=10.1159%2F000113713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer's Disease</span></div><div class="casAuthors">Francis, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">241-243</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The glutamatergic system has long been recognized for its role in learning and memory and recent studies indicate an early loss of glutamatergic synapses in Alzheimer's disease (AD).  Efforts to produce drugs which address changes in the glutamatergic system in AD are well advanced (e.g. memantine and drugs in development such as ampakines).  Much less is known about the possible role of glutamate in non-cognitive behavioral changes; however, recent data from clin. trials suggest that memantine reduces agitation and aggressive behavior in AD patients.  In this context, it is important to help identify new treatment approaches to replace the use of antipsychotics in this vulnerable population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcEQTfIARvlbVg90H21EOLACvtfcHk0lifgEU12JtGlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Whtbk%253D&md5=20bfea2875be1f69ad6a7286dec1fd2a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1159%2F000113713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113713%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26atitle%3DGlutamatergic%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Cognitive%2520and%2520Behavioural%2520Symptoms%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D241%26epage%3D243%26doi%3D10.1159%2F000113713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fan, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, L. A.</span><span> </span><span class="NLM_article-title">N-Methyl-D-Aspartate (NMDA) Receptor Function and Excitotoxicity in Huntington’s Disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.pneurobio.2006.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=17188796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=272-293&author=M.+M.+Fanauthor=L.+A.+Raymond&title=N-Methyl-D-Aspartate+%28NMDA%29+Receptor+Function+and+Excitotoxicity+in+Huntington%E2%80%99s+Disease&doi=10.1016%2Fj.pneurobio.2006.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease</span></div><div class="casAuthors">Fan, Mannie M. Y.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">272-293</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence support a role for neuronal damage arising as a result of excessive activation of glutamate receptors by excitatory amino acids in the pathogenesis of Huntington disease.  The N-methyl-D-aspartate subclass of inotropic glutamate receptors (NMDARs) is more selective and effective than the other subclasses in mediating this damage.  As well, neurons expressing high levels of NMDARs are lost early from the striatum of individuals affected with Huntington's disease (HD), and injection of NMDAR agonists into the striatum of rodents or non-human primates recapitulates the pattern of neuronal damage obsd. in HD.  Altered NMDAR function has been reported in corticostriatal synapses in one mouse model of HD, and NMDAR-mediated current and/or toxicity have been found to be potentiated in striatal neurons from several HD mouse models as well as heterologous cells expressing the mutant huntington protein.  Changes in NMDAR activity have been correlated with altered calcium homeostasis, mitochondrial membrane depolarization and caspase activation.  NMDAR stimulation is also closely linked to mitochondrial activity, as treatment with mitochondrial toxins has been demonstrated to produce striatal damage that can be reversed by the addn. of NMDAR antagonists.  Recent efforts have focused on the elucidation of mol. pathways linking huntington to NMDARs, as well as the mechanisms which underlie the enhancement of NMDAR activity by mutant huntington.  Here, we review the literature to date and recent findings concerning the role of NMDARs in HD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmSAU9WE51bVg90H21EOLACvtfcHk0liUX3tvqzLqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D&md5=d6ed0834cf6cf86a2134887e459e6991</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DM.%2BM.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DN-Methyl-D-Aspartate%2520%2528NMDA%2529%2520Receptor%2520Function%2520and%2520Excitotoxicity%2520in%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D272%26epage%3D293%26doi%3D10.1016%2Fj.pneurobio.2006.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Corona, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar-y-Romo, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia, R.</span><span> </span><span class="NLM_article-title">Glutamate Excitotoxicity and Therapeutic Targets for Amyotrophic Lateral Sclerosis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.1517/14728222.11.11.1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1517%2F14728222.11.11.1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18028007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1415-1428&author=J.+C.+Coronaauthor=L.+B.+Tovar-y-Romoauthor=R.+Tapia&title=Glutamate+Excitotoxicity+and+Therapeutic+Targets+for+Amyotrophic+Lateral+Sclerosis&doi=10.1517%2F14728222.11.11.1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis</span></div><div class="casAuthors">Corona, Juan C.; Tovar-y-Romo, Luis B.; Tapia, Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1415-1428</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Two forms of amyotrophic lateral sclerosis (ALS) are known, the familial (FALS), due in part to mutations in superoxide dismutase 1 (SOD1), and the sporadic (SALS), which accounts for > 90% of all cases.  The cause of SALS is not known, but excitotoxicity due to overactivation of glutamate receptors may mediate the motor neuron degeneration in the spinal cord, which is the hallmark of this disease.  Overactivation of calcium-permeable α-amino-3-hydroxy-5-isoxazole propionate receptors lacking the subunit glutamate receptor 2, leading to an increase in calcium cytoplasmic concn., seems to play an important role in the mechanism of neuronal death.  The knowledge of this mechanism, in addn. to other factors, provides several possible targets for therapeutic strategies that are reviewed in this article.  Some of these strategies have proven to be partially effective in both human mutant superoxide dismutase 1 transgenic rodents (FALS model) and the few existing in vivo models of spinal motor neurodegeneration induced by excitotoxicity (SALS models), although observable benefits are still to be shown in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqei-EMokx_ZrVg90H21EOLACvtfcHk0liUX3tvqzLqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnI&md5=e5ff781db6a38f272e70602cbab67553</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1415%26sid%3Dliteratum%253Aachs%26aulast%3DCorona%26aufirst%3DJ.%2BC.%26aulast%3DTovar-y-Romo%26aufirst%3DL.%2BB.%26aulast%3DTapia%26aufirst%3DR.%26atitle%3DGlutamate%2520Excitotoxicity%2520and%2520Therapeutic%2520Targets%2520for%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1415%26epage%3D1428%26doi%3D10.1517%2F14728222.11.11.1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Muir, K. W.</span><span> </span><span class="NLM_article-title">Glutamate-Based Therapeutic Approaches: Clinical Trials with NMDA Antagonists</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/j.coph.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.coph.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16359918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=53-60&author=K.+W.+Muir&title=Glutamate-Based+Therapeutic+Approaches%3A+Clinical+Trials+with+NMDA+Antagonists&doi=10.1016%2Fj.coph.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists</span></div><div class="casAuthors">Muir, Keith W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The majority of clin. trials of N-Me D-aspartate antagonists were conducted in the fields of stroke, traumatic brain injury (TBI), and dementia.  Stroke and TBI trials have involved more than 9000 patients, but have yielded no therapeutically useful agents, with the possible exception of magnesium for treatment of subarachnoid hemorrhage.  Several of the synthetic N-Me -aspartate antagonist development programs were abandoned owing to concerns about drug toxicity, particularly in stroke.  Systematic reviews in stroke and TBI have shown that definitive conclusions cannot be drawn for most agents owing to early termination of trials.  In dementia, memantinec has shown some benefit in moderate-to-severe Alzheimer's disease, with no clear benefit to date for milder stages of Alzheimer's disease or for vascular dementia.  Other therapeutic areas of promise remain inadequately explored at present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGNYjrNzhI7Vg90H21EOLACvtfcHk0li9_2DR_mwi4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVygtg%253D%253D&md5=1fd02215bb9125304666f8db06d624c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMuir%26aufirst%3DK.%2BW.%26atitle%3DGlutamate-Based%2520Therapeutic%2520Approaches%253A%2520Clinical%2520Trials%2520with%2520NMDA%2520Antagonists%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.coph.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Alexander, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, D. W.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors as a Strategic Target for the Treatment of Epilepsy</span> <span class="citation_source-journal">Epilepsy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.eplepsyres.2006.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.eplepsyres.2006.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16787741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVOgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1-22&author=G.+M.+Alexanderauthor=D.+W.+Godwin&title=Metabotropic+Glutamate+Receptors+as+a+Strategic+Target+for+the+Treatment+of+Epilepsy&doi=10.1016%2Fj.eplepsyres.2006.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy</span></div><div class="casAuthors">Alexander, Georgia M.; Godwin, Dwayne W.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsy Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">EPIRE8</span>;
        ISSN:<span class="NLM_cas:issn">0920-1211</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Epilepsy is a chronic neurol. disorder that has many known types, including generalized epilepsies that involve cortical and subcortical structures.  A proportion of patients have seizures that are resistant to traditional anti-epilepsy drugs, which mainly target ion channels or postsynaptic receptors.  This resistance to conventional therapies makes it important to identify novel targets for the treatment of epilepsy.  Given the involvement of the neurotransmitter glutamate in the etiol. of epilepsy, targets that control glutamatergic neurotransmission are of special interest.  The metabotropic glutamate receptors (mGluRs) are of a family of eight G-protein-coupled receptors that serve unique regulatory functions at synapses that use the neurotransmitter glutamate.  Their distribution within the central nervous system provides a platform for both presynaptic control of glutamate release, as well as postsynaptic control of neuronal responses to glutamate.  In recent years, substantial efforts have been made towards developing selective agonists and antagonists which may be useful for targeting specific receptor subtypes in an attempt to harness the therapeutic potential of these receptors.  We examine the possibility of intervening at these receptors by considering the specific example of absence seizures, a form of generalized, non-convulsive seizure that involves the thalamus.  Views of the etiol. of absence seizures have evolved over time from the "centerncephalic" concept of a diffuse subcortical pacemaker toward the "cortical focus" theory in which cortical hyperexcitability leads the thalamus into the 3-4 Hz rhythms that are characteristic of absence seizures.  Since the cortex communicates with the thalamus via a massive glutamatergic projection, ionotropic glutamate receptor (iGluR) blockade has held promise, but the global nature of iGluR intervention has precluded the clin. effectiveness of drugs that block iGluRs.  In contrast, mGluRs, because they modulate iGluRs at glutamatergic synapses only under certain conditions, may quell seizure activity by selectively reducing hyperactive glutamatergic synaptic communication within the cortex and thalamus without significantly affecting normal response rates.  In this article, we review the circuitry and events leading to absence seizure generation within the corticothalamic network, we present a comprehensive review of the synaptic location and function of mGluRs within the thalamus and cerebral cortex, and review the current knowledge of mGluR modulation and seizure generation.  We conclude by reviewing the potential advantages of Group II mGluRs, specifically mGluR2, in the treatment of both convulsive and non-convulsive seizures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLBqc6wcG5bVg90H21EOLACvtfcHk0li9_2DR_mwi4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVOgsb0%253D&md5=939bcf760fa9b900da11e71cbffc10c5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.eplepsyres.2006.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eplepsyres.2006.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DG.%2BM.%26aulast%3DGodwin%26aufirst%3DD.%2BW.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%2520as%2520a%2520Strategic%2520Target%2520for%2520the%2520Treatment%2520of%2520Epilepsy%26jtitle%3DEpilepsy%2520Res.%26date%3D2006%26volume%3D71%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.eplepsyres.2006.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Subtype Selective Kainic Acid Receptor Agonists: Discovery and Approaches to Rational Design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1002/med.20133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fmed.20133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=18623169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=3-28&author=L.+Bunchauthor=P.+Krogsgaard-Larsen&title=Subtype+Selective+Kainic+Acid+Receptor+Agonists%3A+Discovery+and+Approaches+to+Rational+Design&doi=10.1002%2Fmed.20133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype selective kainic acid receptor agonists: discovery and approaches to rational design</span></div><div class="casAuthors">Bunch, Lennart; Krogsgaard-Larsen, Povl</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  (S)-Glutamic acid (Glu) is the major excitatory neurotransmitter in the mammalian central nervous system, activating the plethora of glutamate receptors (GluRs).  In broad lines, the GluRs are divided into two major classes: the ionotropic Glu receptors (iGluRs) and the metabotropic Glu receptors (mGluRs).  Within the iGluRs, five subtypes (KA1, KA2, iGluR5-7) show high affinity and express full agonist activity upon binding of the naturally occurring amino acid kainic acid (KA).  Thus these receptors have been named the KA receptors.  This review describes all-to our knowledge-published KA receptor agonists.  In total, over 100 compds. are described by means of chem. structure and available pharmacol. data.  With this perspective review, it is our intention to ignite and stimulate inspiration for future design and synthesis of novel subtype selective KA receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYYXqBUFL8bVg90H21EOLACvtfcHk0li9_2DR_mwi4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SrtLk%253D&md5=a2440ac0304aaf563bcc8ae9689b0b40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fmed.20133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20133%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DSubtype%2520Selective%2520Kainic%2520Acid%2520Receptor%2520Agonists%253A%2520Discovery%2520and%2520Approaches%2520to%2520Rational%2520Design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D3%26epage%3D28%26doi%3D10.1002%2Fmed.20133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation, and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation%2C+and+Function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0lhE_yjDvtElYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%252C%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Vaidya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashaw, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, R. K.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors: A Review on Perspectives and Therapeutic Aspects</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1967-1981&author=A.+Vaidyaauthor=S.+Jainauthor=A.+K.+Jainauthor=A.+Agrawalauthor=S.+K.+Kashawauthor=S.+K.+Jainauthor=R.+K.+Agrawal&title=Metabotropic+Glutamate+Receptors%3A+A+Review+on+Perspectives+and+Therapeutic+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaidya%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DKashaw%26aufirst%3DS.%2BK.%26aulast%3DJain%26aufirst%3DS.%2BK.%26aulast%3DAgrawal%26aufirst%3DR.%2BK.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%253A%2520A%2520Review%2520on%2520Perspectives%2520and%2520Therapeutic%2520Aspects%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1967%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Larsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valadés, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of a New Class of Ionotropic Glutamate Receptor Antagonists by the Rational Design of (2<i>S</i>,3<i>R</i>)-3-(3-Carboxyphenyl)-Pyrrolidine-2-Carboxylic Acid</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1021/cn100093f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100093f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWhsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=107-114&author=A.+M.+Larsenauthor=R.+Venskutonyt%C4%97author=E.+A.+Valad%C3%A9sauthor=B.+Nielsenauthor=D.+S.+Pickeringauthor=L.+Bunch&title=Discovery+of+a+New+Class+of+Ionotropic+Glutamate+Receptor+Antagonists+by+the+Rational+Design+of+%282S%2C3R%29-3-%283-Carboxyphenyl%29-Pyrrolidine-2-Carboxylic+Acid&doi=10.1021%2Fcn100093f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Class of Ionotropic Glutamate Receptor Antagonists by the Rational Design of (2S,3R)-3-(3-Carboxyphenyl)-pyrrolidine-2-carboxylic Acid</span></div><div class="casAuthors">Larsen, Ann M.; Venskutonyte, Raminta; Valades, Elena Anton; Nielsen, Birgitte; Pickering, Darryl S.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The kainic acid (KA) receptors belong to the class of glutamate (Glu) receptors in the brain and constitute a promising target for the treatment of neurol. and/or psychiatric diseases such as schizophrenia, major depression, and epilepsy.  Five KA subtypes have been identified and named GluK1-5.  In this article, we present the discovery of (2S,3R)-3-(3-carboxyphenyl)-pyrrolidine-2-carboxylic acid (1) based on a rational design process.  Target compd. 1 was synthesized by a stereoselective strategy in 10 steps from com. available starting materials.  Binding affinities of 1 at native ionotropic Glu receptors were detd. to be in the micromolar range (AMPA, 51 μM; KA, 22 μM; NMDA 6 μM), with the highest affinity for cloned homomeric KA receptor subtypes GluK1,3 (3.0 and 8.1 μM, resp.).  Functional characterization of 1 by two electrode voltage clamp (TEVC) electrophysiol. at a nondesensitizing mutant of GluK1 showed full competitive antagonistic behavior with a Kb of 11.4 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe72VGdj51HrVg90H21EOLACvtfcHk0lhE_yjDvtElYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWhsbvE&md5=dfe53691cb11fa493b0aaaec96a60909</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn100093f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100093f%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BM.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DValad%25C3%25A9s%26aufirst%3DE.%2BA.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Class%2520of%2520Ionotropic%2520Glutamate%2520Receptor%2520Antagonists%2520by%2520the%2520Rational%2520Design%2520of%2520%25282S%252C3R%2529-3-%25283-Carboxyphenyl%2529-Pyrrolidine-2-Carboxylic%2520Acid%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D107%26epage%3D114%26doi%3D10.1021%2Fcn100093f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Møller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brehm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Resolution, Absolute Stereochemistry, and Enantiopharmacology of the GluR1–4 and GluR5 Antagonist 2-Amino-3-[5-Tert-Butyl-3-(phosphonomethoxy)-4-Isoxazolyl]propionic Acid</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1002/(SICI)1520-636X(1999)11:10<752::AID-CHIR3>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=752-759&author=E.+H.+M%C3%B8llerauthor=J.+Egebjergauthor=L.+Brehmauthor=T.+B.+Stensb%C3%B8lauthor=T.+N.+Johansenauthor=U.+Madsenauthor=P.+Krogsgaard-Larsen&title=Resolution%2C+Absolute+Stereochemistry%2C+and+Enantiopharmacology+of+the+GluR1%E2%80%934+and+GluR5+Antagonist+2-Amino-3-%5B5-Tert-Butyl-3-%28phosphonomethoxy%29-4-Isoxazolyl%5Dpropionic+Acid&doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-636X%25281999%252911%253A10%253C752%253A%253AAID-CHIR3%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8ller%26aufirst%3DE.%2BH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DBrehm%26aufirst%3DL.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DResolution%252C%2520Absolute%2520Stereochemistry%252C%2520and%2520Enantiopharmacology%2520of%2520the%2520GluR1%25E2%2580%25934%2520and%2520GluR5%2520Antagonist%25202-Amino-3-%255B5-Tert-Butyl-3-%2528phosphonomethoxy%2529-4-Isoxazolyl%255Dpropionic%2520Acid%26jtitle%3DChirality%26date%3D1999%26volume%3D11%26spage%3D752%26epage%3D759%26doi%3D10.1002%2F%28SICI%291520-636X%281999%2911%3A10%3C752%3A%3AAID-CHIR3%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dolman, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troop, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knauss, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nistico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolotto, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacology of Willardiine Derivatives Acting as Antagonists of Kainate Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7867</span><span class="NLM_x">–</span> <span class="NLM_lpage">7881</span><span class="refDoi"> DOI: 10.1021/jm050584l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050584l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7867-7881&author=N.+P.+Dolmanauthor=H.+M.+Troopauthor=J.+C.+Moreauthor=A.+Altauthor=J.+L.+Knaussauthor=R.+Nisticoauthor=S.+Jackauthor=R.+M.+Morleyauthor=Z.+A.+Bortolottoauthor=P.+J.+Roberts&title=Synthesis+and+Pharmacology+of+Willardiine+Derivatives+Acting+as+Antagonists+of+Kainate+Receptors&doi=10.1021%2Fjm050584l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm050584l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050584l%26sid%3Dliteratum%253Aachs%26aulast%3DDolman%26aufirst%3DN.%2BP.%26aulast%3DTroop%26aufirst%3DH.%2BM.%26aulast%3DMore%26aufirst%3DJ.%2BC.%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DKnauss%26aufirst%3DJ.%2BL.%26aulast%3DNistico%26aufirst%3DR.%26aulast%3DJack%26aufirst%3DS.%26aulast%3DMorley%26aufirst%3DR.%2BM.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520Pharmacology%2520of%2520Willardiine%2520Derivatives%2520Acting%2520as%2520Antagonists%2520of%2520Kainate%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7867%26epage%3D7881%26doi%3D10.1021%2Fjm050584l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pøhlsgaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Lessons from More than 80 Structures of the GluA2 Ligand-Binding Domain in Complex with Agonists, Antagonists and Allosteric Modulators</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuropharm.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20713069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=135-150&author=J.+P%C3%B8hlsgaardauthor=K.+Frydenvangauthor=U.+Madsenauthor=J.+S.+Kastrup&title=Lessons+from+More+than+80+Structures+of+the+GluA2+Ligand-Binding+Domain+in+Complex+with+Agonists%2C+Antagonists+and+Allosteric+Modulators&doi=10.1016%2Fj.neuropharm.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators</span></div><div class="casAuthors">Pohlsgaard, Jacob; Frydenvang, Karla; Madsen, Ulf; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-150</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system.  These receptors play an important role for the development and function of the nervous system, and are essential in learning and memory.  However, iGluRs are also implicated in or have causal roles for several brain disorders, e.g. epilepsy, Alzheimer's disease, Parkinson's disease and schizophrenia.  Their involvement in neurol. diseases has stimulated widespread interest in their structure and function.  Since the first publication in 1998 of the structure of a recombinant sol. protein comprising the ligand-binding domain of GluA2 extensive studies have afforded numerous crystal structures of wildtype and mutant proteins including different ligands.  The structural information obtained combined with functional data have led to models for receptor activation and desensitization by agonists, inhibition by antagonists and block of desensitization by pos. allosteric modulators.  Furthermore, the structural and functional studies have formed a powerful platform for the design of new selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA5_dFKFmce7Vg90H21EOLACvtfcHk0ljAbs5oYrNzTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FK&md5=cade4bfad431cb7da3f8620d56c9926b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25B8hlsgaard%26aufirst%3DJ.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DLessons%2520from%2520More%2520than%252080%2520Structures%2520of%2520the%2520GluA2%2520Ligand-Binding%2520Domain%2520in%2520Complex%2520with%2520Agonists%252C%2520Antagonists%2520and%2520Allosteric%2520Modulators%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D135%26epage%3D150%26doi%3D10.1016%2Fj.neuropharm.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate Receptor: Crystal Structures of the GluR2 Ligand Binding Core</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)00094-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS0896-6273%2800%2900094-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=11086992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=165-181&author=N.+Armstrongauthor=E.+Gouaux&title=Mechanisms+for+Activation+and+Antagonism+of+an+AMPA-Sensitive+Glutamate+Receptor%3A+Crystal+Structures+of+the+GluR2+Ligand+Binding+Core&doi=10.1016%2FS0896-6273%2800%2900094-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core</span></div><div class="casAuthors">Armstrong, Neali; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-181</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Crystal structures of the GluR2 ligand binding core (S1S2) have been detd. in the apo state and in the presence of the antagonist DNQX, the partial agonist kainate, and the full agonists AMPA and glutamate.  The domains of the S1S2 ligand binding core are expanded in the apo state and contract upon ligand binding with the extent of domain sepn. decreasing in the order of apo > DNQX > kainate > glutamate ≃ AMPA.  These results suggest that agonist-induced domain closure gates the transmembrane channel and the extent of receptor activation depends upon the degree of domain closure.  AMPA and glutamate also promote a 180° flip of a trans peptide bond in the ligand binding site.  The crystal packing of the ligand binding cores suggests modes for subunit-subunit contact in the intact receptor and mechanisms by which allosteric effectors modulate receptor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNnbcNBzyXN7Vg90H21EOLACvtfcHk0lgU1GMFchsy2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGltLw%253D&md5=6be3ca25ce094c142ba3977a404afb3d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2900094-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252900094-5%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanisms%2520for%2520Activation%2520and%2520Antagonism%2520of%2520an%2520AMPA-Sensitive%2520Glutamate%2520Receptor%253A%2520Crystal%2520Structures%2520of%2520the%2520GluR2%2520Ligand%2520Binding%2520Core%26jtitle%3DNeuron%26date%3D2000%26volume%3D28%26spage%3D165%26epage%3D181%26doi%3D10.1016%2FS0896-6273%2800%2900094-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sobolevsky, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosconi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">X-Ray Structure, Symmetry and Mechanism of an AMPA-Subtype Glutamate Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span><span class="refDoi"> DOI: 10.1038/nature08624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1038%2Fnature08624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19946266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVylsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=745-756&author=A.+I.+Sobolevskyauthor=M.+P.+Rosconiauthor=E.+Gouaux&title=X-Ray+Structure%2C+Symmetry+and+Mechanism+of+an+AMPA-Subtype+Glutamate+Receptor&doi=10.1038%2Fnature08624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor</span></div><div class="casAuthors">Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">745-756</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate.  Despite their crucial role in neurobiol., the architecture and at. structure of an intact ionotropic glutamate receptor are unknown.  Here we report the crystal structure of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 Å resoln. in complex with a competitive antagonist.  The receptor harbors an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry.  A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D.  Therefore, the stereochem. manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits.  Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-d-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern.  We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcgGne1xeDrVg90H21EOLACvtfcHk0lgU1GMFchsy2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVylsb7N&md5=778cc7a01cbae8a5b33c0bf20adb6fed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnature08624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08624%26sid%3Dliteratum%253Aachs%26aulast%3DSobolevsky%26aufirst%3DA.%2BI.%26aulast%3DRosconi%26aufirst%3DM.%2BP.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DX-Ray%2520Structure%252C%2520Symmetry%2520and%2520Mechanism%2520of%2520an%2520AMPA-Subtype%2520Glutamate%2520Receptor%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D745%26epage%3D756%26doi%3D10.1038%2Fnature08624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span> </span><span class="NLM_article-title">Mixed Cyano-Gilman Cuprates - Advances in Conjugate Addition to Alpha,beta-Unsaturated Pyroglutaminol</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1055/s-2002-19303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1055%2Fs-2002-19303" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2002&publication_year=2002&pages=31-33&author=L.+Bunchauthor=P.+Krogsgaard-Larsenauthor=U.+Madsen&title=Mixed+Cyano-Gilman+Cuprates+-+Advances+in+Conjugate+Addition+to+Alpha%2Cbeta-Unsaturated+Pyroglutaminol&doi=10.1055%2Fs-2002-19303"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-19303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-19303%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26aulast%3DMadsen%26aufirst%3DU.%26atitle%3DMixed%2520Cyano-Gilman%2520Cuprates%2520-%2520Advances%2520in%2520Conjugate%2520Addition%2520to%2520Alpha%252Cbeta-Unsaturated%2520Pyroglutaminol%26jtitle%3DSynthesis%26date%3D2002%26volume%3D2002%26spage%3D31%26epage%3D33%26doi%3D10.1055%2Fs-2002-19303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crick, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase by Lipophilic Phosphonates: SAR, QSAR, and Crystallographic Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">54</span><span class="NLM_x">) </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4734</span><span class="refDoi"> DOI: 10.1021/jm200363d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200363d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4721-4734&issue=54&author=L.+Dengauthor=J.+Diaoauthor=P.+Chenauthor=V.+Pujariauthor=Y.+Yaoauthor=G.+Chengauthor=D.+C.+Crickauthor=B.+V.+V+Prasadauthor=Y.+Song&title=Inhibition+of+1-Deoxy-D-Xylulose-5-Phosphate+Reductoisomerase+by+Lipophilic+Phosphonates%3A+SAR%2C+QSAR%2C+and+Crystallographic+Studies&doi=10.1021%2Fjm200363d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm200363d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200363d%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DPujari%26aufirst%3DV.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DCrick%26aufirst%3DD.%2BC.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%25201-Deoxy-D-Xylulose-5-Phosphate%2520Reductoisomerase%2520by%2520Lipophilic%2520Phosphonates%253A%2520SAR%252C%2520QSAR%252C%2520and%2520Crystallographic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D54%26spage%3D4721%26epage%3D4734%26doi%3D10.1021%2Fjm200363d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Demmer, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Review on Modern Advances of Chemical Methods for the Introduction of a Phosphonic Acid Group</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">7981</span><span class="NLM_x">–</span> <span class="NLM_lpage">8006</span><span class="refDoi"> DOI: 10.1021/cr2002646</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2002646" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCiur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=7981-8006&author=C.+S.+Demmerauthor=N.+Krogsgaard-Larsenauthor=L.+Bunch&title=Review+on+Modern+Advances+of+Chemical+Methods+for+the+Introduction+of+a+Phosphonic+Acid+Group&doi=10.1021%2Fcr2002646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Review on Modern Advances of Chemical Methods for the Introduction of a Phosphonic Acid Group</span></div><div class="casAuthors">Demmer, Charles S.; Krogsgaard-Larsen, Niels; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7981-8006</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phys.-org. properties of the phosphonic acid group in connection to medicinal chem. aspects, together with an in depth review on advances and modern synthetic methods for its introduction compiled into sections with respect to substrate-carbon hybridization is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGn8S7af3R57Vg90H21EOLACvtfcHk0ljY2X1p25OlLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCiur3O&md5=0813dd3e32704ecff31051eaed88d1cb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcr2002646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2002646%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DC.%2BS.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DN.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DReview%2520on%2520Modern%2520Advances%2520of%2520Chemical%2520Methods%2520for%2520the%2520Introduction%2520of%2520a%2520Phosphonic%2520Acid%2520Group%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D7981%26epage%3D8006%26doi%3D10.1021%2Fcr2002646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Carlsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A Greatly Improved Procedure for Ruthenium Tetroxide Catalyzed Oxidations of Organic Compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3936</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span><span class="refDoi"> DOI: 10.1021/jo00332a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00332a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=3936-3938&author=P.+H.+Carlsenauthor=T.+Katsukiauthor=V.+S.+Martinauthor=K.+B.+Sharpless&title=A+Greatly+Improved+Procedure+for+Ruthenium+Tetroxide+Catalyzed+Oxidations+of+Organic+Compounds&doi=10.1021%2Fjo00332a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span></div><div class="casAuthors">Carlsen, Per H. J.; Katsuki, Tsutomu; Martin, Victor S.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3936-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Addn. of MeCN to the traditional CCl4/H2O solvent system for RuO4-catalyzed oxidns. causes a great improvement apparently by preventing formation of insol. Ru species and thereby maintaining high catalyst activity.  Applications of the new catalytic system to the oxidn. of org. substrates (olefins, alcs., 1,2-diols, arom. rings, and ethers) are described.  Primary Me ethers are oxidized directly to the esters.  The Ru analog of the abnormal permanganate oxidn. of 1,5-dienes was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRHM2swdg5rVg90H21EOLACvtfcHk0ljY2X1p25OlLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D&md5=ed05bc7a5eb549752691f363f6f2893c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00332a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00332a045%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsen%26aufirst%3DP.%2BH.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DV.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520Greatly%2520Improved%2520Procedure%2520for%2520Ruthenium%2520Tetroxide%2520Catalyzed%2520Oxidations%2520of%2520Organic%2520Compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D3936%26epage%3D3938%26doi%3D10.1021%2Fjo00332a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Venskutonyté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabassa, A. C. de</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Kainate Induces Various Domain Closures in AMPA and Kainate Receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1016/j.neuint.2012.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.neuint.2012.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=22425692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFChtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=536-545&author=R.+Venskutonyt%C3%A9author=K.+Frydenvangauthor=H.+Haldauthor=A.+C.+de+Rabassaauthor=M.+Gajhedeauthor=P.+K.+Ahringauthor=J.+S.+Kastrup&title=Kainate+Induces+Various+Domain+Closures+in+AMPA+and+Kainate+Receptors&doi=10.1016%2Fj.neuint.2012.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kainate induces various domain closures in AMPA and kainate receptors</span></div><div class="casAuthors">Venskutonyte, Raminta; Frydenvang, Karla; Hald, Helle; Rabassa, Anna Ceravalls de; Gajhede, Michael; Ahring, Philip K.; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">536-545</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors are key players in fast excitatory synaptic transmission within the central nervous system.  These receptors have been divided into three subfamilies: the N-methyl-d-aspartic acid (NMDA), 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and kainate receptors.  Kainate has previously been crystd. with the ligand binding domain (LBD) of AMPA receptors (GluA2 and GluA4) and kainate receptors (GluK1 and GluK2).  Here, the authors report the structures of the kainate receptor GluK3 LBD in complex with kainate and GluK1 LBD in complex with kainate in the absence of glycerol.  Kainate introduces a conformational change in GluK3 LBD comparable to that of GluK2, but different from the conformational changes induced in GluA2 and GluK1.  Compared to their domain closures in a glutamate bound state, GluA2 and GluK1 become more open and kainate induces a domain closure of 60% and 62%, resp., relative to glutamate (100%).  In GluK2 and GluK3 with kainate, the domain closure is 88% and 83%, resp.  In previously detd. structures of GluK1 LBD in complex with kainate, glycerol is present in the binding site where it bridges interlobe residues and thus, might contribute to the large domain opening.  However, the structure of GluK1 LBD with kainate in the absence of glycerol confirms that the obsd. domain closure is not an artifact of crystn. conditions.  Comparison of the LBD structures with glutamate and kainate reveals that contacts are lost upon binding of kainate in the three kainate receptors, which is in contrast to the AMPA receptors where similar contacts are seen.  It was revealed by patch clamp electrophysiol. studies that kainate is a partial agonist at GluK1 with 36% efficacy compared to glutamate, which is in between the published efficacies of kainate at GluK2 and AMPA receptors.  The ranking of efficacies seems to correlate with LBD domain closures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqrkoC7BoerVg90H21EOLACvtfcHk0lg13HUoZFbp0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFChtLw%253D&md5=3ddf3623824f36bcd1ca24a77a67a220</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DVenskutonyt%25C3%25A9%26aufirst%3DR.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DHald%26aufirst%3DH.%26aulast%3DRabassa%26aufirst%3DA.%2BC.%2Bde%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DKainate%2520Induces%2520Various%2520Domain%2520Closures%2520in%2520AMPA%2520and%2520Kainate%2520Receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D536%26epage%3D545%26doi%3D10.1016%2Fj.neuint.2012.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ayala-Mata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera-Mendoza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Vázquez, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas-Díaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zepeda, L. G.</span><span> </span><span class="NLM_article-title">Efficient Preparation of A-Ketoacetals</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13864</span><span class="NLM_x">–</span> <span class="NLM_lpage">13878</span><span class="refDoi"> DOI: 10.3390/molecules171213864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.3390%2Fmolecules171213864" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=13864-13878&author=F.+Ayala-Mataauthor=C.+Barrera-Mendozaauthor=H.+A.+Jim%C3%A9nez-V%C3%A1zquezauthor=E.+Vargas-D%C3%ADazauthor=L.+G.+Zepeda&title=Efficient+Preparation+of+A-Ketoacetals&doi=10.3390%2Fmolecules171213864"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules171213864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules171213864%26sid%3Dliteratum%253Aachs%26aulast%3DAyala-Mata%26aufirst%3DF.%26aulast%3DBarrera-Mendoza%26aufirst%3DC.%26aulast%3DJim%25C3%25A9nez-V%25C3%25A1zquez%26aufirst%3DH.%2BA.%26aulast%3DVargas-D%25C3%25ADaz%26aufirst%3DE.%26aulast%3DZepeda%26aufirst%3DL.%2BG.%26atitle%3DEfficient%2520Preparation%2520of%2520A-Ketoacetals%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D13864%26epage%3D13878%26doi%3D10.3390%2Fmolecules171213864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of New 2,4-<i>syn</i>-Functionalized (<i>S</i>)-Glutamate Analogues and Structure?Activity Relationship Studies at Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1021/jm301433m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301433m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1614-1628&author=Z.+Assafauthor=A.+P.+Larsenauthor=R.+Venskutonyt%C4%97author=L.+Hanauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=M.+Gajhedeauthor=J.+S.+Kastrupauthor=A.+A.+Jensenauthor=D.+S.+Pickeringauthor=K.+Frydenvangauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+New+2%2C4-syn-Functionalized+%28S%29-Glutamate+Analogues+and+Structure%3FActivity+Relationship+Studies+at+Ionotropic+Glutamate+Receptors+and+Excitatory+Amino+Acid+Transporters&doi=10.1021%2Fjm301433m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm301433m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301433m%26sid%3Dliteratum%253Aachs%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DLarsen%26aufirst%3DA.%2BP.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520New%25202%252C4-syn-Functionalized%2520%2528S%2529-Glutamate%2520Analogues%2520and%2520Structure%253FActivity%2520Relationship%2520Studies%2520at%2520Ionotropic%2520Glutamate%2520Receptors%2520and%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1614%26epage%3D1628%26doi%3D10.1021%2Fjm301433m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Krintel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceravalls de Rabassa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaern, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">L-Asp Is a Useful Tool in the Purification of the Ionotropic Glutamate Receptor A2 Ligand-Binding Domain</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">2422</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span><span class="refDoi"> DOI: 10.1111/febs.12795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1111%2Ffebs.12795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=24673938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=2422-2430&author=C.+Krintelauthor=K.+Frydenvangauthor=A.+Ceravalls+de+Rabassaauthor=A.+M.+Kaernauthor=M.+Gajhedeauthor=D.+S.+Pickeringauthor=J.+S.+Kastrup&title=L-Asp+Is+a+Useful+Tool+in+the+Purification+of+the+Ionotropic+Glutamate+Receptor+A2+Ligand-Binding+Domain&doi=10.1111%2Ffebs.12795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">L-Asp is a useful tool in the purification of the ionotropic glutamate receptor A2 ligand-binding domain</span></div><div class="casAuthors">Krintel, Christian; Frydenvang, Karla; Ceravalls de Rabassa, Anna; Kaern, Anne M.; Gajhede, Michael; Pickering, Darryl S.; Kastrup, Jette S.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2422-2430</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the purifn. of the ionotropic glutamate receptor A2 (GluA2) ligand-binding domain (LBD), L-glutamate-supplemented buffers have previously been used for protein stabilization during the procedure.  This sometimes hampers structural studies of low-affinity ligands, because L-glutamate is difficult to displace, despite extensive dialysis.  Here, the authors show that L-aspartate binds to full-length GluA2 with low affinity (Ki = 0.63 mM) and to the GluA2 LBD with even lower affinity (Ki = 2.6 mM), and they used differential scanning fluorometry to show that L-aspartate was able to stabilize the isolated GluA2 LBD.  The authors also show that L-aspartate can replace L-glutamate during purifn., providing both equal yields and purity of the resulting protein sample.  Furthermore, the authors solved 3 structures of the GluA2 LBD in the presence of 7.5, 50 and 250 mM L-aspartate.  Surprisingly, with 7.5 mM L-aspartate, the GluA2 LBD crystd. as a mixed dimer, with L-glutamate being present in one subunit, and neither L-aspartate nor L-glutamate being present in the other subunit.  Thus, residual L-glutamate was retained from the expression medium.  On the other hand, only L-aspartate was found at the binding site when 50 or 250 mM L-aspartate was used for crystn.  The binding mode obsd. for L-aspartate at the GluA2 LBD was very similar to that described for L-glutamate.  Taking these findings together, The authors showed that L-aspartate could be used instead of L-glutamate for ligand-dependent stabilization of the GluA2 LBD during purifn.  This will enable structural studies of low-affinity ligands for lead optimization in structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqggksXGyeYiLVg90H21EOLACvtfcHk0ljVDvbgqKlt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFemt78%253D&md5=e18cbd794383c1472059058aecf821bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12795%26sid%3Dliteratum%253Aachs%26aulast%3DKrintel%26aufirst%3DC.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DCeravalls%2Bde%2BRabassa%26aufirst%3DA.%26aulast%3DKaern%26aufirst%3DA.%2BM.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DL-Asp%2520Is%2520a%2520Useful%2520Tool%2520in%2520the%2520Purification%2520of%2520the%2520Ionotropic%2520Glutamate%2520Receptor%2520A2%2520Ligand-Binding%2520Domain%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D2422%26epage%3D2430%26doi%3D10.1111%2Ffebs.12795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Naur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Kainate Receptor GluR5 Ligand-Binding Core in Complex with (S)-Glutamate</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span><span class="refDoi"> DOI: 10.1016/j.febslet.2005.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2Fj.febslet.2005.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=15710405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlOnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=1154-1160&author=P.+Naurauthor=B.+Vestergaardauthor=L.+K.+Skovauthor=J.+Egebjergauthor=M.+Gajhedeauthor=J.+S.+Kastrup&title=Crystal+Structure+of+the+Kainate+Receptor+GluR5+Ligand-Binding+Core+in+Complex+with+%28S%29-Glutamate&doi=10.1016%2Fj.febslet.2005.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate</span></div><div class="casAuthors">Naur, Peter; Vestergaard, Bente; Skov, Lars K.; Egebjerg, Jan; Gajhede, Michael; Kastrup, Jette Sandholm</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The x-ray structure of the ligand-binding core of the kainate receptor GluR5 (GluR5-S1S2) in complex with (S)-glutamate was detd. to 1.95 Å resoln.  The overall GluR5-S1S2 structure comprises two domains and is similar to the related AMPA receptor GluR2-S1S2J. (S)-glutamate binds as in GluR2-S1S2J.  Distinct features are obsd. for Ser741, which stabilizes a highly coordinated network of water mols. and forms an interdomain bridge.  The GluR5 complex exhibits a high degree of domain closure (26°) relative to apo GluR2-S1S2J.  In addn., GluR5-S1S2 forms a novel dimer interface with a different arrangement of the two protomers compared to GluR2-S1S2J.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtbs9jrVfsbVg90H21EOLACvtfcHk0ljVDvbgqKlt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlOnsLg%253D&md5=53693a84dad10af87aa0cff370788d8b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2005.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2005.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DNaur%26aufirst%3DP.%26aulast%3DVestergaard%26aufirst%3DB.%26aulast%3DSkov%26aufirst%3DL.%2BK.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Kainate%2520Receptor%2520GluR5%2520Ligand-Binding%2520Core%2520in%2520Complex%2520with%2520%2528S%2529-Glutamate%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D1154%26epage%3D1160%26doi%3D10.1016%2Fj.febslet.2005.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ursby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredslund, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, M. M. G. M.</span><span> </span><span class="NLM_article-title">The Macromolecular Crystallography Beamline I911–3 at the MAX IV Laboratory</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1107/S0909049513011734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0909049513011734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=23765310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsVenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=648-653&author=T.+Ursbyauthor=J.+Ungeauthor=R.+Appioauthor=D.+T.+Loganauthor=F.+Fredslundauthor=C.+Svenssonauthor=K.+Larssonauthor=A.+Labradorauthor=M.+M.+G.+M.+Thunnissen&title=The+Macromolecular+Crystallography+Beamline+I911%E2%80%933+at+the+MAX+IV+Laboratory&doi=10.1107%2FS0909049513011734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The macromolecular crystallography beamline I911-3 at the MAX IV laboratory</span></div><div class="casAuthors">Ursby, Thomas; Unge, Johan; Appio, Roberto; Logan, Derek T.; Fredslund, Folmer; Svensson, Christer; Larsson, Krister; Labrador, Ana; Thunnissen, Marjolein M. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-653</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The macromol. crystallog. beamline I911-3, part of the Cassiopeia/I911 suite of beamlines, is based on a superconducting wiggler at the MAX II ring of the MAX IV Lab. in Lund, Sweden.  The beamline is energy-tunable within a range between 6 and 18 keV.  I911-3 opened for users in 2005.  In 2010-2011 the exptl. station was completely rebuilt and refurbished such that it has become a state-of-the-art exptl. station with better possibilities for rapid throughput, crystal screening and work with smaller samples.  This paper describes the complete I911-3 beamline and how it is embedded in the Cassiopeia suite of beamlines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHrhyNC6OdLLVg90H21EOLACvtfcHk0ljVDvbgqKlt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsVenu7Y%253D&md5=4f204e3c3a4f2b8afe560f3e1b0f30c8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0909049513011734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049513011734%26sid%3Dliteratum%253Aachs%26aulast%3DUrsby%26aufirst%3DT.%26aulast%3DUnge%26aufirst%3DJ.%26aulast%3DAppio%26aufirst%3DR.%26aulast%3DLogan%26aufirst%3DD.%2BT.%26aulast%3DFredslund%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DLarsson%26aufirst%3DK.%26aulast%3DLabrador%26aufirst%3DA.%26aulast%3DThunnissen%26aufirst%3DM.%2BM.%2BG.%2BM.%26atitle%3DThe%2520Macromolecular%2520Crystallography%2520Beamline%2520I911%25E2%2580%25933%2520at%2520the%2520MAX%2520IV%2520Laboratory%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2013%26volume%3D20%26spage%3D648%26epage%3D653%26doi%3D10.1107%2FS0909049513011734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosflm</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powell&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosflm%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lilJPG98XSHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lilJPG98XSHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and Assessment of Data Quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+Assessment+of+Data+Quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lilJPG98XSHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520Assessment%2520of%2520Data%2520Quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljG2h8Vk5tFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Szymańska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras-Sanz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafimoska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span> </span><span class="NLM_article-title">A New Phenylalanine Derivative Acts as an Antagonist at the AMPA Receptor GluA2 and Introduces Partial Domain Closure: Synthesis, Resolution, Pharmacology, and Crystal Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7289</span><span class="NLM_x">–</span> <span class="NLM_lpage">7298</span><span class="refDoi"> DOI: 10.1021/jm200862h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200862h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7289-7298&author=E.+Szyma%C5%84skaauthor=K.+Frydenvangauthor=A.+Contreras-Sanzauthor=D.+S.+Pickeringauthor=E.+Frolaauthor=Z.+Serafimoskaauthor=B.+Nielsenauthor=J.+S.+Kastrupauthor=T.+N.+Johansen&title=A+New+Phenylalanine+Derivative+Acts+as+an+Antagonist+at+the+AMPA+Receptor+GluA2+and+Introduces+Partial+Domain+Closure%3A+Synthesis%2C+Resolution%2C+Pharmacology%2C+and+Crystal+Structure&doi=10.1021%2Fjm200862h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm200862h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200862h%26sid%3Dliteratum%253Aachs%26aulast%3DSzyma%25C5%2584ska%26aufirst%3DE.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DContreras-Sanz%26aufirst%3DA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrola%26aufirst%3DE.%26aulast%3DSerafimoska%26aufirst%3DZ.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26atitle%3DA%2520New%2520Phenylalanine%2520Derivative%2520Acts%2520as%2520an%2520Antagonist%2520at%2520the%2520AMPA%2520Receptor%2520GluA2%2520and%2520Introduces%2520Partial%2520Domain%2520Closure%253A%2520Synthesis%252C%2520Resolution%252C%2520Pharmacology%252C%2520and%2520Crystal%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7289%26epage%3D7298%26doi%3D10.1021%2Fjm200862h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljG2h8Vk5tFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Electronic Ligand Builder and Optimization Workbench (eLBOW): A Tool for Ligand Coordinate and Restraint Generation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=Electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+A+Tool+for+Ligand+Coordinate+and+Restraint+Generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lhRMCzcgM-iXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DElectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520A%2520Tool%2520for%2520Ligand%2520Coordinate%2520and%2520Restraint%2520Generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: A Comprehensive Python-Based System for Macromolecular Structure Solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+Comprehensive+Python-Based+System+for+Macromolecular+Structure+Solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhRMCzcgM-iXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520Comprehensive%2520Python-Based%2520System%2520for%2520Macromolecular%2520Structure%2520Solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valadés, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymańska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span> </span><span class="NLM_article-title">Structural and Pharmacological Characterization of Phenylalanine-Based AMPA Receptor Antagonists at Kainate Receptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span><span class="refDoi"> DOI: 10.1002/cmdc.201100599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1002%2Fcmdc.201100599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1793-1798&author=R.+Venskutonyt%C4%97author=K.+Frydenvangauthor=E.+A.+Valad%C3%A9sauthor=E.+Szyma%C5%84skaauthor=T.+N.+Johansenauthor=J.+S.+Kastrupauthor=D.+S.+Pickering&title=Structural+and+Pharmacological+Characterization+of+Phenylalanine-Based+AMPA+Receptor+Antagonists+at+Kainate+Receptors&doi=10.1002%2Fcmdc.201100599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100599%26sid%3Dliteratum%253Aachs%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DValad%25C3%25A9s%26aufirst%3DE.%2BA.%26aulast%3DSzyma%25C5%2584ska%26aufirst%3DE.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26atitle%3DStructural%2520and%2520Pharmacological%2520Characterization%2520of%2520Phenylalanine-Based%2520AMPA%2520Receptor%2520Antagonists%2520at%2520Kainate%2520Receptors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1793%26epage%3D1798%26doi%3D10.1002%2Fcmdc.201100599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hayward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. A.</span><span> </span><span class="NLM_article-title">Improvements in the Analysis of Domain Motions in Proteins from Conformational Change: DynDom Version 1.50</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/S1093-3263(02)00140-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1016%2FS1093-3263%2802%2900140-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=12463636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Shsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=181-183&author=S.+Haywardauthor=R.+A.+Lee&title=Improvements+in+the+Analysis+of+Domain+Motions+in+Proteins+from+Conformational+Change%3A+DynDom+Version+1.50&doi=10.1016%2FS1093-3263%2802%2900140-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50</span></div><div class="casAuthors">Hayward, Steven; Lee, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-183</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">DynDom is a program that analyses conformational change in proteins for dynamic domains, hinge axes, and hinge-bending regions.  Here, a no. of improvements and addns. are reported which have been implemented in the new version 1.50.  The most significant improvement is in the detn. of the hinge-bending residues.  A new routine also compares quantities relating to the main-chain dihedrals of bending residues with the hinge-bending motion.  This version of the program can now be run from the DynDom website at: http://www.sys.uea.ac.uk/dyndom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Q8EuiL6bC7Vg90H21EOLACvtfcHk0liPm5t8BR27mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Shsb4%253D&md5=0cf86455d3af0b0e7f253d9ed1d1566d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900140-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900140-7%26sid%3Dliteratum%253Aachs%26aulast%3DHayward%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BA.%26atitle%3DImprovements%2520in%2520the%2520Analysis%2520of%2520Domain%2520Motions%2520in%2520Proteins%2520from%2520Conformational%2520Change%253A%2520DynDom%2520Version%25201.50%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2002%26volume%3D21%26spage%3D181%26epage%3D183%26doi%3D10.1016%2FS1093-3263%2802%2900140-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Mayer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2852</span><span class="NLM_x">–</span> <span class="NLM_lpage">2861</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0123-06.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=10.1523%2FJNEUROSCI.0123-06.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=16540562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFKmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2852-2861&author=M.+L.+Mayerauthor=A.+Ghosalauthor=N.+P.+Dolmanauthor=D.+E.+Jane&title=Crystal+Structures+of+the+Kainate+Receptor+GluR5+Ligand+Binding+Core+Dimer+with+Novel+GluR5-Selective+Antagonists&doi=10.1523%2FJNEUROSCI.0123-06.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists</span></div><div class="casAuthors">Mayer, Mark L.; Ghosal, Alokesh; Dolman, Nigel P.; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2852-2861</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Glutamate receptor (GluR) ion channels mediate fast synaptic transmission in the mammalian CNS.  Numerous crystallog. studies, the majority on the GluR2-subtype AMPA receptor, have revealed the structural basis for binding of subtype-specific agonists.  In contrast, because there are far fewer antagonist-bound structures, the mechanisms for antagonist binding are much less well understood, particularly for kainate receptors that exist as multiple subtypes with a distinct biol. encoded by the GluR5-7, KA1, and KA2 genes.  We describe here high-resoln. crystal structures for the GluR5 ligand-binding core complex with UBP302 and UBP310, novel GluR5-selective antagonists.  The crystal structures reveal the structural basis for the high selectivity for GluR5 obsd. in radiolabel displacement assays for the isolated ligand binding cores of the GluR2, GluR5, and GluR6 subunits and during inhibition of glutamate-activated currents in studies on full-length ion channels.  The antagonists bind via a novel mechanism and do not form direct contacts with the E723 side chain, as occurs in all previously solved AMPA and kainate receptor agonist and antagonist complexes.  This results from a hyperextension of the ligand binding core compared with previously solved structures.  As a result, in dimer assemblies, there is a 22 Å extension of the ion channel linkers in the transition from antagonist- to glutamate-bound forms.  This large conformational change is substantially different from that described for AMPA receptors, was not possible to predict from previous work, and suggests that glutamate receptors are capable of much larger movements than previously thought.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkS4TUumki7Vg90H21EOLACvtfcHk0liPm5t8BR27mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFKmtLs%253D&md5=5a880d1af759237096a2919d856d5e2a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0123-06.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0123-06.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DDolman%26aufirst%3DN.%2BP.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Kainate%2520Receptor%2520GluR5%2520Ligand%2520Binding%2520Core%2520Dimer%2520with%2520Novel%2520GluR5-Selective%2520Antagonists%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D2852%26epage%3D2861%26doi%3D10.1523%2FJNEUROSCI.0123-06.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N0T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N0T','PDB','1N0T'); return false;">PDB: 1N0T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTJ','PDB','1FTJ'); return false;">PDB: 1FTJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FTL','PDB','1FTL'); return false;">PDB: 1FTL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FW0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FW0','PDB','1FW0'); return false;">PDB: 1FW0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E0X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E0X','PDB','4E0X'); return false;">PDB: 4E0X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TZA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TZA','PDB','3TZA'); return false;">PDB: 3TZA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DLD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DLD','PDB','4DLD'); return false;">PDB: 4DLD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F36" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F36','PDB','2F36'); return false;">PDB: 2F36</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMA','PDB','4YMA'); return false;">PDB: 4YMA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMB','PDB','4YMB'); return false;">PDB: 4YMB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00750">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67688"></div></div></div></div></div><hr /></hr><p class="last">Crystal data and data collection statistics of GluA2-LBD in complex with <b>2d</b> and the ligand binding domain of GluA2 in complex with <b>2d</b>(PDF). SMILES data (CSV). The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00750">10.1021/acs.jmedchem.5b00750</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00750/suppl_file/jm5b00750_si_001.pdf">jm5b00750_si_001.pdf (369.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00750/suppl_file/jm5b00750_si_002.csv">jm5b00750_si_002.csv (3.89 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors have been deposited in the Protein Data Bank: GluA2-LBD with <b>2e</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMA">4YMA</a>) and GluK1-LBD with <b>2f</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMB">4YMB</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00750&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00750%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-15" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00750" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799646989313bf8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
